General Information of Disease (ID: DISK5QGC)

Disease Name Arteriosclerosis
Synonyms vascular sclerosis; cardiovascular arteriosclerosis; arteriosclerotic vascular disease; arteriosclerotic cardiovascular disease; arteriosclerosis; arterial sclerosis
Disease Class BD40: Arterial occlusive disease
Definition A vascular disorder characterized by thickening and hardening of the walls of the arteries.
Disease Hierarchy
DISLG4XS: Arterial disorder
DISK5QGC: Arteriosclerosis
ICD Code
ICD-11
ICD-11: BD40
ICD-9
ICD-9: 440
Expand ICD-11
'BD40.Z
Expand ICD-9
440
Disease Identifiers
MONDO ID
MONDO_0002277
MESH ID
D001161
UMLS CUI
C0003850
MedGen ID
2076
HPO ID
HP:0002634
SNOMED CT ID
107671003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 8 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Acipimox DMQWGID Approved Small molecular drug [1]
Atorvastatin DMF28YC Approved Small molecular drug [2]
Fluvastatin DM4MDJY Approved Small molecular drug [3]
Lovastatin DM9OZWQ Approved Small molecular drug [4]
Pravastatin DM6A0X7 Approved Small molecular drug [5]
Rosuvastatin DMMIQ7G Approved Small molecular drug [6]
Simvastatin DM30SGU Approved Small molecular drug [7]
LAROPIPRANT DM5FABJ Phase 4 Small molecular drug [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
This Disease is Treated as An Indication in 24 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Anacetrapib DMP2BFG Phase 3 Small molecular drug [9]
LY2157299 DMP8HW1 Phase 2/3 Small molecular drug [10]
PACTIMIBE DM0NZDT Phase 2/3 Small molecular drug [11]
CSL-112 DMZCG91 Phase 2 NA [12]
DRL-17822 DMGD3XT Phase 2 NA [13]
DVC1-0101 DMUGBQK Phase 2 NA [14]
K-134 DMD4OK0 Phase 2 Small molecular drug [15]
K-604 DMQVN6P Phase 2 Small molecular drug [16]
LY3012212 DMRVEHY Phase 2 NA [17]
MK-1903 DMVJB09 Phase 2 Small molecular drug [18]
PRC-4016 DMIPYUU Phase 2 NA [19]
Revacept DMJ37UX Phase 2 NA [20]
VB-201 DMGJR0Y Phase 2 NA [21]
ATL-313 DM75QY9 Phase 1/2 Small molecular drug [22]
ATR-101 DMUMVXK Phase 1 Small molecular drug [23]
BAY-60-5521 DMXIDWE Phase 1 NA [24]
BMS-779788 DMKR8S1 Phase 1 NA [25]
BMS-852927 DMZS1D2 Phase 1 NA [26]
CS-8080 DMRH740 Phase 1 NA [27]
LXR 623 DM3OP41 Phase 1 Small molecular drug [28]
MDCO-216 DMAQ24G Phase 1 NA [29]
Rilapladib DMB9861 Phase 1 Small molecular drug [30]
SLV-342 DMB3TCN Phase 1 NA [31]
XL-041 DMYSQHT Phase 1 NA [32]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 Drug(s)
This Disease is Treated as An Indication in 1 Patented Agent(s)
Drug Name Drug ID Highest Status Drug Type REF
Quinazoline derivative 13 DMFU6OD Patented Small molecular drug [33]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 67 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Acifran DM2DJTA Discontinued in Phase 3 Small molecular drug [34]
Darapladib DMSWLA3 Discontinued in Phase 3 Small molecular drug [35]
CETi-1 DMUG5OB Discontinued in Phase 2 Vaccine [36]
ET-642 DMOLMIR Discontinued in Phase 2 NA [37]
FCP-3P1 DMTQLIJ Discontinued in Phase 2 Small molecular drug [38]
Gantofiban DMHAM2J Discontinued in Phase 2 Small molecular drug [39]
Lifibrol DMLN81Q Discontinued in Phase 2 Small molecular drug [40]
SQ-32709 DMSQRXW Discontinued in Phase 2 Small molecular drug [41]
TA-7552 DML9OOY Discontinued in Phase 2 Small molecular drug [42]
AC3056 DM54W9A Discontinued in Phase 1 NA [43]
APP-018 DM5L9I2 Discontinued in Phase 1 NA [44]
CL-277082 DMSB7WV Discontinued in Phase 1 Small molecular drug [45]
CP-800569 DMZ0YU7 Discontinued in Phase 1 Small molecular drug [46]
F-1394 DMPC9K3 Discontinued in Phase 1 Small molecular drug [47]
Goxalapladib DMSGUY9 Discontinued in Phase 1 Small molecular drug [48]
GR-328713 DMUANK9 Discontinued in Phase 1 NA [49]
GSK568859 DM6E84O Discontinued in Phase 1 NA [50]
LF-08-0133 DMCMFXG Discontinued in Phase 1 NA [51]
LG-101280 DM0PXGU Discontinued in Phase 1 NA [52]
NICANARTINE DM8Z1I1 Discontinued in Phase 1 Small molecular drug [53]
P-0654 DMAL727 Discontinued in Phase 1 NA [54]
PF-3052334 DMOQZIW Discontinued in Phase 1 Small molecular drug [55]
PF-3185043 DMCFYZM Discontinued in Phase 1 NA [56]
PF-3491165 DMAZD66 Discontinued in Phase 1 NA [57]
PF-807925 DMQLWBO Discontinued in Phase 1 NA [58]
RG7418 DMXRHDL Discontinued in Phase 1 NA [59]
RUS 3108 DMSHYAP Discontinued in Phase 1 NA [60]
SB-435495 DM92BXN Discontinued in Phase 1 NA [61]
2164U90 DMIERIG Terminated NA [66]
AL-0671 DMRYJ40 Terminated NA [67]
Astenose DMROJZY Terminated NA [68]
B-5354a DM8I5UF Terminated NA [69]
Barixibat DM8PDTZ Terminated Small molecular drug [70]
BB-476 DM948BN Terminated NA [71]
BIBB-515 DM6QT9P Terminated Small molecular drug [72]
BIBX-79 DMRXWCO Terminated Small molecular drug [73]
Bio-Flow DM01LX4 Terminated NA [74]
CGP-43371 DMI63CY Terminated Small molecular drug [75]
CGS-23425 DMAPCI2 Terminated Small molecular drug [76]
CGS-24565 DM6SAIL Terminated Small molecular drug [77]
Cholazol DMPLKKV Terminated NA [78]
CI-999 DMV1J0P Terminated NA [79]
CP-230821 DMGT4YC Terminated NA [80]
CP-83101 DMSOT07 Terminated Small molecular drug [81]
F-12509A DM3786U Terminated NA [82]
F-2833 DM3BZ8D Terminated Small molecular drug [83]
FR-129169 DM9V6AU Terminated NA [84]
FR-145237 DMHV43M Terminated NA [85]
GT-16-239 DMA6RL2 Terminated NA [86]
IL1aQb DMKS4Z9 Terminated Vaccine [87]
INCB3344 DMW39DV Terminated Small molecular drug [88]
LF-13-0491c DM7ZDXJ Terminated NA [89]
LF-7-0165c DMU8MP0 Terminated NA [90]
MDL-29311 DMNK0HO Terminated Small molecular drug [91]
NTE-122 DMU3D1K Terminated NA [92]
PD-146176 DMHQSF8 Terminated Small molecular drug [93]
RP-73163 DMO3FYI Terminated Small molecular drug [94]
RPR-101821 DM21Y75 Terminated NA [95]
S-12340 DMFHXPF Terminated Small molecular drug [96]
SDZ-267-489 DMOR0MU Terminated NA [97]
Squalestatin 1 DM4JZPT Terminated Small molecular drug [98]
SR12813 DMU2ZVY Terminated Small molecular drug [99]
T-686 DMOGQ2L Terminated Small molecular drug [100]
TA-993 DM4J05S Terminated Small molecular drug [101]
TEI-6522 DMHS5DX Terminated NA [102]
WAY-121898 DM9W6HC Terminated Small molecular drug [103]
ZD-9720 DMFV47R Terminated NA [104]
------------------------------------------------------------------------------------
⏷ Show the Full List of 67 Drug(s)
This Disease is Treated as An Indication in 4 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BAY-38-1315 DMVESTF Preclinical Small molecular drug [62]
ETX-6107 DMM762F Preclinical NA [63]
HL-004 DMRE52S Preclinical NA [64]
Quinoxaline DMNB13U Preclinical Small molecular drug [65]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 23 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
2NTX-99 DMJLPVZ Investigative Small molecular drug [19]
Adiponectin mimetics DMOBKEX Investigative NA [19]
AG-4070 DM7BQRS Investigative NA [19]
AM-1101 DM6MB9R Investigative NA [19]
Apovasc DMKSE04 Investigative NA [19]
ARI-1778 DMII6FZ Investigative NA [19]
BAY-1006451 DM8RXPP Investigative NA [19]
BMS-753951 DMB7LV3 Investigative NA [19]
GSK-1344386B DMHBUG5 Investigative NA [105]
GX-401 DMXLB17 Investigative NA [19]
HL-135 DMWBII1 Investigative NA [19]
ICI-245991 DMKOEF4 Investigative NA [19]
Integrin alpha-V/beta-3 receptor mab DMF1CF2 Investigative NA [19]
INV-400 DMMAWGZ Investigative NA [19]
KM-011 DMKDKQ8 Investigative NA [19]
KY-382 DMA9VBD Investigative NA [106]
MK-6892 DMR9C4Q Investigative Small molecular drug [107]
Radiolabeled VEGF DMUIRUW Investigative NA [19]
RP-805 DM8GFGZ Investigative NA [19]
RXP-470 DM5GIUY Investigative NA [108]
SCH-602539 DMRDM9S Investigative Small molecular drug [109]
TGFTX-1 DMUFX4F Investigative NA [19]
VULM-1457 DMWRX4T Investigative NA [106]
------------------------------------------------------------------------------------
⏷ Show the Full List of 23 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 565 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ADAMTS4 TTYG6BU Limited Altered Expression [110]
ANGPT2 TTKLQTJ Limited Biomarker [111]
ANGPTL3 TT59GO7 Limited Altered Expression [112]
BIRC3 TTAIWZN Limited Biomarker [113]
BMP2 TTP3IGX Limited Biomarker [114]
CCL21 TTLZK1U Limited Biomarker [115]
CCL5 TT9DWLC Limited Altered Expression [116]
CD47 TT28S46 Limited Biomarker [117]
CD59 TTBGTEJ Limited Biomarker [118]
CFH TTUW6OP Limited Genetic Variation [119]
CHRM3 TTQ13Z5 Limited Biomarker [120]
CTH TTLQUZS Limited Biomarker [121]
CXCL1 TTLK1RW Limited Altered Expression [122]
DKK1 TTE3RAC Limited Biomarker [123]
DKK3 TTY2ZV6 Limited Biomarker [124]
ENTPD1 TTYM8DJ Limited Altered Expression [125]
EPHX2 TT7WVHI Limited Genetic Variation [126]
F10 TTCIHJA Limited Biomarker [127]
FCGR2A TTXT21W Limited Genetic Variation [128]
FCGR3A TTIFOC0 Limited Biomarker [129]
FPR2 TTOJ1NF Limited Biomarker [130]
FURIN TTH9WF6 Limited Biomarker [131]
GCH1 TTLSWP6 Limited Biomarker [132]
GHSR TTWDC17 Limited Biomarker [133]
GP6 TTTJUVZ Limited Biomarker [134]
GZMB TTKEPHX Limited Biomarker [135]
HMGA1 TTBA219 Limited Biomarker [136]
HMGCR TTPADOQ Limited Altered Expression [137]
IDO1 TTZJYKH Limited Biomarker [138]
IL15 TTJFA35 Limited Genetic Variation [139]
IL17D TTC5LTG Limited Genetic Variation [140]
IL23R TT6H4QR Limited Biomarker [141]
IL25 TTVMO5W Limited Biomarker [142]
IL9 TT0JTFD Limited Biomarker [143]
IRAK1 TTXAJWN Limited Biomarker [144]
IRF8 TTHUBNK Limited Biomarker [145]
IRS2 TTF95B8 Limited Biomarker [146]
JUP TTREN0G Limited Biomarker [147]
KDR TTUTJGQ Limited Biomarker [148]
LIPA TTS8T1M Limited Biomarker [149]
LTB4R TTN53ZF Limited Biomarker [150]
MAP3K5 TTOQCD8 Limited Biomarker [151]
MFGE8 TT1GLAJ Limited Genetic Variation [152]
MSR1 TT2TDH9 Limited Altered Expression [153]
NPC1L1 TTPD1CN Limited Biomarker [154]
PKM TT4LOT8 Limited Altered Expression [155]
PTAFR TTQL5VC Limited Biomarker [156]
PTGIR TTOFYT1 Limited Biomarker [157]
PTGS1 TT8NGED Limited Biomarker [158]
RBP4 TT0C8BY Limited Biomarker [159]
RPS6KA1 TTIXKA4 Limited Biomarker [160]
S100A8 TT4AF6N Limited Biomarker [161]
S1PR1 TT9JZCK Limited Biomarker [162]
SCD TT6RIOV Limited Altered Expression [163]
SERPINA1 TTA7UJC Limited Biomarker [164]
SERPINF1 TTR59S1 Limited Altered Expression [165]
SIRT3 TTVZLIJ Limited Biomarker [166]
SIRT6 TTUXYWF Limited Biomarker [167]
SLC33A1 TTL69WB Limited Biomarker [168]
SLC9A1 TTGSEFH Limited Altered Expression [169]
SMPD1 TTJTM88 Limited Biomarker [170]
SOCS1 TT8COJM Limited Biomarker [171]
THBD TTAPV67 Limited Altered Expression [172]
TLR7 TTRJ1K4 Limited Altered Expression [173]
TNFRSF12A TTKPS7V Limited Biomarker [174]
TNFRSF13C TT7NJSE Limited Biomarker [175]
TNFSF12 TTBTDM1 Limited Biomarker [176]
TNFSF15 TTEST6I Limited Genetic Variation [177]
VKORC1 TTEUC8H Limited Genetic Variation [178]
GPBAR1 TTSDVTR Disputed Altered Expression [179]
HBEGF TT15SL0 Disputed Altered Expression [180]
IGFBP7 TTUQ01B Disputed Biomarker [181]
IRF3 TTYR7OH Disputed Biomarker [182]
NAGLU TTDM6HZ Disputed Biomarker [183]
OSCAR TT71Q5Y Disputed Altered Expression [184]
SFRP4 TTX8I1Y Disputed Altered Expression [185]
TNFSF11 TT9E8HR Disputed Biomarker [186]
TNFSF14 TTKVENM Disputed Biomarker [187]
ABCG5 TTKZ7WY moderate Altered Expression [188]
ACAT1 TTK3C21 moderate Biomarker [189]
ACKR1 TTKY2NS moderate Biomarker [190]
ACLY TT0Z6Y2 moderate Biomarker [191]
ALDH2 TTFLN4T moderate Biomarker [192]
ANPEP TTPHMWB moderate Biomarker [193]
ANXA1 TTUCK4B moderate Biomarker [194]
BTLA TTER58P moderate Biomarker [195]
CASP1 TTCQIBE moderate Biomarker [196]
CCL23 TTHAPJK moderate Biomarker [197]
CD163 TTTZ9DE moderate Biomarker [198]
CLU TTRL76H moderate Biomarker [199]
CTSS TTUMQVO moderate Biomarker [200]
CXCR6 TT2BVUA moderate Biomarker [201]
EHMT1 TTOFXD7 moderate Genetic Variation [202]
ELANE TTPLTSQ moderate Biomarker [203]
GJA4 TTQO1VY moderate Genetic Variation [204]
IL23A TTC1GLB moderate Altered Expression [205]
INSR TTCBFJO moderate Biomarker [206]
LANCL1 TTZW8NS moderate Genetic Variation [207]
LRP6 TTSXOWE moderate Biomarker [208]
MMP1 TTMX39J moderate Biomarker [209]
MYD88 TTB6Q2O moderate Biomarker [210]
NPEPPS TT371QC moderate Biomarker [211]
NPY TT64REZ moderate Altered Expression [212]
PADI4 TTQHAXM moderate Biomarker [213]
PCSK9 TTNIZ2B moderate Biomarker [214]
PPARD TT2JWF6 moderate Biomarker [215]
PTK2B TTTEFBV moderate Biomarker [216]
REN TTB2MXP moderate Biomarker [217]
SLC11A2 TT2IS7P moderate Biomarker [218]
SOST TTYRO4F moderate Biomarker [123]
TNFRSF9 TTPW9LJ moderate Biomarker [219]
TRAF6 TTCDR6M moderate Biomarker [220]
TXN TTZJ5U9 moderate Altered Expression [221]
ABCA4 TTLB52K Strong Biomarker [222]
ACE2 TTUI5H7 Strong Biomarker [223]
ACKR3 TTRQJTC Strong Biomarker [224]
ADAM10 TTVXEGU Strong Biomarker [225]
ADAM17 TT6AZXG Strong Biomarker [226]
ADAM33 TTQICM2 Strong Biomarker [227]
ADAM9 TTTYQNS Strong Altered Expression [228]
ADAMTS1 TTS2TEI Strong Biomarker [229]
ADAMTS13 TTUREBK Strong Biomarker [230]
ADAMTS5 TTXSU2Y Strong Biomarker [231]
ADK TTL732K Strong Biomarker [232]
ADM2 TTM642F Strong Biomarker [233]
ADRA1A TTNGILX Strong Biomarker [224]
ADRA2B TTWM4TY Strong Biomarker [224]
ADRB3 TTMXGCW Strong Genetic Variation [234]
AGRP TT4DE1O Strong Biomarker [235]
AGTR2 TTQVOEI Strong Biomarker [236]
AHCY TTE2KUJ Strong Biomarker [237]
AIMP2 TTXWHGF Strong Altered Expression [238]
AKR1B1 TTFBNVI Strong Altered Expression [239]
ALOX5AP TTDMBF5 Strong Genetic Variation [240]
ALPL TTMR5UV Strong Altered Expression [241]
AMOT TTI48OS Strong Posttranslational Modification [242]
ANGPT1 TTWNQ1T Strong Biomarker [243]
ANGPTL4 TTWALY5 Strong Biomarker [244]
ANXA5 TT2Z83I Strong Biomarker [245]
AOC3 TT7HC21 Strong Biomarker [246]
APCS TTB7VAT Strong Biomarker [247]
APLN TT87D3J Strong Biomarker [248]
APOA4 TTNC3WS Strong Biomarker [249]
APOH TT2OUI9 Strong Biomarker [250]
AQP1 TTSF1KH Strong Biomarker [251]
ARG1 TT7ZQEV Strong Altered Expression [252]
ARSB TTESQTG Strong Altered Expression [253]
ATF4 TTQCKWT Strong Altered Expression [254]
ATG7 TTLVB9Z Strong Genetic Variation [255]
ATIC TT9NVXQ Strong Biomarker [256]
AZGP1 TTUPYLV Strong Biomarker [257]
BACE1 TTJUNZF Strong Altered Expression [258]
BDKRB2 TTGY8IW Strong Altered Expression [259]
BECN1 TT5M7LN Strong Biomarker [260]
BRD7 TT07ZS1 Strong Biomarker [261]
BRS3 TTKYEPM Strong Biomarker [224]
BSG TT5UJWD Strong Biomarker [262]
C1QBP TTWTD7F Strong Altered Expression [263]
CA1 TTHQPL7 Strong Biomarker [264]
CA2 TTANPDJ Strong Genetic Variation [265]
CACNA1C TTZIFHC Strong Biomarker [266]
CAD TT2YT1K Strong Genetic Variation [267]
CAMKK2 TTV298Y Strong Biomarker [268]
CAPN1 TT1WBIJ Strong Altered Expression [269]
CBS TTVZJ7G Strong Biomarker [270]
CCL17 TTMPHAE Strong Altered Expression [271]
CCL22 TTBTWI1 Strong Biomarker [272]
CCR2 TTFZYTO Strong Biomarker [273]
CCR3 TTD3XFU Strong Altered Expression [274]
CCR5 TTJIH8Q Strong Biomarker [275]
CCR8 TTE836A Strong Biomarker [276]
CCR9 TTIPS8B Strong Biomarker [277]
CD248 TTYJWT7 Strong Biomarker [278]
CD27 TTDO1MV Strong Biomarker [279]
CD69 TTPQE9F Strong Altered Expression [280]
CD70 TTNCIE0 Strong Biomarker [281]
CD74 TTCMYP9 Strong Biomarker [282]
CDH5 TTXLCFO Strong Biomarker [283]
CDK9 TT1LVF2 Strong Biomarker [284]
CEACAM1 TTA9CK4 Strong Biomarker [285]
CEL TTTRNQW Strong Biomarker [286]
CES1 TTMF541 Strong Biomarker [287]
CHIT1 TTDYX6T Strong Biomarker [288]
CIT TT3BKTU Strong Biomarker [289]
CLCF1 TTI6V13 Strong Biomarker [290]
CLCN2 TT30NW6 Strong Biomarker [291]
CLEC6A TTQ02HK Strong Genetic Variation [292]
CLEC9A TTGUSRB Strong Altered Expression [293]
CLIC1 TT8KZG6 Strong Altered Expression [294]
CMKLR1 TT4UGZL Strong Biomarker [295]
CNP TT71P0H Strong Biomarker [296]
CNR2 TTMSFAW Strong Biomarker [297]
COL1A2 TTUABC1 Strong Biomarker [298]
COPS5 TTSTNJR Strong Biomarker [299]
CR1 TTEA8OW Strong Genetic Variation [300]
CRK TTFEUYR Strong Altered Expression [238]
CRY1 TT5MLZR Strong Altered Expression [301]
CSF2RB TTPYS82 Strong Biomarker [302]
CTPS1 TTN12BZ Strong Biomarker [303]
CTSC TT4H0V2 Strong Altered Expression [304]
CTSD TTPT2QI Strong Biomarker [305]
CTSG TTQAJF1 Strong Biomarker [306]
CTSK TTDZN01 Strong Biomarker [307]
CX3CR1 TT2T98G Strong Biomarker [308]
CXCL2 TTZF0K2 Strong Altered Expression [309]
CXCR4 TTBID49 Strong Biomarker [310]
CYBB TT5T8MR Strong Altered Expression [311]
CYP1A2 TTS1DTU Strong Biomarker [312]
CYP26A1 TTD7Q0R Strong Biomarker [313]
CYP2B6 TTMH124 Strong Genetic Variation [314]
CYP2J2 TTNE1C7 Strong Biomarker [315]
CYP3A5 TTHS0OK Strong Genetic Variation [316]
CYSLTR1 TTGKOY9 Strong Altered Expression [317]
DCLK3 TTMYK4Z Strong Biomarker [292]
DDR1 TTI1FPZ Strong Biomarker [318]
DDR2 TTU98HG Strong Altered Expression [319]
DEFB4A TTIVY12 Strong Biomarker [320]
DGAT1 TT0GV3R Strong Biomarker [321]
DHCR24 TTTK0NH Strong Biomarker [322]
DLL4 TTV23LH Strong Biomarker [323]
DNASE1 TTYWGOJ Strong Biomarker [324]
DPP8 TTJGLZF Strong Biomarker [325]
DPP9 TTNDUL7 Strong Biomarker [325]
DUSP1 TTG8HIM Strong Biomarker [326]
DUSP5 TTZN92A Strong Altered Expression [327]
ECE2 TT5U914 Strong Genetic Variation [328]
EGFL7 TT7WD0H Strong Altered Expression [329]
EGR1 TTE8LGD Strong Altered Expression [330]
ENG TTB30LE Strong Biomarker [331]
EPHA1 TTLFZVU Strong Biomarker [332]
EPHA2 TTRJB2G Strong Biomarker [333]
EREG TTYSB89 Strong Altered Expression [334]
ERN1 TTKIAT3 Strong Biomarker [335]
F11 TTDM4ZU Strong Biomarker [336]
F11R TT3C8EG Strong Genetic Variation [337]
F12 TTRJSMV Strong Biomarker [338]
F2RL1 TTQR74A Strong Altered Expression [339]
F5 TT1O264 Strong Genetic Variation [340]
FABP3 TT3TGLR Strong Biomarker [341]
FABP5 TTNT2S6 Strong Biomarker [342]
FADS2 TTT2VDU Strong Altered Expression [343]
FBXO3 TTUX14L Strong Biomarker [344]
FCGR2B TT5RWKQ Strong Biomarker [345]
FDPS TTIKWV4 Strong Biomarker [346]
FFAR1 TTB8FUC Strong Biomarker [347]
FFAR4 TT08JVB Strong Biomarker [347]
FGF1 TTMY81X Strong Altered Expression [348]
FGF19 TTGCH11 Strong Biomarker [349]
FN1 TTPJ921 Strong Biomarker [350]
FOLR2 TTT54CI Strong Biomarker [351]
FOXP3 TT1X3QF Strong Biomarker [352]
FSTL3 TTWRPM8 Strong Biomarker [353]
FTH1 TT975ZT Strong Biomarker [354]
FTO TTFW3BT Strong Biomarker [355]
FUT3 TTUPAD7 Strong Biomarker [356]
FYN TT2B9KF Strong Biomarker [357]
G3BP1 TTG0R8Z Strong Biomarker [358]
GAS6 TT69QD2 Strong Biomarker [359]
GCG TT6Y4PN Strong Genetic Variation [202]
GCGR TT9O6WS Strong Biomarker [360]
GCK TTDLNGZ Strong Biomarker [361]
GCLM TTNFESW Strong Genetic Variation [362]
GDF15 TT4MXVG Strong Biomarker [363]
GDF2 TTAP4T1 Strong Biomarker [364]
GHRHR TTG4R8V Strong Genetic Variation [365]
GHRL TT1OCL0 Strong Genetic Variation [133]
GIP TT40HS5 Strong Altered Expression [366]
GJA5 TTFQKZ7 Strong Altered Expression [367]
GLP1R TTVIMDE Strong Genetic Variation [202]
GLRX TTRJCNG Strong Biomarker [368]
GP1BA TTVB0Q9 Strong Biomarker [369]
GPER1 TTDSB34 Strong Biomarker [370]
GPR119 TT7QNVC Strong Altered Expression [371]
GPR39 TTTPCNU Strong Biomarker [372]
GPR55 TTNET8J Strong Biomarker [373]
GREM1 TTOUZN5 Strong Biomarker [374]
GSTO1 TTWO3SH Strong Biomarker [375]
HAL TTXQOZW Strong Genetic Variation [376]
HCAR2 TTWNV8U Strong Biomarker [377]
HCAR3 TT8WFXV Strong Biomarker [378]
HDAC3 TT4YWTO Strong Biomarker [379]
HDAC5 TTUELN5 Strong Biomarker [380]
HDAC9 TT8M4E1 Strong Altered Expression [381]
HDC TTV9GOF Strong Altered Expression [382]
HEXIM1 TTFOKAH Strong Biomarker [383]
HMGB1 TTWQYB7 Strong Biomarker [384]
HP TTLC8E1 Strong Genetic Variation [385]
HPSE TTR7GJO Strong Biomarker [386]
HRH1 TTTIBOJ Strong Altered Expression [387]
HRH2 TTQHJ1K Strong Biomarker [388]
HSPA5 TTW26OG Strong Biomarker [389]
HSPB3 TTLH8WG Strong Altered Expression [390]
HSPB8 TTY0OJN Strong Biomarker [391]
HTATIP2 TTC6IX5 Strong Biomarker [392]
ID1 TTBXVDE Strong Biomarker [393]
IGF2R TTPNE41 Strong Biomarker [206]
IGFBP1 TTCJTWF Strong Biomarker [394]
IGFBP5 TTDWEA8 Strong Biomarker [395]
IKBKB TTJ3E9X Strong Altered Expression [396]
IL17A TTG0MT6 Strong Altered Expression [352]
IL19 TT87RWS Strong Genetic Variation [397]
IL1A TTPM6HI Strong Altered Expression [398]
IL1RL1 TT4GZA4 Strong Biomarker [399]
IL20 TTNZMY2 Strong Biomarker [400]
IL33 TT5MD4P Strong Biomarker [401]
IL37 TTQTX98 Strong Biomarker [402]
IL5 TTPREZD Strong Biomarker [403]
INPP5D TTTP2Z1 Strong Biomarker [404]
IRAK4 TTILUKB Strong Genetic Variation [405]
IRF1 TT4TU3L Strong Biomarker [406]
ITGA5 TTHIZP9 Strong Biomarker [407]
ITGAE TTH0Z37 Strong Biomarker [408]
ITGAL TT48WR6 Strong Biomarker [409]
ITGAV TTT1R2L Strong Altered Expression [410]
ITGB2 TTIJWR7 Strong Biomarker [409]
ITGB3 TTJA1ZO Strong Biomarker [411]
ITPR1 TT5HWAT Strong Altered Expression [412]
ITPR2 TTK9OV3 Strong Altered Expression [412]
ITPR3 TTH1769 Strong Altered Expression [412]
KCNJ11 TT329V4 Strong Genetic Variation [413]
KDM4A TTZHPB8 Strong Biomarker [414]
KDM6B TTDIJUQ Strong Biomarker [415]
KHDRBS1 TTAT6C7 Strong Biomarker [416]
KISS1R TT3KBZY Strong Biomarker [417]
KLF4 TTTI53X Strong Altered Expression [367]
KLK1 TT5T3P6 Strong Biomarker [418]
KLRG1 TT299E6 Strong Altered Expression [142]
KLRK1 TTLRN4A Strong Altered Expression [419]
LAG3 TTNVXAW Strong Genetic Variation [420]
LAIR1 TTSI7A8 Strong Biomarker [421]
LBP TTVQJLY Strong Biomarker [422]
LCAT TTGZ91P Strong Biomarker [423]
LCN2 TTKTLAI Strong Biomarker [424]
LGMN TTPTWV5 Strong Biomarker [425]
LILRB4 TTREOKA Strong Biomarker [426]
LIPE TTLUQ8E Strong Genetic Variation [427]
LIPG TTHSZXO Strong Biomarker [428]
LOX TTQHNAM Strong Biomarker [429]
LPAR1 TTQ6S1K Strong Biomarker [430]
LPAR2 TTB7Y8I Strong Biomarker [224]
LPAR4 TT7ZMY4 Strong Biomarker [431]
LRP2 TTPH1AJ Strong Biomarker [432]
LRP5 TT7VMG4 Strong Biomarker [433]
LRRC32 TT0FAYT Strong Altered Expression [434]
LTA TTP73TM Strong Biomarker [435]
LTA4H TTXZEAJ Strong Biomarker [436]
LTB TTHQ6US Strong Biomarker [437]
LTB4R2 TTVJX54 Strong Biomarker [438]
LYZ TTAOZBW Strong Biomarker [439]
MAOA TT3WG5C Strong Biomarker [440]
MAP3K10 TT9FN4J Strong Altered Expression [441]
MAP4K4 TT6NI13 Strong Biomarker [442]
MAPK14 TTQBR95 Strong Altered Expression [238]
MAPK7 TTU6FSC Strong Biomarker [160]
MAPK9 TT3IVG2 Strong Genetic Variation [443]
MARK2 TTAJ45Y Strong Biomarker [444]
MAS1 TTOISYB Strong Biomarker [223]
MAZ TT059DA Strong Biomarker [445]
MBTPS1 TTNSM2I Strong Biomarker [446]
MC1R TT0MV2T Strong Biomarker [447]
MC4R TTD0CIQ Strong Genetic Variation [448]
MCAM TTHRE05 Strong Biomarker [449]
MERTK TTO7LKR Strong Biomarker [450]
MGLL TTZ963I Strong Biomarker [451]
MMP10 TTXLEG7 Strong Altered Expression [452]
MMP11 TTZW4MV Strong Biomarker [453]
MMP12 TTXZ0KQ Strong Biomarker [454]
MMP13 TTHY57M Strong Biomarker [455]
MMP14 TTJ4QE7 Strong Altered Expression [456]
MMP17 TTVSZKN Strong Biomarker [457]
MMP8 TTGA1IV Strong Biomarker [458]
MRC1 TTKV8W5 Strong Biomarker [459]
MST1R TTBQ3OC Strong Biomarker [460]
MSTN TTM8I2X Strong Biomarker [461]
MTTP TTUS1RD Strong Biomarker [462]
MYLK TT18ETS Strong Altered Expression [463]
NAAA TTMN4HY Strong Biomarker [464]
NCF1 TTZ4JC3 Strong Biomarker [465]
NEDD4 TT1QU6G Strong Altered Expression [466]
NFKB2 TTKLNRV Strong Biomarker [467]
NISCH TT789FN Strong Biomarker [468]
NLRP3 TT4EN8X Strong Biomarker [469]
NNT TTKIH76 Strong Biomarker [470]
NOD1 TTYSRXM Strong Biomarker [471]
NOP2 TTBLG3H Strong Biomarker [472]
NOTCH4 TTXDIK2 Strong Altered Expression [473]
NOX4 TTQRBSJ Strong Biomarker [474]
NPPB TTY63XT Strong Biomarker [296]
NPPC TTRK0B9 Strong Altered Expression [475]
NR1H3 TTECBXN Strong Altered Expression [476]
NR1H4 TTS4UGC Strong Biomarker [477]
NR1I2 TT7LCTF Strong Biomarker [444]
NR4A1 TTMXE2Q Strong Altered Expression [280]
NR4A3 TTJQB49 Strong Biomarker [478]
NR5A2 TTAU3SY Strong Genetic Variation [479]
NRG4 TTWAGKJ Strong Altered Expression [480]
OLR1 TTKSND3 Strong Biomarker [481]
OPRK1 TTQW87Y Strong Altered Expression [482]
OSM TTIVXSE Strong Biomarker [483]
OSMR TTAH0KM Strong Biomarker [484]
P2RX1 TTJW7B3 Strong Biomarker [485]
P2RX3 TT2THBD Strong Biomarker [485]
P2RX4 TT1NLOA Strong Biomarker [485]
P2RY1 TTA93TL Strong Biomarker [485]
P2RY12 TTZ1DT0 Strong Genetic Variation [486]
P2RY13 TT1FE3L Strong Biomarker [487]
PAOX TTNQ760 Strong Biomarker [488]
PARP3 TTD8MEH Strong Biomarker [489]
PCSK1 TTED9LZ Strong Biomarker [490]
PCSK5 TTPFWHU Strong Biomarker [491]
PCSK6 TT75LN9 Strong Biomarker [296]
PCYT1B TTUAIKM Strong Biomarker [492]
PDE5A TTJ0IQB Strong Biomarker [493]
PDGFA TTSM78N Strong Biomarker [494]
PDGFC TTOABM9 Strong Biomarker [495]
PDZK1 TTDTBLM Strong Biomarker [496]
PECAM1 TT4EZB2 Strong Biomarker [497]
PEMT TT735V2 Strong Altered Expression [498]
PF4 TTSG7Q5 Strong Biomarker [499]
PIK3CB TT9H4P3 Strong Biomarker [500]
PIN1 TTJNTSI Strong Biomarker [501]
PLA2G1B TT9V5JH Strong Biomarker [502]
PLA2G2A TTO8QRU Strong Altered Expression [503]
PLA2G4A TTT1JVS Strong Biomarker [504]
PLA2G4C TTBYG4O Strong Biomarker [505]
PLG TTP86E2 Strong Biomarker [506]
PLIN1 TTIV27N Strong Biomarker [507]
PLTP TTZF6SN Strong Biomarker [508]
PNP TTMCF1Y Strong Biomarker [509]
PNPLA3 TTEUAEH Strong Biomarker [510]
PRDX4 TTPBL9I Strong Biomarker [511]
PREP TTNGKET Strong Biomarker [512]
PRMT3 TTL4XSQ Strong Biomarker [513]
PROC TTZUXYS Strong Biomarker [514]
PRTN3 TT5MLC4 Strong Biomarker [515]
PSMB8 TTEAD9J Strong Biomarker [516]
PTGER3 TTPNGDE Strong Altered Expression [517]
PTGES TTYLQ8V Strong Biomarker [518]
PTGIS TTLXKZR Strong Biomarker [157]
PTH TT6F7GZ Strong Biomarker [519]
PTPN1 TTELIN2 Strong Biomarker [520]
RARA TTW38KT Strong Biomarker [521]
RASA1 TTPNZ1F Strong Biomarker [472]
RCE1 TT2AP5B Strong Biomarker [522]
RENBP TTZCG0Q Strong Biomarker [523]
RGS2 TTKB7T3 Strong Biomarker [524]
RHBDF2 TTH1ZOP Strong Biomarker [525]
RIPK2 TTCQ2E5 Strong Genetic Variation [526]
ROCK1 TTZN7RP Strong Biomarker [527]
ROR2 TTUDPCI Strong Altered Expression [528]
RORA TT1TYN7 Strong Biomarker [529]
RPSA TTLUW5B Strong Biomarker [530]
RXRA TT6PEUO Strong Biomarker [531]
S100A12 TTQ4ESF Strong Biomarker [532]
S100A9 TT0TMQG Strong Biomarker [533]
SCAP TTL6U2P Strong Biomarker [534]
SCARB1 TTRE324 Strong Biomarker [535]
SELE TT1PL7M Strong Biomarker [536]
SELP TTE5VG0 Strong Biomarker [537]
SELPLG TTS5K8U Strong Biomarker [538]
SEMA4D TT5UT28 Strong Altered Expression [539]
SENP1 TTW9HY5 Strong Biomarker [540]
SERPIND1 TT8XSKJ Strong Altered Expression [541]
SFTPD TTGLMU7 Strong Biomarker [542]
SGCB TTEDCQ0 Strong Biomarker [543]
SGPL1 TT618Q2 Strong Biomarker [544]
SIRPA TTBRJS9 Strong Altered Expression [545]
SLAMF7 TT7ILZ1 Strong Biomarker [546]
SLC12A3 TTP362L Strong Biomarker [547]
SLC16A3 TTG6VD5 Strong Posttranslational Modification [548]
SLC17A5 TTFSUIA Strong Biomarker [549]
SLC22A1 TTM5Q4V Strong Biomarker [550]
SLC2A9 TTIF3GB Strong Genetic Variation [551]
SLC3A2 TT5CZSM Strong Biomarker [552]
SLC40A1 TT6Y1PG Strong Biomarker [553]
SLC5A2 TTF8JAT Strong Biomarker [554]
SLC8A1 TTCF82X Strong Biomarker [555]
SLIT2 TTDWK85 Strong Biomarker [556]
SMAD1 TT9GR53 Strong Biomarker [557]
SMPD2 TTE5VI6 Strong Biomarker [558]
SOAT2 TTAK0IN Strong Biomarker [559]
SOCS3 TTI0ME6 Strong Biomarker [560]
SORT1 TTRX9AV Strong Biomarker [561]
SPHK2 TTCN0M9 Strong Biomarker [562]
SPRY1 TT0PSN6 Strong Biomarker [563]
SQSTM1 TTOT2RY Strong Biomarker [416]
SREBF2 TTRQ4AP Strong Biomarker [564]
SSRP1 TTETDKQ Strong Biomarker [565]
SSTR2 TTZ6T9E Strong Genetic Variation [566]
SSTR4 TTAE1BR Strong Biomarker [224]
ST14 TTPRO7W Strong Biomarker [567]
STAB1 TTJFEOC Strong Biomarker [568]
STAR TTEI40H Strong Biomarker [569]
STAT1 TTN7R6K Strong Altered Expression [570]
STAT6 TTWOE1T Strong Biomarker [571]
STC2 TT4EFTR Strong Biomarker [572]
SUCNR1 TT4FX9Y Strong Biomarker [573]
SYK TT2HUPM Strong Biomarker [574]
TAGLN TTDRZ9H Strong Biomarker [575]
TBXA2R TT2O84V Strong Genetic Variation [576]
TBXAS1 TTKNWZ4 Strong Biomarker [577]
TCF7L2 TT80QAL Strong Biomarker [578]
TCIRG1 TTVRN05 Strong Genetic Variation [579]
TDO2 TTXNCBV Strong Altered Expression [138]
TFAP2A TTDY4BS Strong Biomarker [580]
TFPI TT068JH Strong Biomarker [581]
THBS1 TTKI0H1 Strong Biomarker [582]
TIE1 TTT4236 Strong Biomarker [583]
TLR2 TTY7ZHS Strong Biomarker [584]
TLR5 TTCXP8J Strong Biomarker [585]
TLR6 TTWRI8V Strong Genetic Variation [586]
TLR8 TT8CWFK Strong Biomarker [587]
TM6SF2 TTE1OHM Strong Altered Expression [588]
TNC TTUCPMY Strong Biomarker [589]
TNFRSF11B TT2CJ75 Strong Biomarker [590]
TNFRSF4 TTL31H0 Strong Genetic Variation [591]
TNFSF13B TTWMIDN Strong Genetic Variation [145]
TNFSF4 TTBW580 Strong Biomarker [592]
TPH1 TTZSJHV Strong Biomarker [593]
TPT1 TT3PTB6 Strong Biomarker [594]
TREM1 TTHZQP0 Strong Biomarker [595]
TRIM28 TTQ2BKV Strong Biomarker [596]
TRPA1 TTELV3W Strong Genetic Variation [597]
TRPC1 TTA76X0 Strong Altered Expression [598]
TRPC3 TTNVC34 Strong Biomarker [599]
TRPM6 TTV76RD Strong Biomarker [600]
TRPV4 TTKP2SU Strong Biomarker [601]
TSLP TTHMW3T Strong Biomarker [602]
TSPO TTPTXIN Strong Biomarker [603]
TTR TTPOYU7 Strong Biomarker [604]
TXNIP TTTLDZK Strong Altered Expression [605]
TXNRD1 TTR7UJ3 Strong Biomarker [606]
UCP1 TTI12YJ Strong Altered Expression [607]
UCP2 TTSC2YM Strong Biomarker [608]
USP20 TT07QDI Strong Altered Expression [609]
UTS2 TTERU0T Strong Biomarker [610]
VCAM1 TTHCEF6 Strong Biomarker [611]
VEGFD TTOM5H4 Strong Biomarker [612]
VWF TT3SZBT Strong Biomarker [613]
WNT5A TTKG7F8 Strong Biomarker [614]
WRN TT2H5WQ Strong Genetic Variation [615]
XDH TT7RJY8 Strong Biomarker [616]
ZNF202 TTD9R62 Strong Biomarker [617]
ADM TTV14YH Definitive Altered Expression [618]
AIF1 TT12MEP Definitive Altered Expression [619]
APP TTE4KHA Definitive Genetic Variation [620]
CAMP TTULOB6 Definitive Biomarker [621]
CCL11 TTCF05Y Definitive Biomarker [622]
CCR7 TT2GIDQ Definitive Biomarker [623]
CPB2 TTP18AY Definitive Genetic Variation [624]
F2 TT6L509 Definitive Biomarker [625]
F2R TTL935N Definitive Biomarker [444]
FABP2 TTS4YLO Definitive Genetic Variation [626]
GPX1 TTYAHBP Definitive Altered Expression [627]
GRN TT0LWE3 Definitive Biomarker [628]
HSPG2 TT5UM29 Definitive Altered Expression [629]
NOD2 TTYPUHA Definitive Biomarker [630]
NT5E TTK0O6Y Definitive Biomarker [631]
NTN1 TT0AH4L Definitive Altered Expression [632]
P2RX7 TT473XN Definitive Biomarker [633]
P2RY2 TTOZHQC Definitive Biomarker [634]
PDGFD TTSN0GA Definitive Biomarker [635]
PGF TT48I1Y Definitive Biomarker [636]
SLC26A4 TT7X02I Definitive Genetic Variation [637]
SREBF1 TTER0UB Definitive Altered Expression [638]
------------------------------------------------------------------------------------
⏷ Show the Full List of 565 DTT(s)
This Disease Is Related to 14 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
ABCA12 DT7LDG0 moderate Biomarker [639]
ABCB6 DTF9Y2V Strong Biomarker [640]
ABCC11 DTWN7FC Strong Biomarker [161]
ATP2B1 DTJWQ1L Strong Biomarker [641]
ATP7A DT0LT17 Strong Biomarker [504]
SLC16A8 DT39AOM Strong Posttranslational Modification [548]
SLC17A4 DTHE530 Strong Biomarker [642]
SLC25A20 DTQOUM4 Strong Genetic Variation [265]
SLC2A6 DTS4MKQ Strong Genetic Variation [551]
SLC35A1 DTVZIRG Strong Biomarker [643]
SLC39A1 DTLWPXS Strong Biomarker [489]
SLC39A8 DTLPQGT Strong Biomarker [644]
SLC52A1 DT7NOKR Strong Biomarker [645]
SLC5A10 DTQNIG7 Strong Genetic Variation [646]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 DTP(s)
This Disease Is Related to 29 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
CYP27A1 DEBS639 Limited Biomarker [647]
DHCR7 DEL7GFA Limited Genetic Variation [648]
CHDH DEAHED0 moderate Biomarker [649]
GSTA4 DEH7XYP moderate Biomarker [650]
ACP3 DEDW5H6 Strong Altered Expression [651]
ACP5 DESITDW Strong Altered Expression [652]
ACSS2 DEE76VW Strong Biomarker [653]
ADH5 DEIOH6A Strong Biomarker [654]
AOC2 DE8DP90 Strong Biomarker [246]
APRT DE2MV1R Strong Biomarker [655]
AS3MT DE9KJP3 Strong Biomarker [656]
CES3 DEMI4VE Strong Biomarker [657]
CHST3 DEQIZP2 Strong Biomarker [658]
CYP26B1 DEZT8FM Strong Biomarker [313]
CYP2C8 DES5XRU Strong Genetic Variation [659]
CYP4F2 DE3GT9C Strong Altered Expression [660]
CYP7A1 DEDZRQ1 Strong Biomarker [661]
DDAH1 DEY0TQC Strong Biomarker [662]
FADS1 DE05S8C Strong Biomarker [663]
GSTT1 DE3PKUG Strong Genetic Variation [664]
MSRA DEU2ZBY Strong Biomarker [665]
MT2A DEFKGT7 Strong Biomarker [666]
NNMT DECVGJ3 Strong Biomarker [667]
PON2 DEHJU7E Strong Biomarker [668]
PTGDS DER3H9C Strong Altered Expression [669]
SAT1 DEMWO83 Strong Genetic Variation [670]
SMOX DEOH5V3 Strong Biomarker [488]
SULT2A1 DE0P6LK Strong Biomarker [671]
FMO3 DEP76YL Definitive Altered Expression [672]
------------------------------------------------------------------------------------
⏷ Show the Full List of 29 DME(s)
This Disease Is Related to 637 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ABI2 OT8GIIS5 Limited Biomarker [113]
ACSL1 OTB06ESI Limited Altered Expression [673]
ACTRT1 OTHFKSIZ Limited Biomarker [113]
ADIPOR2 OT2HDTL8 Limited Biomarker [674]
ADTRP OTFI2BQX Limited Biomarker [675]
ANGPTL8 OTQFINCD Limited Biomarker [676]
ARL6IP1 OT536XAV Limited Biomarker [113]
ATOX1 OT05LF59 Limited Biomarker [677]
BHLHE22 OTZUQY5L Limited Biomarker [678]
CANX OTYP1F6J Limited Biomarker [160]
CAP1 OTYM8A2N Limited Biomarker [679]
CCDC8 OTO295IH Limited Biomarker [160]
CCL19 OTQ2UJMH Limited Biomarker [115]
CCL7 OTDIS99H Limited Biomarker [680]
CCL8 OTCTWYN8 Limited Biomarker [680]
COMP OTS2FPMI Limited Biomarker [681]
CP OTM8JE4Y Limited Genetic Variation [682]
DAB2IP OTF456VC Limited Biomarker [113]
DNER OT2GH2E5 Limited Biomarker [683]
EARS2 OTNCJKY7 Limited Genetic Variation [684]
ELAVL2 OT6EJ8MQ Limited Biomarker [685]
FCGR3B OTSLSPZG Limited Biomarker [129]
HHIPL1 OT3GMU2X Limited Biomarker [686]
HSPA4 OT5HR0AR Limited Biomarker [687]
IL27 OTIS3OF8 Limited Genetic Variation [140]
JPH3 OTHTJO2I Limited Biomarker [688]
KLF14 OT8BXLBS Limited Biomarker [689]
LDB2 OT6Y8IEK Limited Altered Expression [690]
LGALS3BP OT9AGQKH Limited Biomarker [691]
LMNA OT3SG7ZR Limited Genetic Variation [692]
LPCAT3 OTWI96P4 Limited Biomarker [693]
LSAMP OTYXVQX2 Limited Altered Expression [694]
MAGI2 OTXDDKZS Limited Biomarker [113]
MYOCD OTSJNHTH Limited Altered Expression [695]
P4HB OTTYNYPF Limited Genetic Variation [696]
PDCD5 OT6T2DDL Limited Biomarker [697]
PDCD6IP OTS8T6A7 Limited Biomarker [113]
PHACTR1 OTAMPX9V Limited Biomarker [698]
PITX3 OTE2KT8P Limited Altered Expression [699]
PLIN2 OTRXJ9UN Limited Biomarker [700]
PROS1 OTXQWNOI Limited Biomarker [211]
RYR3 OT4EHIP4 Limited Genetic Variation [701]
SEPTIN9 OT1VMRFQ Limited Genetic Variation [702]
SERPINB9 OTJ811IF Limited Altered Expression [135]
SGSM3 OTIB1P8A Limited Biomarker [703]
SHC1 OT1J5IRN Limited Biomarker [704]
SOX6 OTT0W0LE Limited Genetic Variation [705]
SRSF1 OTF61HOV Limited Genetic Variation [706]
SRSF2 OTVDHO6U Limited Genetic Variation [706]
TCF21 OT393IMA Limited Biomarker [707]
TES OTL8PP6V Limited Biomarker [708]
TIMP3 OTDGQAD1 Limited Biomarker [709]
TMEM98 OTKDUEED Limited Biomarker [710]
TRAF3IP2 OTLLZERL Limited Biomarker [711]
TRAF4 OTJLRVMC Limited Biomarker [677]
NBAS OTW9IBRI Disputed Biomarker [183]
SAMD9 OTDG48P0 Disputed Biomarker [712]
SCN7A OTK05PXY Disputed Biomarker [183]
ACP1 OTJ9CKLU moderate Biomarker [713]
ARMH1 OTTJC0D6 moderate Genetic Variation [207]
ATP6AP2 OT0IABVV moderate Biomarker [714]
BIK OTTH1T3D moderate Biomarker [389]
CD180 OTITK5E6 moderate Biomarker [715]
CD68 OTOYEY3J moderate Biomarker [716]
CHMP2B OTZA7RJB moderate Biomarker [218]
DIO2 OTGPNSLH moderate Altered Expression [607]
DMRT1 OT5PU9U1 moderate Biomarker [218]
EBNA1BP2 OTBRVMZH moderate Genetic Variation [207]
ELK1 OTH9MXD6 moderate Altered Expression [687]
FZD5 OTXFFY56 moderate Altered Expression [717]
GPR162 OTK4LT3K moderate Altered Expression [718]
HGS OTCYYCAC moderate Genetic Variation [719]
IL6ST OT1N9C70 moderate Biomarker [720]
ITGAX OTOGIMHE moderate Biomarker [721]
LRP8 OTZ71YV2 moderate Biomarker [722]
NECTIN1 OTTE5ZR6 moderate Biomarker [714]
NOS1AP OTDFOBRU moderate Genetic Variation [723]
PHF14 OTZT3GV1 moderate Genetic Variation [724]
PIP OTH719AH moderate Biomarker [725]
PSMD7 OT7PZZ4K moderate Genetic Variation [207]
RABEPK OTCZSREH moderate Genetic Variation [207]
SORL1 OTQ8FFNS moderate Biomarker [726]
TRAF2 OT1MEZZN moderate Altered Expression [727]
A2M OTFTX90K Strong Biomarker [728]
AAAS OTJT9T23 Strong Biomarker [729]
ABHD2 OTCRUOCS Strong Genetic Variation [152]
ABR OTZQK8JF Strong Biomarker [730]
ACAN OTUOCW8K Strong Altered Expression [731]
ACCS OTHIHI9D Strong Biomarker [653]
ACER2 OTS3DDE5 Strong Altered Expression [732]
ADAM12 OTZKOTDB Strong Biomarker [733]
ADAM15 OTZ7VLTP Strong Biomarker [734]
ADAMTS18 OTRMFI04 Strong Biomarker [735]
ADAMTS3 OT2U6VF5 Strong Altered Expression [736]
ADAMTS7 OTVKZ1DV Strong Genetic Variation [737]
ADCY10 OTYSTB0R Strong Biomarker [378]
ADCY8 OTR1WCZX Strong Altered Expression [738]
ADCY9 OT1IZT5K Strong Altered Expression [739]
ADD1 OTTF68DC Strong Genetic Variation [740]
ADGRA2 OTBT4W36 Strong Biomarker [741]
AGXT2 OTO6QUTM Strong Genetic Variation [742]
AHSA1 OTC7AFHT Strong Altered Expression [238]
AIM2 OT86QUI8 Strong Biomarker [743]
AIMP1 OTTA5C3U Strong Biomarker [744]
AKAP12 OTCVRDDX Strong Biomarker [745]
AKT1S1 OT4JHN4Y Strong Biomarker [746]
ALKBH1 OTADGU5D Strong Biomarker [747]
ANGPTL2 OTB6JG41 Strong Biomarker [748]
ANKS1B OT26DGM9 Strong Genetic Variation [749]
AP2A1 OTEFZB21 Strong Altered Expression [750]
APOA5 OTEVKLVA Strong Genetic Variation [751]
APOBEC1 OTY8QX2R Strong Biomarker [752]
APOBR OT9EUZX3 Strong Biomarker [753]
APOC2 OTLINYIQ Strong Altered Expression [754]
APOL6 OTYTBJEG Strong Biomarker [755]
APOM OTI3FQQC Strong Biomarker [756]
APPL1 OT8VR95S Strong Biomarker [757]
ARHGAP18 OTYMJP6H Strong Biomarker [758]
ARHGEF1 OTXU4HBW Strong Biomarker [759]
ARHGEF26 OTX0U8PX Strong Biomarker [760]
ARHGEF28 OT3F32IU Strong Biomarker [761]
ARHGEF5 OTUVGFT9 Strong Biomarker [762]
ARID5B OTUQ4CQY Strong Altered Expression [763]
ARSL OTF1VTCR Strong Biomarker [764]
ARTN OTWIWGL6 Strong Biomarker [235]
ASS1 OT4ZMG0Q Strong Biomarker [765]
ATF2 OTNIZPEA Strong Biomarker [766]
ATG13 OTYMHNEJ Strong Altered Expression [767]
ATG16L1 OTEOYC5D Strong Biomarker [768]
ATP6V0A2 OTJBDX0Y Strong Biomarker [769]
AZU1 OTHXU264 Strong Biomarker [770]
BAMBI OTCEJ8W5 Strong Biomarker [771]
BCL3 OT1M5B95 Strong Biomarker [772]
BGLAP OTK1YLWQ Strong Biomarker [773]
BLM OTEJOAJX Strong Genetic Variation [615]
BMS1 OTEGQ8ZO Strong Biomarker [774]
BPIFB4 OTHF0EOJ Strong Genetic Variation [775]
BRAP OTB7BAFQ Strong Biomarker [776]
BRD8 OTIKS3PC Strong Biomarker [472]
BRINP1 OTEUVSCP Strong Genetic Variation [777]
BRINP3 OT4VFHWN Strong Genetic Variation [778]
C1D OTI9PMN1 Strong Biomarker [779]
C1QL3 OT4TZH3J Strong Biomarker [780]
C1QTNF1 OT7I7KHC Strong Biomarker [781]
C1QTNF12 OTFAIQHR Strong Biomarker [782]
C1QTNF6 OT57EPQC Strong Biomarker [783]
CACNA2D4 OTVYNX7N Strong Genetic Variation [784]
CALU OTSYQN71 Strong Biomarker [785]
CAPG OTJ86KI6 Strong Biomarker [786]
CAPN10 OTS9LJW4 Strong Biomarker [787]
CARD8 OTXXZYWU Strong Altered Expression [788]
CARD9 OTJ81AWD Strong Biomarker [292]
CARHSP1 OTAUG6Y9 Strong Biomarker [789]
CAST OTBXZZGF Strong Genetic Variation [790]
CASZ1 OTWJ2OR8 Strong Biomarker [643]
CCAR2 OTLUDG5T Strong Genetic Variation [777]
CCDC80 OTOZSYEM Strong Altered Expression [791]
CCL1 OT23NON8 Strong Biomarker [276]
CCL18 OT7JYSK9 Strong Altered Expression [792]
CCL25 OTLWJ8CJ Strong Biomarker [277]
CCL4 OT6B8P25 Strong Biomarker [793]
CCL4L2 OTDBSXOU Strong Biomarker [794]
CCN3 OTOW5YL4 Strong Biomarker [795]
CCN5 OTADU8JJ Strong Altered Expression [796]
CD151 OTF3UZS7 Strong Biomarker [797]
CD5L OTPY4WQR Strong Biomarker [457]
CD81 OTQFXNAZ Strong Biomarker [798]
CDKAL1 OTA0SGNE Strong Genetic Variation [799]
CELA2A OTY8QG2J Strong Genetic Variation [800]
CH25H OT9S2BSW Strong Biomarker [312]
CHGA OTXYX5JH Strong Biomarker [801]
CHI3L1 OT2Z7VJH Strong Biomarker [802]
CIDEC OTMDZ56K Strong Posttranslational Modification [803]
CISD1 OT0MTVGF Strong Biomarker [804]
CISH OT8T5NYL Strong Altered Expression [805]
CLDN7 OTNE0XHQ Strong Altered Expression [806]
CLEC4D OTT7X1UC Strong Biomarker [292]
CLEC4E OT7P8ICY Strong Biomarker [807]
CLEC5A OT19WV30 Strong Altered Expression [808]
CLEC7A OTRTBH27 Strong Altered Expression [434]
CLIC4 OT6KTPKD Strong Biomarker [809]
CLOCK OTNEOJY7 Strong Genetic Variation [810]
CNBP OTTGM9NK Strong Biomarker [564]
CNN2 OTH3CSXA Strong Altered Expression [811]
CNTN3 OTC1274J Strong Biomarker [530]
COL15A1 OTTFKK18 Strong Genetic Variation [812]
COL4A1 OTL6D1YE Strong Genetic Variation [813]
COLEC12 OTIQTK9G Strong Altered Expression [814]
COPB2 OT82JIGC Strong Genetic Variation [815]
COPE OTBKHBT7 Strong Biomarker [816]
CORT OTX3GUHB Strong Biomarker [817]
COX1 OTG3O9BN Strong Biomarker [158]
COX2 OTTMVBJJ Strong Genetic Variation [818]
COX5A OTP0961M Strong Biomarker [819]
CPT2 OTIN6G20 Strong Genetic Variation [820]
CREB3 OT9617UO Strong Biomarker [821]
CREB3L3 OTDMU3GP Strong Biomarker [822]
CREG1 OTRHJ8HK Strong Biomarker [823]
CRISP2 OT8HLTV5 Strong Altered Expression [824]
CSGALNACT2 OT2SH7HJ Strong Genetic Variation [825]
CST3 OTNZ6AO4 Strong Biomarker [826]
CTBS OT135K92 Strong Biomarker [492]
CXADR OT9ZP02A Strong Biomarker [827]
CXCL14 OTM189TA Strong Altered Expression [828]
CYBA OT16N9ZO Strong Genetic Variation [829]
CYGB OTX153DQ Strong Biomarker [830]
CYTB OTAHB98A Strong Genetic Variation [831]
DAB2 OTRMQTMZ Strong Biomarker [832]
DBN1 OTZVKG8A Strong Altered Expression [833]
DBP OTE0W7LN Strong Biomarker [834]
DCBLD2 OTB71I02 Strong Biomarker [835]
DCTN4 OTM7C943 Strong Biomarker [416]
DDAH2 OT8Q40G2 Strong Posttranslational Modification [836]
DEFB103B OT8RWY64 Strong Biomarker [837]
DENR OTXP9HOY Strong Biomarker [838]
DLC1 OTP8LMCR Strong Altered Expression [839]
DLD OT378CU9 Strong Biomarker [819]
DLEC1 OTMKKBUW Strong Altered Expression [839]
DNAH8 OTGES2OU Strong Biomarker [840]
DOCK4 OTH3XY8B Strong Biomarker [841]
DSC1 OTNII6GZ Strong Altered Expression [842]
DSPP OT1TYNDN Strong Biomarker [843]
DYNLL1 OTR69LHT Strong Altered Expression [839]
EBF1 OTZ61YYH Strong Biomarker [357]
ECSCR OT9L72MD Strong Biomarker [844]
EDA OTAKS5WS Strong Biomarker [845]
EDN3 OTN7Q9BE Strong Altered Expression [846]
EFNB1 OT7JJW8P Strong Altered Expression [847]
EID1 OT3OI5H4 Strong Biomarker [848]
ELMO1 OTY2ORXK Strong Biomarker [784]
ELN OTFSO7PG Strong Biomarker [849]
ELOVL6 OTB26UJJ Strong Biomarker [850]
EMP1 OTSZHUHQ Strong Biomarker [851]
ENHO OT91QASK Strong Biomarker [852]
ENPP7 OTWOBMQ9 Strong Biomarker [853]
ERG OTOTX9VU Strong Genetic Variation [854]
ESAM OTF518AI Strong Altered Expression [855]
ESM1 OT331Y8V Strong Biomarker [856]
EVPL OTZIAFEK Strong Biomarker [492]
FA2H OT8HA13U Strong Biomarker [857]
FAM20C OTW5YZ7X Strong Biomarker [858]
FBLN2 OTEHR7N7 Strong Biomarker [859]
FBN2 OT3KYJQL Strong Biomarker [860]
FBRS OTUVH446 Strong Biomarker [861]
FBXO8 OTZNGJGW Strong Biomarker [861]
FCRL6 OTLIXQMQ Strong Biomarker [862]
FETUB OT7V07NI Strong Genetic Variation [863]
FGB OT6RKLI9 Strong Altered Expression [864]
FGF12 OTBM9QIO Strong Biomarker [865]
FGF13 OTHNNVSG Strong Biomarker [866]
FHL2 OT0OAYWT Strong Biomarker [867]
FMOD OT9EJ5H8 Strong Biomarker [868]
FNDC5 OT5CSK9X Strong Altered Expression [869]
FOXA3 OTRGT2OT Strong Biomarker [870]
FOXO4 OT90X9LN Strong Biomarker [193]
FRS2 OTDMD800 Strong Biomarker [871]
FUT7 OTJF6BSN Strong Biomarker [872]
FUT8 OTJJCVG1 Strong Biomarker [873]
GABPA OT9YB2SA Strong Altered Expression [874]
GAL3ST1 OTSFFZRD Strong Biomarker [643]
GATA2 OTBP2QQ2 Strong Biomarker [540]
GC OTWS63BY Strong Genetic Variation [875]
GCA OTAJ7ZHG Strong Biomarker [876]
GCKR OTSIWXGG Strong Biomarker [877]
GDF11 OTOSNMND Strong Biomarker [878]
GFER OTVK43OK Strong Biomarker [879]
GFM1 OTUN4V3N Strong Biomarker [880]
GGTLC1 OTWJKUHQ Strong Biomarker [881]
GNB3 OTA6HYBA Strong Genetic Variation [882]
GOLGA6A OTHU9MRX Strong Biomarker [883]
GOLGB1 OT2S0GK8 Strong Biomarker [884]
GOSR2 OTYHIYN2 Strong Genetic Variation [885]
GOT2 OT6XBWN0 Strong Genetic Variation [626]
GPIHBP1 OTDF8R2M Strong Biomarker [886]
GPR42 OTEB0ROY Strong Biomarker [224]
GPX4 OTRAFFX2 Strong Altered Expression [887]
GRAP2 OTS5NIZ3 Strong Altered Expression [238]
GTF2H1 OTCRXC6B Strong Biomarker [416]
GTF3A OTVROUVQ Strong Genetic Variation [888]
GUCY1A1 OTPTCBUN Strong Genetic Variation [889]
GYPC OTOEDR7O Strong Altered Expression [890]
H4C1 OTB71W46 Strong Biomarker [891]
H6PD OTO7TNDD Strong Biomarker [892]
HABP2 OTAUIPW0 Strong Biomarker [893]
HACD4 OT85HPZE Strong Altered Expression [894]
HAS2 OTTD3PAL Strong Altered Expression [895]
HAS3 OTPM8IL8 Strong Biomarker [896]
HAT1 OT307KEN Strong Biomarker [897]
HAVCR2 OTOL603T Strong Altered Expression [898]
HBP1 OTDPGGDV Strong Biomarker [899]
HDLBP OTKDEEYX Strong Altered Expression [900]
HILPDA OTEID3ZM Strong Biomarker [901]
HLA-C OTV38BUJ Strong Biomarker [902]
HMBOX1 OTPKTBVI Strong Biomarker [903]
HNRNPU OTLQN1E2 Strong Biomarker [472]
HOXA1 OTMSOJ7D Strong Biomarker [904]
HOXB9 OTMVHQOU Strong Biomarker [905]
HPX OT14T7Q1 Strong Biomarker [906]
HSH2D OTOGB2BR Strong Biomarker [907]
HSPA1A OTKGIE76 Strong Genetic Variation [908]
HSPA2 OTSDET7B Strong Biomarker [909]
HSPB2 OTS01646 Strong Altered Expression [390]
HYLS1 OT3SW5UC Strong Genetic Variation [860]
ID3 OTUULW5Z Strong Biomarker [910]
IFNA1 OTPMKY0L Strong Biomarker [911]
IGSF1 OT3XD6U2 Strong Biomarker [472]
IL17B OTS86H50 Strong Biomarker [400]
IL18BP OTW0LRYZ Strong Altered Expression [912]
IL1F10 OTJAASGC Strong Biomarker [913]
IL27RA OTSQBAKI Strong Biomarker [914]
IL34 OTZ15VVK Strong Biomarker [915]
INPP5K OTQFLQKA Strong Biomarker [916]
INSIG2 OTX4VY51 Strong Genetic Variation [917]
IRF2 OTAZRUW3 Strong Biomarker [918]
IRF2BP2 OTSSRRCA Strong Biomarker [918]
IRF5 OT8SIIAP Strong Biomarker [919]
IRF6 OTKJ44EV Strong Biomarker [916]
IRGM OTKD3O5Z Strong Altered Expression [920]
ITGA2B OT4Y17PY Strong Genetic Variation [921]
ITGA7 OTTBTAYW Strong Biomarker [922]
ITGAD OTNS69WO Strong Biomarker [923]
ITGB4 OT28UK84 Strong Altered Expression [924]
ITIH4 OT460OO1 Strong Biomarker [925]
IVD OT8JFXUQ Strong Biomarker [926]
JCAD OT7G1WJW Strong Biomarker [927]
KALRN OT8WRCBH Strong Biomarker [928]
KAT5 OTL7257A Strong Biomarker [929]
KCNE2 OTUO214Y Strong Genetic Variation [930]
KCNH4 OTHJ8WTU Strong Altered Expression [931]
KCNH8 OT3I5FLB Strong Altered Expression [931]
KCNMB1 OTO4KNJ4 Strong Biomarker [932]
KCTD15 OTM6L4A0 Strong Biomarker [933]
KDM5D OTEKG0KD Strong Biomarker [934]
KERA OTAP9L2A Strong Genetic Variation [935]
KIF6 OTDH3MR4 Strong Genetic Variation [936]
KLF15 OTGMQMVR Strong Biomarker [937]
KLF5 OT1ABI9N Strong Altered Expression [938]
KMT2B OTMMAZQX Strong Altered Expression [939]
KMT2E OTYOLNOG Strong Biomarker [940]
KPNA3 OTLI3TM2 Strong Altered Expression [941]
KPNA4 OTP0EX18 Strong Altered Expression [941]
KRIT1 OT58AP1I Strong Biomarker [942]
LAD1 OT6YGTVX Strong Biomarker [819]
LBR OT1HG3HG Strong Altered Expression [943]
LCOR OT1K7DKB Strong Altered Expression [944]
LDLRAP1 OT6QTX7R Strong Biomarker [945]
LECT2 OTSFZ9JD Strong Biomarker [946]
LGALS14 OTOR23GX Strong Biomarker [291]
LIPC OTZY5SC9 Strong Biomarker [947]
LMNB1 OT100T3P Strong Biomarker [945]
LMOD1 OTZ2MEMG Strong Genetic Variation [948]
LPP OT6TU8SE Strong Biomarker [949]
LRP2BP OTVEH7V5 Strong Biomarker [950]
LUM OTSRC874 Strong Biomarker [951]
LYST OTIUB1B3 Strong Biomarker [952]
MAFB OTH2N3T8 Strong Altered Expression [953]
MAGEC3 OT0KDWZN Strong Biomarker [378]
MAGEE2 OTL3E0G7 Strong Biomarker [378]
MAGI1 OTMV4ASV Strong Biomarker [954]
MAK16 OTD546E5 Strong Biomarker [283]
MAML1 OTQA4DDN Strong Biomarker [955]
MARCHF10 OTAYGHDM Strong Genetic Variation [956]
MARK4 OT6Z2TGV Strong Biomarker [957]
MCF2L OTEURA8N Strong Biomarker [958]
MCM3 OTOOHQPM Strong Genetic Variation [815]
MED1 OTOO24C4 Strong Biomarker [959]
MEF2A OTV2SF6E Strong Genetic Variation [960]
MEF2C OTZGF1Y5 Strong Biomarker [961]
MEFV OTRJ6S6K Strong Biomarker [962]
METRN OTI2645G Strong Biomarker [963]
MFAP1 OTZN4FT3 Strong Biomarker [655]
MGP OTZWU3FU Strong Biomarker [964]
MICU1 OTS7N0LE Strong Biomarker [965]
MINDY4 OTBZ2SZB Strong Biomarker [966]
MLC1 OTCNZLSP Strong Biomarker [967]
MLKL OTDSLC81 Strong Biomarker [857]
MLXIPL OTR9MLLW Strong Biomarker [968]
MMD OTB5I4OC Strong Biomarker [969]
MOCOS OT0TL3Q5 Strong Genetic Variation [970]
MPEG1 OT7DAO0F Strong Biomarker [148]
MPRIP OT5FV5NS Strong Biomarker [971]
MPV17 OT579DMU Strong Biomarker [972]
MRTFA OTCVXASM Strong Biomarker [973]
MT1F OTZVUYG1 Strong Altered Expression [666]
MTSS1 OT5DTDO2 Strong Genetic Variation [974]
MYH11 OTVNVWY3 Strong Biomarker [975]
MYH15 OTWZA8IF Strong Genetic Variation [976]
MYH9 OT94Z706 Strong Genetic Variation [977]
MZB1 OT071TET Strong Biomarker [978]
NAA25 OTS3QVF1 Strong Biomarker [472]
NANOS2 OTFM2IDJ Strong Biomarker [979]
NANOS3 OTGX9IQU Strong Genetic Variation [980]
NANS OTMQ2FUH Strong Biomarker [981]
NBEAL2 OTMCAXWR Strong Biomarker [982]
NBL1 OTT37U4O Strong Altered Expression [983]
NCEH1 OTZ66CKX Strong Biomarker [984]
NCF2 OTAUW7L2 Strong Genetic Variation [985]
NCOR1 OT04XNOU Strong Genetic Variation [986]
NDUFA2 OTNSTATK Strong Genetic Variation [987]
NDUFS6 OT9IOONQ Strong Biomarker [988]
NECTIN2 OTIE0W6O Strong Biomarker [989]
NEU1 OTH9BY8Y Strong Biomarker [990]
NEXN OTKB0B0H Strong Biomarker [991]
NFAT5 OTKIE59S Strong Altered Expression [992]
NFE2 OTLM94BI Strong Biomarker [993]
NFIA OTDHQ9CG Strong Altered Expression [994]
NGB OTW0SIUY Strong Biomarker [995]
NIF3L1 OT4MP90J Strong Biomarker [996]
NINJ2 OTUG1AOV Strong Biomarker [997]
NKX2-5 OTS1SAWM Strong Biomarker [998]
NME2 OTCYGLHV Strong Biomarker [999]
NOX1 OTZPJQCC Strong Biomarker [1000]
NOX5 OTHTH59G Strong Altered Expression [897]
NOXA1 OTQDX9RY Strong Altered Expression [1001]
NPHP1 OTZHCFFQ Strong Genetic Variation [1002]
NPHS2 OTLCNUII Strong Genetic Variation [1003]
NR6A1 OTFZOOQ9 Strong Biomarker [1004]
NRF1 OTOXWNV8 Strong Genetic Variation [1005]
NRIP1 OTIZOJQV Strong Biomarker [1006]
NSUN5 OTBN7RS8 Strong Biomarker [472]
NUP62 OTMN63DH Strong Biomarker [416]
OCLN OTSUTVWL Strong Altered Expression [806]
OGA OT7ZBWT1 Strong Biomarker [1007]
OGN OTKP5S4L Strong Biomarker [305]
ORMDL3 OTAB7MZF Strong Genetic Variation [1008]
OSBP OT7R0OQQ Strong Biomarker [1009]
OSBPL1A OTQ33OQV Strong Genetic Variation [1010]
OSCP1 OTZ4IFGJ Strong Biomarker [478]
OSGIN1 OT9KIVZW Strong Biomarker [1011]
P2RX2 OT0LF34A Strong Biomarker [485]
P2RX5 OTLBR20R Strong Biomarker [485]
P2RX6 OT1FNTXA Strong Biomarker [485]
PACS2 OTPU9HUA Strong Biomarker [1012]
PADI1 OT13WAQX Strong Genetic Variation [696]
PALD1 OTLGUM8H Strong Genetic Variation [1013]
PALLD OTZ2MUJZ Strong Genetic Variation [1013]
PANX1 OTXPEDOK Strong Biomarker [1014]
PAPPA OTTTG9PG Strong Biomarker [1015]
PAQR7 OTIWX5AM Strong Biomarker [1016]
PATZ1 OT0X9WGR Strong Altered Expression [1017]
PC OT6O0V51 Strong Biomarker [1018]
PCDH8 OTDDOQM2 Strong Altered Expression [1019]
PCLAF OTMVIOUU Strong Altered Expression [1020]
PCOLCE OTJXOAN4 Strong Biomarker [1021]
PCOLCE2 OTSUEQZ1 Strong Biomarker [1021]
PCP4 OTM1XXYX Strong Biomarker [1022]
PDIA2 OTC2WMXS Strong Genetic Variation [696]
PDIK1L OTISF4KG Strong Altered Expression [1023]
PDK4 OTCMHMBZ Strong Altered Expression [1024]
PDLIM5 OTLQVV22 Strong Genetic Variation [867]
PHOX2B OT3SFR2O Strong Biomarker [1025]
PIEZO1 OTBG1FU4 Strong Biomarker [1026]
PIK3R5 OT4LNXJU Strong Biomarker [815]
PINK1 OT50NR57 Strong Biomarker [1027]
PLA2G10 OTRZ2L5A Strong Altered Expression [503]
PLA2G12A OTHHCQ17 Strong Altered Expression [1028]
PLA2G15 OT6VJTPA Strong Biomarker [653]
PLA2G2D OTU604XM Strong Biomarker [1029]
PLAAT1 OTM3M6P4 Strong Biomarker [1030]
PLB1 OTZ6TTYV Strong Biomarker [1031]
PLEKHO1 OTMVUQ9W Strong Biomarker [1032]
PLIN5 OTV8G50L Strong Biomarker [1033]
PLPP3 OTSSF7BK Strong Altered Expression [1034]
PLXNA2 OTNNBJMQ Strong Biomarker [1035]
PMPCA OT5X1G9Q Strong Biomarker [1036]
PNKD OT6G9UXN Strong Biomarker [1037]
PNO1 OT010GIS Strong Biomarker [283]
PNPLA2 OTR3ERMR Strong Biomarker [1038]
PODN OTV3P7P5 Strong Altered Expression [1039]
PODXL OTPNQXF3 Strong Biomarker [1040]
POLDIP2 OT8SZSJ6 Strong Altered Expression [238]
POT1 OTNBXJCQ Strong Biomarker [1041]
POU2F1 OTK7ELJ0 Strong Biomarker [550]
POU2F3 OTIOOJWD Strong Genetic Variation [1042]
PPIG OTZ8BTTM Strong Genetic Variation [1043]
PPP1R1A OTGTAGCV Strong Biomarker [790]
PPP1R3B OTVCRXEZ Strong Biomarker [877]
PPP2R2A OT9297OG Strong Biomarker [1044]
PRAP1 OT48QD82 Strong Biomarker [1045]
PRDM1 OTQLSVBS Strong Biomarker [1046]
PRDX1 OTZ3BEC4 Strong Biomarker [1047]
PRKAA1 OT7TNF0L Strong Genetic Variation [1048]
PRKAA2 OTU1KZPV Strong Genetic Variation [1048]
PRKAB1 OT1OG4QZ Strong Genetic Variation [1048]
PROCR OTRHED17 Strong Genetic Variation [948]
PROX1 OT68R6IO Strong Biomarker [479]
PRRX1 OTTZK5G8 Strong Altered Expression [1049]
PSMC5 OTJOORMR Strong Biomarker [993]
PSME3 OTSTC4YY Strong Altered Expression [1050]
PSRC1 OT7MDJMN Strong Altered Expression [1051]
PSTPIP2 OTG6F93V Strong Biomarker [859]
PTOV1 OT94WT5X Strong Biomarker [1052]
PTPN22 OTDCNTC3 Strong Biomarker [1053]
PTPRF OTH5KF2D Strong Biomarker [1054]
PTX3 OTPXHRKU Strong Biomarker [1055]
RAC2 OTAOHFNH Strong Biomarker [1056]
RAG1 OTV131E4 Strong Biomarker [1057]
RAG2 OTG9UYTW Strong Biomarker [1058]
RAPGEF5 OT53VS75 Strong Biomarker [1059]
RARRES2 OT1BJE8K Strong Biomarker [1060]
RASGRF1 OTNWJ7EN Strong Biomarker [760]
RASL11B OTHEVZS6 Strong Biomarker [1061]
RBMS3 OTFSC9MR Strong Biomarker [283]
RCAN1 OT1MVXC7 Strong Biomarker [1062]
RCBTB1 OTAYELI8 Strong Biomarker [883]
RCN2 OTIU8JWD Strong Biomarker [1063]
RELA OTUJP9CN Strong Altered Expression [1064]
RETNLB OT9JJQQQ Strong Altered Expression [1065]
RFX1 OTZUDMPR Strong Altered Expression [1066]
RFX5 OT73KJ5P Strong Altered Expression [1067]
RGCC OTYJMLWM Strong Biomarker [1068]
RGS1 OTGXJYMG Strong Biomarker [1069]
RGS3 OTYG5OXI Strong Biomarker [1070]
RGS5 OTUY0Q2I Strong Genetic Variation [1071]
RGS7 OTDQA90X Strong Genetic Variation [749]
RIPK3 OTL1D484 Strong Biomarker [971]
RLN2 OTY3OG71 Strong Biomarker [1072]
RMC1 OT7K8MTJ Strong Biomarker [1073]
RNASE1 OTKZ7CO9 Strong Altered Expression [1074]
RNF19A OTKWCV80 Strong Altered Expression [238]
RNF213 OT4OVE9O Strong Genetic Variation [969]
RPS19 OTBKGP48 Strong Biomarker [651]
RSAD2 OTCA9WCM Strong Biomarker [1075]
S100A1 OT1F2G4J Strong Biomarker [1076]
S100A7 OTJFVJRF Strong Biomarker [1077]
S100A7A OTNM8DCP Strong Biomarker [1077]
SAA2 OTYAVJWG Strong Biomarker [1078]
SAMD1 OT2LK4JW Strong Biomarker [1079]
SAMSN1 OT7N88T1 Strong Genetic Variation [1080]
SASH1 OTQA8BD4 Strong Biomarker [1081]
SCARA5 OTOVA96E Strong Biomarker [1082]
SCG2 OTXWUQQL Strong Biomarker [1083]
SCP2 OTPAFCPQ Strong Biomarker [1084]
SDC4 OTKUVUGZ Strong Altered Expression [1085]
SELENOS OTUEWIU9 Strong Biomarker [606]
SEMA3E OTD4S36H Strong Biomarker [1086]
SEMA6A OTDQ7QAW Strong Biomarker [1087]
SEMA7A OT0ZJK64 Strong Biomarker [1088]
SENP2 OTPQJXIR Strong Biomarker [1089]
SERPINA12 OTS1E6IP Strong Biomarker [1090]
SERPINF2 OTZGAF8B Strong Biomarker [728]
SESN2 OT889IXY Strong Genetic Variation [1091]
SFRP5 OTLCVVSH Strong Biomarker [1092]
SFTPA1 OT87XL1U Strong Biomarker [1093]
SFTPA2 OT6SFOMU Strong Biomarker [1093]
SGMS1 OTZQE7PW Strong Biomarker [1094]
SGMS2 OT3NHO99 Strong Biomarker [1095]
SHBG OTPWU5IW Strong Biomarker [1096]
SIGIRR OTNC3XFD Strong Biomarker [1097]
SIGLEC9 OTZC7SIM Strong Altered Expression [1098]
SIRT7 OT5M4OT4 Strong Biomarker [1099]
SLC22A18 OT9C3KR4 Strong Biomarker [1100]
SLC2A4RG OTW3LX8D Strong Altered Expression [1017]
SMARCAL1 OTTKXLUZ Strong Genetic Variation [1101]
SMCP OTXKY794 Strong Genetic Variation [970]
SMPD3 OTHQBETH Strong Biomarker [558]
SMS OT8JYKNH Strong Biomarker [1102]
SMUG1 OT2YIOCQ Strong Biomarker [1103]
SNAI2 OT7Y8EJ2 Strong Altered Expression [242]
SNF8 OTRQA2AI Strong Biomarker [1104]
SNX19 OTGNS3HG Strong Genetic Variation [976]
SOAT1 OTB4Y5RJ Strong Biomarker [1105]
SOD3 OTIOZQAB Strong Genetic Variation [1106]
SOX18 OTPUMHWA Strong Biomarker [1107]
SP6 OTRAB1PN Strong Biomarker [689]
SPEG OTQXWJR4 Strong Genetic Variation [1108]
SPI1 OTVCA1D0 Strong Biomarker [580]
SPON2 OTE7JLNM Strong Biomarker [1109]
SPX OTY3G4AR Strong Biomarker [1110]
SRI OT4R3EAC Strong Biomarker [1111]
SRRM2 OTSIMMC9 Strong Biomarker [283]
SSBP1 OTH2PZWH Strong Altered Expression [1112]
ST3GAL4 OTNENJZQ Strong Biomarker [1113]
ST6GAL1 OT7US3NO Strong Biomarker [1114]
STAT4 OTAK3VFR Strong Biomarker [1115]
STEAP4 OTFTLAEZ Strong Biomarker [1116]
STK25 OT4YPNTF Strong Biomarker [1117]
STRIP2 OTQLZ6Z7 Strong Biomarker [1118]
STUB1 OTSUYI9A Strong Biomarker [1119]
SUCLA2 OTMZD4PW Strong Genetic Variation [1120]
SUMO1 OTJFD4P5 Strong Biomarker [1089]
TADA1 OTV9RKSL Strong Altered Expression [1121]
TAF3 OTVMULE9 Strong Biomarker [1122]
TBPL2 OTDEC1KO Strong Biomarker [1123]
TBX20 OTMPU2XQ Strong Biomarker [1124]
TCF15 OTA6UCWC Strong Altered Expression [1125]
TDRD9 OTS4UBI8 Strong Genetic Variation [860]
TESC OTI8C76M Strong Biomarker [547]
TET3 OT76U3YF Strong Biomarker [1091]
TFAM OTXXV5V7 Strong Biomarker [1005]
TFEB OTJUJJQY Strong Biomarker [1126]
TFPI2 OTZCRWOR Strong Biomarker [1127]
TGFB1I1 OTIK337D Strong Biomarker [1128]
THBS4 OTA1T9KK Strong Biomarker [728]
TIMELESS OTD8DCBJ Strong Biomarker [762]
TM7SF2 OTILU5S7 Strong Biomarker [243]
TMEM18 OT05YQ1E Strong Biomarker [1129]
TMSB10 OTLVZ13T Strong Altered Expression [1130]
TNFAIP6 OT1SLUZH Strong Biomarker [1131]
TNFAIP8L1 OTVVKOTV Strong Biomarker [1132]
TNFAIP8L2 OTII0RM0 Strong Biomarker [1133]
TNFSF9 OTV9L89D Strong Biomarker [219]
TOLLIP OTYEO4NR Strong Biomarker [1134]
TPI1 OT14KP4B Strong Biomarker [762]
TPM2 OTA1L0P8 Strong Biomarker [685]
TRAF1 OTTLM5RU Strong Biomarker [1135]
TRAM1 OT3I0H8E Strong Genetic Variation [1136]
TRAT1 OTMPUNPD Strong Biomarker [596]
TRIB3 OTG5OS7X Strong Genetic Variation [1137]
TRIM14 OTLQKUG0 Strong Biomarker [1138]
TRPV5 OTWF4L0U Strong Biomarker [1139]
TSPAN31 OT8WQ83R Strong Biomarker [981]
ADIPOR1 OT65ZFZN Definitive Altered Expression [1140]
AHRR OTSJ12W6 Definitive Genetic Variation [724]
ALOX15B OTWQQ08W Definitive Biomarker [1141]
ATOH1 OTBZYG2R Definitive Biomarker [1142]
C1QTNF5 OTLKU5I2 Definitive Biomarker [1143]
C1QTNF9 OTLI3VA3 Definitive Altered Expression [1144]
DHX40 OTOL02QN Definitive Biomarker [1145]
EPRS1 OTXK0FLB Definitive Genetic Variation [1146]
FOXO3 OTHXQG4P Definitive Biomarker [500]
HS3ST1 OT5DVN9P Definitive Genetic Variation [1147]
ISG20 OTCWRJJW Definitive Biomarker [1057]
LYPLA1 OTENU47T Definitive Biomarker [1148]
MFRP OTHY9ZA5 Definitive Biomarker [1143]
MMRN1 OT7ZNYHT Definitive Biomarker [1149]
MPZL2 OTKFNDUI Definitive Genetic Variation [637]
MTHFD2 OT1LQSGX Definitive Biomarker [1150]
MYDGF OT9HRPL6 Definitive Biomarker [142]
PIK3R3 OTXGJ8N1 Definitive Altered Expression [675]
PLA2G6 OT5FL0WU Definitive Altered Expression [1030]
PRSS55 OTXXWI5Y Definitive Altered Expression [824]
RAMP1 OT7UT2XB Definitive Altered Expression [1151]
RFC2 OTJ9N6BD Definitive Genetic Variation [1152]
SORBS3 OTVEUODC Definitive Biomarker [1153]
SPZ1 OTQH8HJ5 Definitive Altered Expression [824]
TOR2A OT1EGCDU Definitive Altered Expression [1154]
------------------------------------------------------------------------------------
⏷ Show the Full List of 637 DOT(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1596).
2 Atorvastatin FDA Label
3 Fluvastatin FDA Label
4 Lovastatin FDA Label
5 Pravastatin FDA Label
6 Rosuvastatin FDA Label
7 Simvastatin FDA Label
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023729)
9 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8400).
10 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7797).
11 ClinicalTrials.gov (NCT00151788) Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.. U.S. National Institutes of Health.
12 ClinicalTrials.gov (NCT02108262) A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.. U.S. National Institutes of Health.
13 ClinicalTrials.gov (NCT01388816) A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels. U.S. National Institutes of Health.
14 DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial. Mol Ther. 2013 Mar;21(3):707-14.
15 ClinicalTrials.gov (NCT00783081) Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication. U.S. National Institutes of Health.
16 ClinicalTrials.gov (NCT00851500) A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis. U.S. National Institutes of Health.
17 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024862)
18 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5785).
19 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
20 ClinicalTrials.gov (NCT01645306) Revacept in Symptomatic Carotid Stenosis (Revacept/CS/02). U.S. National Institutes of Health.
21 VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clin Exp Immunol. 2014 Jan;175(1):126-37.
22 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5594).
23 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002679)
24 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034993)
25 ClinicalTrials.gov (NCT00836602) Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects. U.S. National Institutes of Health.
26 ClinicalTrials.gov (NCT01651273) A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia. U.S. National Institutes of Health.
27 ClinicalTrials.gov (NCT00796575) Effects of Multiple Doses of CS-8080 in Healthy Volunteers. U.S. National Institutes of Health.
28 Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014 Jun;13(6):433-44.
29 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012886)
30 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7376).
31 ClinicalTrials.gov (NCT00985478) First in Man Study With SLV342. U.S. National Institutes of Health.
32 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029634)
33 Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.
34 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1595).
35 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6696).
36 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008445)
37 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012887)
38 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008143)
39 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010688)
40 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000343)
41 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005302)
42 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004425)
43 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012486)
44 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022118)
45 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001648)
46 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025536)
47 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003109)
48 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020582)
49 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008868)
50 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025982)
51 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012955)
52 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014823)
53 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004102)
54 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004661)
55 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025539)
56 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025537)
57 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025540)
58 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025541)
59 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019399)
60 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021613)
61 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015443)
62 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017234)
63 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030801)
64 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033616)
65 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015904)
66 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003719)
67 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005136)
68 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003704)
69 B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination. J Antibiot (Tokyo). 2000 Aug;53(8):753-8.
70 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017452)
71 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003702)
72 Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. J Lipid Res. 1997 Mar;38(3):564-75.
73 Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J Lipid Res. 1996 Jan;37(1):148-58.
74 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004635)
75 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001538)
76 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007178)
77 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001910)
78 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004510)
79 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010990)
80 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004500)
81 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000245)
82 F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete. J Antibiot (Tokyo). 2000 May;53(5):459-66.
83 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001907)
84 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002683)
85 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006465)
86 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011586)
87 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021743)
88 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 777).
89 WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting.
90 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005472)
91 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001533)
92 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008195)
93 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010267)
94 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003588)
95 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006470)
96 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004423)
97 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009165)
98 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3057).
99 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2763).
100 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008057)
101 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003139)
102 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004501)
103 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003268)
104 Toxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouse. Toxicol Pathol. 2001 Mar-Apr;29(2):174-9.
105 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 59).
106 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2592).
107 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5788).
108 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1636).
109 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 347).
110 A novel association between TGFb1 and ADAMTS4 in coronary artery disease: A new potential mechanism in the progression of atherosclerosis and diabetes.Anatol J Cardiol. 2015 Oct;15(10):823-9. doi: 10.5152/akd.2014.5762. Epub 2014 Oct 31.
111 Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.Medicine (Baltimore). 2019 Feb;98(5):e14216. doi: 10.1097/MD.0000000000014216.
112 New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.Curr Opin Lipidol. 2019 Jun;30(3):205-211. doi: 10.1097/MOL.0000000000000600.
113 Short AIP1 (ASK1-Interacting Protein-1) Isoform Localizes to the Mitochondria and Promotes Vascular Dysfunction.Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):112-127. doi: 10.1161/ATVBAHA.119.312976. Epub 2019 Oct 17.
114 BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation.J Cell Mol Med. 2018 Nov;22(11):5429-5438. doi: 10.1111/jcmm.13814. Epub 2018 Aug 13.
115 Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1933-41. doi: 10.1161/ATVBAHA.113.303081. Epub 2014 Jul 2.
116 Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain.J Vis Exp. 2018 Jan 4;(131):56410. doi: 10.3791/56410.
117 Resolvin D1 promotes the targeting and clearance of necroptotic cells.Cell Death Differ. 2020 Feb;27(2):525-539. doi: 10.1038/s41418-019-0370-1. Epub 2019 Jun 20.
118 Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.J Diabetes Complications. 2017 Feb;31(2):311-317. doi: 10.1016/j.jdiacomp.2016.08.021. Epub 2016 Aug 28.
119 Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis.Acta Ophthalmol. 2012 Dec;90(8):695-703. doi: 10.1111/j.1755-3768.2011.02295.x. Epub 2011 Nov 8.
120 Injection of hTERT-Transduced Endothelial Progenitor Cells Promotes Beneficial Aortic Changes in a High-Fat Dietary Model of Early Atherosclerosis.Cardiology. 2017;136(4):230-240. doi: 10.1159/000447997. Epub 2016 Nov 9.
121 Shear stress regulates cystathionine lyase expression to preserve endothelial redox balance and reduce membrane lipid peroxidation.Redox Biol. 2020 Jan;28:101379. doi: 10.1016/j.redox.2019.101379. Epub 2019 Nov 13.
122 Interleukin-33 induces growth-regulated oncogene- expression and secretion in human umbilical vein endothelial cells.Am J Physiol Regul Integr Comp Physiol. 2017 Sep 1;313(3):R272-R279. doi: 10.1152/ajpregu.00435.2016. Epub 2017 Jun 21.
123 Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes.J Diabetes Complications. 2020 Jan;34(1):107469. doi: 10.1016/j.jdiacomp.2019.107469. Epub 2019 Nov 1.
124 Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.J Am Heart Assoc. 2017 Feb 20;6(2):e004690. doi: 10.1161/JAHA.116.004690.
125 CD39 identifies a microenvironment-specific anti-inflammatory CD8(+) T-cell population in atherosclerotic lesions.Atherosclerosis. 2019 Jun;285:71-78. doi: 10.1016/j.atherosclerosis.2019.04.217. Epub 2019 Apr 11.
126 Soluble epoxide hydrolase in atherosclerosis.Curr Atheroscler Rep. 2010 May;12(3):174-83. doi: 10.1007/s11883-010-0108-5.
127 Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.Sci Rep. 2019 Mar 7;9(1):3909. doi: 10.1038/s41598-019-40602-w.
128 Human low-affinity IgG receptor FcRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.J Thromb Haemost. 2019 Mar;17(3):532-537. doi: 10.1111/jth.14385. Epub 2019 Feb 13.
129 Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients.Mediators Inflamm. 2017;2017:1070959. doi: 10.1155/2017/1070959. Epub 2017 Oct 22.
130 Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(-/-) mice.Br J Pharmacol. 2017 Nov;174(22):4043-4054. doi: 10.1111/bph.13707. Epub 2017 Feb 14.
131 FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):387-401. doi: 10.1161/ATVBAHA.118.311903.
132 Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression.Cardiovasc Res. 2018 Aug 1;114(10):1385-1399. doi: 10.1093/cvr/cvy078.
133 Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.Acc Chem Res. 2017 Jul 18;50(7):1541-1556. doi: 10.1021/acs.accounts.7b00114. Epub 2017 Jun 9.
134 Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells.Diabetes. 2004 Aug;53(8):2117-21. doi: 10.2337/diabetes.53.8.2117.
135 Peripheral leucocytes and tissue gene expression of granzyme B/perforin system and serpinB9: Impact on inflammation and insulin resistance in coronary atherosclerosis.Diabetes Res Clin Pract. 2017 Sep;131:132-141. doi: 10.1016/j.diabres.2017.07.013. Epub 2017 Jul 12.
136 HMGA1 is a novel candidate gene for myocardial infarction susceptibility.Int J Cardiol. 2017 Jan 15;227:331-334. doi: 10.1016/j.ijcard.2016.11.088. Epub 2016 Nov 9.
137 Allergic asthma aggravated atherosclerosis increases cholesterol biosynthesis and foam cell formation in apolipoprotein E-deficient mice.Biochem Biophys Res Commun. 2019 Nov 19;519(4):861-867. doi: 10.1016/j.bbrc.2019.09.085. Epub 2019 Sep 24.
138 The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis.Signal Transduct Target Ther. 2019 Jul 19;4:23. doi: 10.1038/s41392-019-0058-5. eCollection 2019.
139 IL-15 polymorphisms are associated with subclinical atherosclerosis and cardiovascular risk factors. The Genetics of Atherosclerosis Disease (GEA) Mexican Study.Cytokine. 2017 Nov;99:173-178. doi: 10.1016/j.cyto.2017.09.006. Epub 2017 Sep 15.
140 Interleukin 27 polymorphisms, their association with insulin resistance and their contribution to subclinical atherosclerosis. The GEA Mexican study.Cytokine. 2019 Feb;114:32-37. doi: 10.1016/j.cyto.2018.11.028. Epub 2018 Dec 26.
141 IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice.J Am Heart Assoc. 2018 Apr 4;7(8):e008257. doi: 10.1161/JAHA.117.008257.
142 ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.BMC Immunol. 2019 Dec 10;20(1):47. doi: 10.1186/s12865-019-0330-z.
143 LncRNA CASC11 improves atherosclerosis by downregulating IL-9 and regulating vascular smooth muscle cell apoptosis and proliferation.Biosci Biotechnol Biochem. 2019 Jul;83(7):1284-1288. doi: 10.1080/09168451.2019.1597621. Epub 2019 Mar 27.
144 IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux.Bioessays. 2016 Jul;38(7):591-604. doi: 10.1002/bies.201600085. Epub 2016 Jun 8.
145 Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.J Autoimmun. 2019 Nov;104:102317. doi: 10.1016/j.jaut.2019.102317. Epub 2019 Aug 20.
146 The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.Diabetologia. 2017 Sep;60(9):1801-1812. doi: 10.1007/s00125-017-4330-3. Epub 2017 Jun 12.
147 Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.PLoS One. 2012;7(10):e47985. doi: 10.1371/journal.pone.0047985. Epub 2012 Oct 24.
148 Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish.Atherosclerosis. 2019 Nov;290:125-135. doi: 10.1016/j.atherosclerosis.2019.09.017. Epub 2019 Sep 27.
149 Overexpression of lysosomal acid lipase and other proteins in atherosclerosis.J Biochem. 2006 Jul;140(1):23-38. doi: 10.1093/jb/mvj137.
150 Leukotriene B(4)-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression.Oncoimmunology. 2017 Aug 10;6(12):e1361593. doi: 10.1080/2162402X.2017.1361593. eCollection 2017.
151 NLRP3 inflammasome: Its regulation and involvement in atherosclerosis.J Cell Physiol. 2018 Mar;233(3):2116-2132. doi: 10.1002/jcp.25930. Epub 2017 May 23.
152 Regulation of MFGE8 by the intergenic coronary artery disease locus on 15q26.1.Atherosclerosis. 2019 May;284:11-17. doi: 10.1016/j.atherosclerosis.2019.02.012. Epub 2019 Feb 22.
153 LPS enhances expression of CD204 through the MAPK/ERK pathway in murine bone marrow macrophages.Atherosclerosis. 2017 Nov;266:167-175. doi: 10.1016/j.atherosclerosis.2017.10.005. Epub 2017 Oct 6.
154 Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.Mol Pharmacol. 2019 Jul;96(1):47-55. doi: 10.1124/mol.119.115840. Epub 2019 May 7.
155 Shikonin attenuates hyperhomocysteinemia-induced CD4(+) T cell inflammatory activation and atherosclerosis in ApoE(-/-) mice by metabolic suppression.Acta Pharmacol Sin. 2020 Jan;41(1):47-55. doi: 10.1038/s41401-019-0308-7. Epub 2019 Oct 13.
156 Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophagesImplications in atherosclerosis. Atherosclerosis. 2006 Oct;188(2):433-43.
157 Altered expression of inflammation-related genes in human carotid atherosclerotic plaques.Atherosclerosis. 2012 Jan;220(1):93-101. doi: 10.1016/j.atherosclerosis.2011.10.022. Epub 2011 Oct 25.
158 Sildenafil (Viagra) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE-/- Mice.Cell Physiol Biochem. 2017;44(5):1796-1809. doi: 10.1159/000485817. Epub 2017 Dec 7.
159 Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention.J Diabetes Res. 2018 Aug 16;2018:7329861. doi: 10.1155/2018/7329861. eCollection 2018.
160 A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis.Circulation. 2013 Jan 29;127(4):486-99. doi: 10.1161/CIRCULATIONAHA.112.116988. Epub 2012 Dec 14.
161 Platelet-neutrophil interaction aggravates vascular inammation and promotes the progression of atherosclerosis by activating the TLR4/NF-B pathway.J Cell Biochem. 2019 Apr;120(4):5612-5619. doi: 10.1002/jcb.27844. Epub 2018 Oct 9.
162 Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques.Mol Imaging Biol. 2018 Jun;20(3):448-456. doi: 10.1007/s11307-017-1141-3.
163 Sodium Orthovanadate Changes Fatty Acid Composition and Increased Expression of Stearoyl-Coenzyme A Desaturase in THP-1 Macrophages.Biol Trace Elem Res. 2020 Jan;193(1):152-161. doi: 10.1007/s12011-019-01699-2. Epub 2019 Mar 29.
164 Common coding variant in SERPINA1 increases the risk for large artery stroke.Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3613-3618. doi: 10.1073/pnas.1616301114. Epub 2017 Mar 6.
165 p53 mediates PEDFinduced autophagy in human umbilical vein endothelial cells through sestrin2 signaling.Mol Med Rep. 2019 Aug;20(2):1443-1450. doi: 10.3892/mmr.2019.10319. Epub 2019 Jun 3.
166 Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases.Free Radic Res. 2019 Feb;53(2):139-149. doi: 10.1080/10715762.2018.1549732. Epub 2018 Dec 26.
167 Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells.Biochem Cell Biol. 2020 Apr;98(2):120-129. doi: 10.1139/bcb-2019-0057. Epub 2019 May 7.
168 Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence.Aging Dis. 2019 Oct 1;10(5):1012-1025. doi: 10.14336/AD.2018.0919. eCollection 2019 Oct.
169 Amorphous nano-selenium quantum dots improve endothelial dysfunction in rats and prevent atherosclerosis in mice through Na(+)/H(+) exchanger 1 inhibition.Vascul Pharmacol. 2019 Apr;115:26-32. doi: 10.1016/j.vph.2019.01.005. Epub 2019 Jan 26.
170 Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.Am J Physiol Endocrinol Metab. 2020 Feb 1;318(2):E131-E144. doi: 10.1152/ajpendo.00181.2019. Epub 2019 Dec 10.
171 The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway.Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1175-1187. doi: 10.1016/j.numecd.2018.06.017. Epub 2018 Jun 28.
172 Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.Cardiology. 2017;138(3):141-146. doi: 10.1159/000460239. Epub 2017 Jun 27.
173 Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand.Curr Res Transl Med. 2018 Sep;66(3):71-82. doi: 10.1016/j.retram.2018.02.002. Epub 2018 Aug 11.
174 The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.Exp Ther Med. 2017 Aug;14(2):891-897. doi: 10.3892/etm.2017.4600. Epub 2017 Jun 14.
175 B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.Circulation. 2018 Nov 13;138(20):2263-2273. doi: 10.1161/CIRCULATIONAHA.117.032790.
176 Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.Atherosclerosis. 2017 May;260:130-137. doi: 10.1016/j.atherosclerosis.2017.03.043. Epub 2017 Mar 31.
177 Tumour necrosis factor like cytokine 1A levels and lesion complexity in non-smoking patients with coronary artery disease.Biomarkers. 2019 Dec;24(8):764-770. doi: 10.1080/1354750X.2019.1685004. Epub 2019 Nov 5.
178 VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.Hum Genet. 2013 Jan;132(1):29-37. doi: 10.1007/s00439-012-1222-y. Epub 2012 Aug 23.
179 Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.Mol Metab. 2018 Mar;9:131-140. doi: 10.1016/j.molmet.2018.01.005. Epub 2018 Jan 11.
180 Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.Nutr Metab Cardiovasc Dis. 2019 Mar;29(3):306-315. doi: 10.1016/j.numecd.2018.12.006. Epub 2019 Jan 9.
181 Insulin-like growth factor-binding protein 7 (IGFBP 7) as a new biomarker in coronary heart disease.Adv Med Sci. 2019 Mar;64(1):195-201. doi: 10.1016/j.advms.2018.08.017. Epub 2019 Feb 13.
182 Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.Hypertension. 2017 Mar;69(3):510-520. doi: 10.1161/HYPERTENSIONAHA.116.08395. Epub 2017 Jan 23.
183 The renal tubular damage marker urinary N-acetyl--D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.Cardiovasc Diabetol. 2017 Jan 26;16(1):16. doi: 10.1186/s12933-017-0497-7.
184 OSCAR is a receptor for surfactant protein D that activates TNF- release from human CCR2+ inflammatory monocytes.J Immunol. 2015 Apr 1;194(7):3317-26. doi: 10.4049/jimmunol.1402289. Epub 2015 Feb 25.
185 Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.Cardiovasc Diabetol. 2017 Oct 16;16(1):133. doi: 10.1186/s12933-017-0612-9.
186 RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population.Eur Rev Med Pharmacol Sci. 2016 Nov;20(21):4574-4580.
187 Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1240-1252. doi: 10.1161/ATVBAHA.118.312166.
188 Sitosterolemia presenting with severe hypercholesterolemia and intertriginous xanthomas in a breastfed infant: case report and brief review.J Clin Endocrinol Metab. 2014 May;99(5):1512-8. doi: 10.1210/jc.2013-3274. Epub 2014 Jan 1.
189 Myeloid Acat1/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions.J Biol Chem. 2019 Oct 25;294(43):15836-15849. doi: 10.1074/jbc.RA119.010564. Epub 2019 Sep 8.
190 Atypical Chemokine Receptors in Cardiovascular Disease.Thromb Haemost. 2019 Apr;119(4):534-541. doi: 10.1055/s-0038-1676988. Epub 2019 Feb 4.
191 ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.Prog Lipid Res. 2020 Jan;77:101006. doi: 10.1016/j.plipres.2019.101006. Epub 2019 Sep 6.
192 Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2.Biochem Biophys Res Commun. 2019 Apr 30;512(2):319-325. doi: 10.1016/j.bbrc.2019.03.037. Epub 2019 Mar 15.
193 Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis.Biochem Biophys Res Commun. 2019 Jun 18;514(1):266-272. doi: 10.1016/j.bbrc.2019.04.143. Epub 2019 Apr 25.
194 The advantageous role of annexin A1 in cardiovascular disease.Cell Adh Migr. 2017 May 4;11(3):261-274. doi: 10.1080/19336918.2016.1259059. Epub 2016 Nov 18.
195 B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.Cardiovasc Res. 2020 Feb 1;116(2):295-305. doi: 10.1093/cvr/cvz129.
196 Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort.Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1762-1775. doi: 10.1161/ATVBAHA.119.312603. Epub 2019 Jul 18.
197 Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes.Inflamm Res. 2011 Sep;60(9):889-95. doi: 10.1007/s00011-011-0350-5. Epub 2011 Jun 9.
198 Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.Scand J Rheumatol. 2020 Jan;49(1):33-37. doi: 10.1080/03009742.2019.1614213. Epub 2019 Jun 4.
199 Apolipoprotein J as a predictive biomarker for restenosis after carotid endarterectomy: a retrospective study.Acta Pharmacol Sin. 2018 Jul;39(7):1237-1242. doi: 10.1038/aps.2017.146. Epub 2018 Feb 8.
200 Cystathionine Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis.Circulation. 2019 Jan 2;139(1):101-114. doi: 10.1161/CIRCULATIONAHA.118.034757.
201 CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium.Cytokine. 2019 Oct;122:154081. doi: 10.1016/j.cyto.2017.06.008. Epub 2017 Jun 21.
202 Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):145-158. doi: 10.1161/atv.0000615456.97862.30. Epub 2019 Nov 21.
203 Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.J Am Heart Assoc. 2018 Feb 8;7(4):e008187. doi: 10.1161/JAHA.117.008187.
204 Risky communication in atherosclerosis and thrombus formation.Swiss Med Wkly. 2012 Apr 5;142:w13553. doi: 10.4414/smw.2012.13553. eCollection 2012.
205 The Effects of Anti-IL-23p19 Therapy on Atherosclerosis Development in ApoE(-/-) Mice.J Interferon Cytokine Res. 2019 Sep;39(9):564-571. doi: 10.1089/jir.2019.0050. Epub 2019 Jul 2.
206 Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.Cardiovasc Diabetol. 2018 Feb 20;17(1):31. doi: 10.1186/s12933-018-0675-2.
207 Polymorphism of the 3'-untranslated region of interleukin-12 p40 gene is not associated with the presence or severity of coronary artery disease.Circ J. 2005 Jul;69(7):793-7. doi: 10.1253/circj.69.793.
208 Therapeutic Targeting of LRP6 in Cardiovascular Diseases: Challenging But Not Wnt-Possible!.Can J Cardiol. 2019 Nov;35(11):1567-1575. doi: 10.1016/j.cjca.2019.06.030. Epub 2019 Jul 11.
209 Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1368-1380. doi: 10.1161/ATVBAHA.118.310967. Epub 2018 Apr 5.
210 TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates.Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):86-102. doi: 10.1161/ATVBAHA.119.313200. Epub 2019 Oct 10.
211 Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality.Circ Res. 2019 May 10;124(10):1492-1504. doi: 10.1161/CIRCRESAHA.118.313413.
212 Physical exercise inhibits atherosclerosis development by regulating the expression of neuropeptide Y in apolipoprotein E-deficient mice.Life Sci. 2019 Nov 15;237:116896. doi: 10.1016/j.lfs.2019.116896. Epub 2019 Oct 9.
213 Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation.Thromb Haemost. 2019 Apr;119(4):542-552. doi: 10.1055/s-0039-1678664. Epub 2019 Feb 7.
214 What Proportion of Patients Admitted with Stroke or Transient Ischemic Attack May Be Suitable for Newer Cholesterol-Lowering Treatment?.J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104457. doi: 10.1016/j.jstrokecerebrovasdis.2019.104457. Epub 2019 Nov 13.
215 Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.Genet Mol Res. 2017 Jan 23;16(1). doi: 10.4238/gmr16019324.
216 FAK and Pyk2 activity promote TNF- and IL-1-mediated pro-inflammatory gene expression and vascular inflammation.Sci Rep. 2019 May 20;9(1):7617. doi: 10.1038/s41598-019-44098-2.
217 Improving obesity and blood pressure.Hypertens Res. 2020 Feb;43(2):79-89. doi: 10.1038/s41440-019-0348-x. Epub 2019 Oct 25.
218 The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.Lipids Health Dis. 2017 Oct 30;16(1):207. doi: 10.1186/s12944-017-0594-3.
219 Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia.Cell Mol Neurobiol. 2019 Apr;39(3):451-460. doi: 10.1007/s10571-019-00661-z. Epub 2019 Feb 18.
220 Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure.Int J Cardiol. 2019 Mar 15;279:141-144. doi: 10.1016/j.ijcard.2018.12.076. Epub 2018 Dec 28.
221 Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE(-/-) mice.Biomed Pharmacother. 2019 Nov;119:109410. doi: 10.1016/j.biopha.2019.109410. Epub 2019 Sep 10.
222 Dysfunctional HDL and atherosclerotic cardiovascular disease.Nat Rev Cardiol. 2016 Jan;13(1):48-60. doi: 10.1038/nrcardio.2015.124. Epub 2015 Sep 1.
223 Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.J Vasc Surg. 2019 Nov;70(5):1658-1668.e1. doi: 10.1016/j.jvs.2018.11.045. Epub 2019 Mar 6.
224 Towards Targeting the Urotensinergic System: Overview and Challenges.Trends Pharmacol Sci. 2019 Oct;40(10):725-734. doi: 10.1016/j.tips.2019.08.005. Epub 2019 Sep 6.
225 Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.Aging (Albany NY). 2019 Mar 29;11(6):1695-1715. doi: 10.18632/aging.101863.
226 Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT(1)R/ROS/p38 MAPK/ADAM17 pathway.Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C776-C787. doi: 10.1152/ajpcell.00145.2019. Epub 2019 Aug 7.
227 ADAM33 gene polymorphisms and mortality. A prospective cohort study.PLoS One. 2013 Jul 4;8(7):e67768. doi: 10.1371/journal.pone.0067768. Print 2013.
228 Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.J Cell Biochem. 2003 Jul 1;89(4):808-23. doi: 10.1002/jcb.10550.
229 ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.J Biol Chem. 2006 Jun 30;281(26):17827-37. doi: 10.1074/jbc.M513465200. Epub 2006 Apr 26.
230 ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.PLoS Biol. 2019 Jun 11;17(6):e3000313. doi: 10.1371/journal.pbio.3000313. eCollection 2019 Jun.
231 Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis.J Biol Chem. 2012 Jun 1;287(23):19341-5. doi: 10.1074/jbc.C112.350785. Epub 2012 Apr 9.
232 Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE(-/-) (Apolipoprotein E Deficient) Mice.Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2780-2792. doi: 10.1161/ATVBAHA.118.311806.
233 Intermedin Ameliorates Atherosclerosis by Increasing Cholesterol Efflux Through the cAMP-PKA Pathway in Macrophage RAW264.7 Cell Line.Med Sci Monit. 2017 Nov 17;23:5462-5471. doi: 10.12659/msm.907298.
234 Higher cardiorespiratory fitness attenuates the risk of atherosclerosis associated with ADRB3 Trp64Arg polymorphism.Eur J Appl Physiol. 2014;114(7):1421-8. doi: 10.1007/s00421-014-2862-5. Epub 2014 Mar 23.
235 American Heart Association ideal cardiovascular health score and subclinical atherosclerosis in 22-35-year-old adults conceived with and without assisted reproductive technologies.Hum Reprod. 2020 Jan 1;35(1):232-239. doi: 10.1093/humrep/dez240.
236 The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.Diabetologia. 2016 Aug;59(8):1778-90. doi: 10.1007/s00125-016-3977-5. Epub 2016 May 11.
237 S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis.J Biol Chem. 2008 Aug 29;283(35):23989-99. doi: 10.1074/jbc.M800830200. Epub 2008 Jun 30.
238 Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-B signaling in macrophages.Cell Cycle. 2019 Nov;18(21):2928-2938. doi: 10.1080/15384101.2019.1662678. Epub 2019 Sep 8.
239 Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.Diabetes. 2018 Sep;67(9):1880-1891. doi: 10.2337/db18-0156. Epub 2018 Jun 11.
240 Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.Pharmacol Res. 2018 Aug;134:311-319. doi: 10.1016/j.phrs.2018.06.014. Epub 2018 Jun 18.
241 Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease.J Am Heart Assoc. 2019 Jul 16;8(14):e012486. doi: 10.1161/JAHA.119.012486. Epub 2019 Jul 15.
242 Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway.Int J Cardiol. 2017 Feb 1;228:605-614. doi: 10.1016/j.ijcard.2016.11.195. Epub 2016 Nov 12.
243 Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158535. doi: 10.1016/j.bbalip.2019.158535. Epub 2019 Oct 31.
244 ANGPTL4 in Metabolic and Cardiovascular Disease.Trends Mol Med. 2019 Aug;25(8):723-734. doi: 10.1016/j.molmed.2019.05.010. Epub 2019 Jun 21.
245 Annexin A5 reduces early plaque formation in ApoE -/- mice.PLoS One. 2017 Dec 21;12(12):e0190229. doi: 10.1371/journal.pone.0190229. eCollection 2017.
246 Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.Transl Res. 2018 Jul;197:12-31. doi: 10.1016/j.trsl.2018.03.001. Epub 2018 Mar 27.
247 Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages.Theranostics. 2018 May 11;8(12):3214-3223. doi: 10.7150/thno.22704. eCollection 2018.
248 ROS-Autophagy pathway mediates monocytes-human umbilical vein endothelial cells adhesion induced by apelin-13.J Cell Physiol. 2018 Oct;233(10):6839-6850. doi: 10.1002/jcp.26554. Epub 2018 Apr 24.
249 Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes.Cells. 2019 Apr 5;8(4):319. doi: 10.3390/cells8040319.
250 Interleukin-17/Interleukin-21 and Interferon- producing T cells specific for 2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.Haematologica. 2019 Dec;104(12):2519-2527. doi: 10.3324/haematol.2018.209536. Epub 2019 Mar 14.
251 The water channel AQP1 is expressed in human atherosclerotic vascular lesions and AQP1 deficiency augments angiotensin II-induced atherosclerosis in mice.Acta Physiol (Oxf). 2017 Aug;220(4):446-460. doi: 10.1111/apha.12853. Epub 2017 Feb 22.
252 Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice.J Physiol Biochem. 2018 Feb;74(1):9-16. doi: 10.1007/s13105-017-0597-6. Epub 2017 Nov 3.
253 Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization.Sci Rep. 2017 Jun 28;7(1):4338. doi: 10.1038/s41598-017-04497-9.
254 Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.Acta Pharmacol Sin. 2018 Jan;39(1):48-58. doi: 10.1038/aps.2017.81. Epub 2017 Aug 31.
255 Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis.Front Immunol. 2018 Dec 12;9:2937. doi: 10.3389/fimmu.2018.02937. eCollection 2018.
256 The influence of AICAR - direct activator of AMP-activated protein kinase (AMPK) - on liver proteome in apoE-knockout mice.Eur J Pharm Sci. 2017 Jun 15;104:406-416. doi: 10.1016/j.ejps.2017.04.021. Epub 2017 Apr 26.
257 Role of adipokine zinc-(2)-glycoprotein in coronary heart disease.Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1055-E1062. doi: 10.1152/ajpendo.00075.2019. Epub 2019 Sep 17.
258 TNF- regulates the proteolytic degradation of ST6Gal-1 and endothelial cell-cell junctions through upregulating expression of BACE1.Sci Rep. 2017 Jan 16;7:40256. doi: 10.1038/srep40256.
259 Increased Reactive Oxygen Species Generation Contributes to the Atherogenic Activity of the B2 Bradykinin Receptor.Front Med (Lausanne). 2019 Feb 21;6:32. doi: 10.3389/fmed.2019.00032. eCollection 2019.
260 Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.Eur J Pharmacol. 2019 Sep 5;858:172338. doi: 10.1016/j.ejphar.2019.04.019. Epub 2019 Apr 25.
261 Bromodomain-containing protein 7 deficiency augments atherosclerotic lesions in ApoE(-/-) mice.Biochem Biophys Res Commun. 2018 Jan 15;495(3):2202-2208. doi: 10.1016/j.bbrc.2017.12.103. Epub 2017 Dec 19.
262 Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.Int J Mol Sci. 2018 Feb 8;19(2):507. doi: 10.3390/ijms19020507.
263 gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.Adv Exp Med Biol. 2006;586:95-105. doi: 10.1007/0-387-34134-X_7.
264 Carbonic Anhydrase 1-Mediated Calcification Is Associated With Atherosclerosis, and Methazolamide Alleviates Its Pathogenesis.Front Pharmacol. 2019 Jul 10;10:766. doi: 10.3389/fphar.2019.00766. eCollection 2019.
265 Associations of Unhealthy Food Environment With the Development of Coronary Artery Calcification: The CARDIA Study.J Am Heart Assoc. 2019 Feb 19;8(4):e010586. doi: 10.1161/JAHA.118.010586.
266 Association study of CACNA1C polymorphisms with large artery atherosclerotic stroke in Chinese Han population.Neurol Res. 2018 Aug;40(8):677-682. doi: 10.1080/01616412.2018.1461307. Epub 2018 Apr 23.
267 Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol.BMJ Open. 2019 Jan 25;9(1):e022843. doi: 10.1136/bmjopen-2018-022843.
268 Ca2+/calmodulin-dependent protein kinase kinase phosphorylation of Sirtuin 1 in endothelium is atheroprotective.Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2420-7. doi: 10.1073/pnas.1309354110. Epub 2013 Jun 10.
269 Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.J Vasc Res. 2017;54(3):123-130. doi: 10.1159/000464288. Epub 2017 Apr 28.
270 Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.Circulation. 2009 Nov 10;120(19):1893-902. doi: 10.1161/CIRCULATIONAHA.109.866889. Epub 2009 Oct 26.
271 CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.J Clin Invest. 2011 Jul;121(7):2898-910. doi: 10.1172/JCI44925.
272 Relationship between CCL22 Expression by Vascular Smooth Muscle Cells and Macrophage Histamine Receptors in Atherosclerosis.J Atheroscler Thromb. 2018 Dec 1;25(12):1240-1254. doi: 10.5551/jat.44297. Epub 2018 May 22.
273 Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies.J Biomol Struct Dyn. 2019 Jan;37(1):75-94. doi: 10.1080/07391102.2017.1418679. Epub 2018 Jan 3.
274 Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.Cardiovasc Res. 2006 Feb 15;69(3):706-15. doi: 10.1016/j.cardiores.2005.09.012. Epub 2005 Dec 15.
275 Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients.Sleep Breath. 2019 Dec;23(4):1177-1186. doi: 10.1007/s11325-019-01797-4. Epub 2019 Feb 18.
276 Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.J Mol Cell Cardiol. 2019 Jul;132:154-163. doi: 10.1016/j.yjmcc.2019.05.009. Epub 2019 May 21.
277 Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.J Biol Chem. 2010 Jul 23;285(30):23496-505. doi: 10.1074/jbc.M110.117481. Epub 2010 May 26.
278 Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells.Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):495-505. doi: 10.1161/ATVBAHA.116.308455. Epub 2017 Jan 26.
279 CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice.Eur Heart J. 2017 Dec 21;38(48):3590-3599. doi: 10.1093/eurheartj/ehx517.
280 Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.Circulation. 2019 Jan 8;139(2):243-255. doi: 10.1161/CIRCULATIONAHA.118.034326.
281 CD70 limits atherosclerosis and promotes macrophage function.Thromb Haemost. 2017 Jan 5;117(1):164-175. doi: 10.1160/TH16-04-0318. Epub 2016 Oct 27.
282 Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.Cardiovasc Res. 2009 Aug 1;83(3):586-94. doi: 10.1093/cvr/cvp141. Epub 2009 May 7.
283 Endothelial HuR deletion reduces the expression of proatherogenic molecules and attenuates atherosclerosis.Int Immunopharmacol. 2018 Dec;65:248-255. doi: 10.1016/j.intimp.2018.09.023. Epub 2018 Oct 17.
284 Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation.Oncotarget. 2016 Jan 12;7(2):1854-62. doi: 10.18632/oncotarget.6443.
285 Aging-related carcinoembryonic antigen-related cell adhesion molecule 1 signaling promotes vascular dysfunction.Aging Cell. 2019 Dec;18(6):e13025. doi: 10.1111/acel.13025. Epub 2019 Aug 6.
286 Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.Metabolism. 2008 Oct;57(10):1361-8. doi: 10.1016/j.metabol.2008.05.003.
287 Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr (-/-) mice.Sci Rep. 2017 Dec 19;7(1):17845. doi: 10.1038/s41598-017-18232-x.
288 Increased Risk of Atherosclerosis in Patients with Sarcoidosis.Pathobiology. 2017;84(5):258-263. doi: 10.1159/000477736. Epub 2017 Aug 10.
289 Octogenarian liver grafts: Is their use for transplant currently justified?.World J Gastroenterol. 2017 May 7;23(17):3099-3110. doi: 10.3748/wjg.v23.i17.3099.
290 Cardiotrophin-like Cytokine Increases Macrophage-Foam Cell Transition.J Immunol. 2018 Oct 15;201(8):2462-2471. doi: 10.4049/jimmunol.1800733. Epub 2018 Sep 12.
291 Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.PLoS One. 2019 Jun 17;14(6):e0218096. doi: 10.1371/journal.pone.0218096. eCollection 2019.
292 Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.Sci Rep. 2019 Mar 13;9(1):4337. doi: 10.1038/s41598-019-40663-x.
293 The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.Circ Res. 2017 Jul 21;121(3):234-243. doi: 10.1161/CIRCRESAHA.117.310960. Epub 2017 Jun 12.
294 Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1.Eur J Pharmacol. 2017 Nov 15;815:427-436. doi: 10.1016/j.ejphar.2017.09.047. Epub 2017 Sep 29.
295 Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):685-693. doi: 10.1161/ATVBAHA.119.312386.
296 Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.Int J Mol Sci. 2019 Feb 13;20(4):798. doi: 10.3390/ijms20040798.
297 Role of the Endocannabinoidome in Human and Mouse Atherosclerosis.Curr Pharm Des. 2019;25(29):3147-3164. doi: 10.2174/1381612825666190826162735.
298 Association between an indel polymorphism in the 3'UTR of COL1A2 and the risk of sudden cardiac death in Chinese populations.Leg Med (Tokyo). 2017 Sep;28:22-26. doi: 10.1016/j.legalmed.2017.07.006. Epub 2017 Jul 19.
299 Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2766-E2775. doi: 10.1073/pnas.1618411114. Epub 2017 Mar 14.
300 CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.Blood. 2009 Jan 22;113(4):963-72. doi: 10.1182/blood-2008-07-170787. Epub 2008 Oct 29.
301 Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-B pathway.Int Immunopharmacol. 2015 Sep;28(1):525-30. doi: 10.1016/j.intimp.2015.07.001. Epub 2015 Jul 25.
302 Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio.J Am Heart Assoc. 2016 Nov 7;5(11):e004401. doi: 10.1161/JAHA.116.004401.
303 Vascular, Cognitive, and Psychomental Survey on Elderly Recycling Volunteers in Northern Taiwan.Front Neurol. 2019 Jan 10;9:1176. doi: 10.3389/fneur.2018.01176. eCollection 2018.
304 Up-regulated cathepsin C induces macrophage M1 polarization through FAK-triggered p38 MAPK/NF-B pathway.Exp Cell Res. 2019 Sep 15;382(2):111472. doi: 10.1016/j.yexcr.2019.06.017. Epub 2019 Jun 21.
305 Cancer biomarkers in atherosclerotic plaque: Evidenced from structural and proteomic analyses.Biochem Biophys Res Commun. 2019 Feb 12;509(3):687-693. doi: 10.1016/j.bbrc.2018.12.160. Epub 2019 Jan 5.
306 Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.Circulation. 2016 Oct 18;134(16):1176-1188. doi: 10.1161/CIRCULATIONAHA.116.024790. Epub 2016 Sep 22.
307 Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.Circulation. 2007 May 1;115(17):2292-8. doi: 10.1161/CIRCULATIONAHA.106.660340. Epub 2007 Apr 9.
308 Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.JCI Insight. 2019 Feb 21;4(4):e124574. doi: 10.1172/jci.insight.124574. eCollection 2019 Feb 21.
309 CXCL2, a new critical factor and therapeutic target for cardiovascular diseases.Clin Exp Hypertens. 2020 Jul 3;42(5):428-437. doi: 10.1080/10641963.2019.1693585. Epub 2019 Nov 21.
310 [(68)Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery.Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1616-1625. doi: 10.1007/s00259-019-04322-7. Epub 2019 Apr 19.
311 Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity.Free Radic Biol Med. 2018 Dec;129:504-519. doi: 10.1016/j.freeradbiomed.2018.10.422. Epub 2018 Oct 17.
312 Krppel-Like Factor 4 Regulation of Cholesterol-25-Hydroxylase and Liver X Receptor Mitigates Atherosclerosis Susceptibility.Circulation. 2017 Oct 3;136(14):1315-1330. doi: 10.1161/CIRCULATIONAHA.117.027462. Epub 2017 Aug 9.
313 A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.Mol Med. 2012 May 9;18(1):712-8. doi: 10.2119/molmed.2012.00094.
314 CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.Pediatr Infect Dis J. 2017 Nov;36(11):1039-1043. doi: 10.1097/INF.0000000000001657.
315 CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation.Mol Med Rep. 2017 Feb;15(2):643-648. doi: 10.3892/mmr.2016.6039. Epub 2016 Dec 14.
316 Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.Drug Des Devel Ther. 2018 Feb 28;12:417-428. doi: 10.2147/DDDT.S149340. eCollection 2018.
317 Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.J Mol Med (Berl). 2012 Oct;90(10):1223-31. doi: 10.1007/s00109-012-0904-1. Epub 2012 Apr 20.
318 Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1878-1889. doi: 10.1161/ATVBAHA.118.311238.
319 Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis.Am J Pathol. 2004 May;164(5):1575-85. doi: 10.1016/S0002-9440(10)63716-9.
320 Inducible expression of human -defensin 2 by Chlamydophila pneumoniae in brain capillary endothelial cells.Innate Immun. 2011 Oct;17(5):463-9. doi: 10.1177/1753425910375582. Epub 2010 Jul 20.
321 Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.Biochim Biophys Acta. 2011 Dec;1811(12):1011-20. doi: 10.1016/j.bbalip.2011.08.010. Epub 2011 Sep 1.
322 New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.Eur J Med Chem. 2017 Nov 10;140:305-320. doi: 10.1016/j.ejmech.2017.08.011. Epub 2017 Sep 12.
323 Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1868-77. doi: 10.1073/pnas.1116889109. Epub 2012 Jun 13.
324 Augmented neutrophil extracellular traps formation promotes atherosclerosis development in socially defeated apoE(-/-) mice.Biochem Biophys Res Commun. 2018 Jun 2;500(2):490-496. doi: 10.1016/j.bbrc.2018.04.115. Epub 2018 Apr 19.
325 Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.Basic Res Cardiol. 2013 May;108(3):350. doi: 10.1007/s00395-013-0350-4. Epub 2013 Apr 23.
326 Geniposide regulates the miR-101/MKP-1/p38 pathway and alleviates atherosclerosis inflammatory injury in ApoE(-/-) mice.Immunobiology. 2019 Mar;224(2):296-306. doi: 10.1016/j.imbio.2018.12.005. Epub 2018 Dec 27.
327 Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling.Toxicol Appl Pharmacol. 2019 Feb 1;364:45-54. doi: 10.1016/j.taap.2018.12.002. Epub 2018 Dec 5.
328 Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension.J Hum Hypertens. 2007 Nov;21(11):883-92. doi: 10.1038/sj.jhh.1002234. Epub 2007 May 24.
329 Expression of Egfl7 and miRNA-126-5p in Symptomatic Carotid Artery Disease.Genet Test Mol Biomarkers. 2016 Mar;20(3):125-9. doi: 10.1089/gtmb.2015.0252. Epub 2016 Jan 22.
330 STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells.J Cell Physiol. 2017 Dec;232(12):3496-3509. doi: 10.1002/jcp.25810. Epub 2017 Feb 21.
331 Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition.J Atheroscler Thromb. 2020 Apr 1;27(4):331-341. doi: 10.5551/jat.50898. Epub 2019 Aug 9.
332 EPHA6 rs4857055 C?T polymorphism associates with hypertension through triglyceride and LDL particle size in the Korean population.Lipids Health Dis. 2017 Dec 6;16(1):230. doi: 10.1186/s12944-017-0620-5.
333 EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.Circulation. 2017 Aug 8;136(6):566-582. doi: 10.1161/CIRCULATIONAHA.116.026644. Epub 2017 May 9.
334 Intermittent hypoxia-induced epiregulin expression by IL-6 production in human coronary artery smooth muscle cells.FEBS Open Bio. 2018 Apr 19;8(5):868-876. doi: 10.1002/2211-5463.12430. eCollection 2018 May.
335 Targeting IRE1 with small molecules counteracts progression of atherosclerosis.Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1395-E1404. doi: 10.1073/pnas.1621188114. Epub 2017 Jan 30.
336 Coagulation factor XI induces Ca(2+) response and accelerates cell migration in vascular smooth muscle cells via proteinase-activated receptor 1.Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C377-C392. doi: 10.1152/ajpcell.00426.2018. Epub 2018 Dec 19.
337 A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis.Atherosclerosis. 2019 May;284:92-101. doi: 10.1016/j.atherosclerosis.2019.02.014. Epub 2019 Feb 22.
338 Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.Thromb Haemost. 2017 Jan 5;117(1):176-187. doi: 10.1160/TH16-06-0466. Epub 2016 Oct 27.
339 Upregulation of Protease-Activated Receptor 2 Promotes Proliferation and Migration of Human Vascular Smooth Muscle Cells (VSMCs).Med Sci Monit. 2019 Nov 22;25:8854-8862. doi: 10.12659/MSM.917865.
340 Factor V Leiden and apolipoprotein E genotypes in severe femoropopliteal atherosclerosis with restenosis.Clin Chim Acta. 2007 Feb;377(1-2):256-60. doi: 10.1016/j.cca.2006.10.004. Epub 2006 Oct 13.
341 Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease.Clin Interv Aging. 2017 Dec 5;12:2063-2068. doi: 10.2147/CIA.S137247. eCollection 2017.
342 Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.Sci Rep. 2017 Mar 16;7(1):217. doi: 10.1038/s41598-017-00177-w.
343 Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.J Lipid Res. 2015 Jun;56(6):1191-205. doi: 10.1194/jlr.M059170. Epub 2015 Apr 28.
344 The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis.J Mol Cell Cardiol. 2019 Jan;126:50-59. doi: 10.1016/j.yjmcc.2018.11.006. Epub 2018 Nov 16.
345 FcRIIb on CD11c(+) cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr(-/-) mice.Atherosclerosis. 2019 Jun;285:108-119. doi: 10.1016/j.atherosclerosis.2019.04.221. Epub 2019 Apr 13.
346 Inhibition of farnesyl pyrophosphate synthase attenuates high glucoseinduced vascular smooth muscle cells proliferation.Mol Med Rep. 2017 May;15(5):3153-3160. doi: 10.3892/mmr.2017.6360. Epub 2017 Mar 23.
347 Anti-atherosclerotic action of GW9508 - Free fatty acid receptors activator - In apoE-knockout mice.Pharmacol Rep. 2019 Aug;71(4):551-555. doi: 10.1016/j.pharep.2019.02.014. Epub 2019 Feb 21.
348 TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.Cardiovasc Pathol. 2018 Mar-Apr;33:6-15. doi: 10.1016/j.carpath.2017.11.004. Epub 2017 Dec 2.
349 Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis.J Lipid Res. 2019 Mar;60(3):550-565. doi: 10.1194/jlr.M089961. Epub 2019 Jan 24.
350 The effect of substrate bulk stiffness on focal and fibrillar adhesion formation in human abdominal aortic endothelial cells.Mater Sci Eng C Mater Biol Appl. 2019 May;98:572-583. doi: 10.1016/j.msec.2018.12.130. Epub 2018 Dec 29.
351 Folate-Modified Liposomes Loaded with Telmisartan Enhance Anti-Atherosclerotic Potency for Advanced Atherosclerosis in ApoE(-/-) Mice.J Biomed Nanotechnol. 2019 Jan 1;15(1):42-61. doi: 10.1166/jbn.2019.2676.
352 A systematic review and meta-analysis of randomized controlled trials to evaluating the trend of cytokines to vitamin A supplementation in autoimmune diseases.Clin Nutr. 2019 Oct;38(5):2038-2044. doi: 10.1016/j.clnu.2018.10.026. Epub 2018 Nov 14.
353 FSTL3 Induces Lipid Accumulation and Inflammatory Response in Macrophages and Associates With Atherosclerosis.J Cardiovasc Pharmacol. 2019 Dec;74(6):566-573. doi: 10.1097/FJC.0000000000000742.
354 Physiological origin of biogenic magnetic nanoparticles in health and disease: from bacteria to humans.Int J Nanomedicine. 2017 Jun 12;12:4371-4395. doi: 10.2147/IJN.S130565. eCollection 2017.
355 Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.J Hypertens. 2017 Apr;35(4):810-821. doi: 10.1097/HJH.0000000000001255.
356 Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.Eur J Clin Invest. 2019 May;49(5):e13089. doi: 10.1111/eci.13089. Epub 2019 Mar 3.
357 Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.Int J Mol Med. 2014 May;33(5):1355-63. doi: 10.3892/ijmm.2014.1692. Epub 2014 Mar 10.
358 A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.J Biol Chem. 2018 May 25;293(21):7942-7968. doi: 10.1074/jbc.RA118.002046. Epub 2018 Apr 6.
359 Circulating Gas6 is associated with reduced human carotid atherosclerotic plaque burden in high risk cardiac patients.Clin Biochem. 2019 Feb;64:6-11. doi: 10.1016/j.clinbiochem.2018.11.018. Epub 2018 Dec 1.
360 Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition.Chem Biol Interact. 2018 Feb 25;282:13-21. doi: 10.1016/j.cbi.2018.01.004. Epub 2018 Jan 8.
361 Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.Eur J Endocrinol. 2015 Mar;172(3):277-83. doi: 10.1530/EJE-14-0713. Epub 2014 Dec 10.
362 Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis.Biochem Biophys Res Commun. 2009 Feb 20;379(4):861-5. doi: 10.1016/j.bbrc.2008.12.154. Epub 2009 Jan 4.
363 Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study.Diabetes Obes Metab. 2019 Feb;21(2):412-416. doi: 10.1111/dom.13519. Epub 2018 Oct 2.
364 Effect of BMP-9 on endothelial cells and its role in atherosclerosis.Front Biosci (Landmark Ed). 2019 Mar 1;24(6):994-1023. doi: 10.2741/4764.
365 Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification.Endocrine. 2014 Sep;47(1):191-7. doi: 10.1007/s12020-013-0118-5. Epub 2013 Nov 23.
366 The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(-/-) mice by blocking monocyte/macrophage activation.Mol Metab. 2018 Aug;14:150-157. doi: 10.1016/j.molmet.2018.05.014. Epub 2018 May 23.
367 KLF4-Induced Connexin40 Expression Contributes to Arterial Endothelial Quiescence.Front Physiol. 2019 Feb 12;10:80. doi: 10.3389/fphys.2019.00080. eCollection 2019.
368 Glutaredoxin 1 mediates the protective effect of steady laminar flow on endothelial cells against oxidative stress-induced apoptosis via inhibiting Bim.Sci Rep. 2017 Nov 14;7(1):15539. doi: 10.1038/s41598-017-15672-3.
369 Appropriation of GPIb from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation.Haematologica. 2020 May;105(5):1248-1261. doi: 10.3324/haematol.2018.215145. Epub 2019 Aug 29.
370 Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice.J Ethnopharmacol. 2017 Aug 17;208:185-198. doi: 10.1016/j.jep.2017.06.052. Epub 2017 Jul 12.
371 A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis.J Lipid Res. 2014 Apr;55(4):681-97. doi: 10.1194/jlr.M044669. Epub 2014 Feb 3.
372 Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells.Eur J Pharmacol. 2019 Sep 5;858:172451. doi: 10.1016/j.ejphar.2019.172451. Epub 2019 Jun 13.
373 Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.PLoS One. 2015 May 13;10(5):e0126839. doi: 10.1371/journal.pone.0126839. eCollection 2015.
374 Gremlin-1 potentiates the dedifferentiation of VSMC in early stages of atherosclerosis.Differentiation. 2019 Sep-Oct;109:28-33. doi: 10.1016/j.diff.2019.08.001. Epub 2019 Aug 30.
375 Association of the glutathione S-transferase omega-1 Ala140Asp polymorphism with cerebrovascular atherosclerosis and plaque-associated interleukin-1 alpha expression.Stroke. 2007 Oct;38(10):2847-50. doi: 10.1161/STROKEAHA.107.484162. Epub 2007 Aug 23.
376 Association of Rare Loss-Of-Function Alleles in HAL, Serum Histidine: Levels and Incident Coronary Heart Disease.Circ Cardiovasc Genet. 2015 Apr;8(2):351-5. doi: 10.1161/CIRCGENETICS.114.000697. Epub 2015 Jan 8.
377 Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.Cardiovasc Res. 2020 Dec 1;116(14):2226-2238. doi: 10.1093/cvr/cvz303.
378 Hydroxycarboxylic Acid Receptor Ligands Modulate Proinflammatory Cytokine Expression in Human Macrophages and Adipocytes without Affecting Adipose Differentiation.Biol Pharm Bull. 2018;41(10):1574-1580. doi: 10.1248/bpb.b18-00301.
379 Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.EMBO Mol Med. 2014 Sep;6(9):1124-32. doi: 10.15252/emmm.201404170.
380 Protein kinase B/AKT mediates insulin-like growth factor 1-induced phosphorylation and nuclear export of histone deacetylase 5 via NADPH oxidase 4 activation in vascular smooth muscle cells.J Cell Physiol. 2019 Aug;234(10):17337-17350. doi: 10.1002/jcp.28353. Epub 2019 Feb 22.
381 Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis.Front Pharmacol. 2019 Oct 29;10:1242. doi: 10.3389/fphar.2019.01242. eCollection 2019.
382 Histamine promotes the differentiation of macrophages from CD11b(+) myeloid cells and formation of foam cells through a Stat6-dependent pathway.Atherosclerosis. 2017 Aug;263:42-52. doi: 10.1016/j.atherosclerosis.2017.05.024. Epub 2017 May 23.
383 Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.Int J Biochem Cell Biol. 2017 Feb;83:56-64. doi: 10.1016/j.biocel.2016.12.010. Epub 2016 Dec 21.
384 Chronic Unpredictable Mild Stress Promotes Atherosclerosis via HMGB1/TLR4-Mediated Downregulation of PPAR/LXR/ABCA1 in ApoE(-/-) Mice.Front Physiol. 2019 Mar 1;10:165. doi: 10.3389/fphys.2019.00165. eCollection 2019.
385 Endothelial cell apoptosis correlates with low haptoglobin concentrations in diabetes.Diab Vasc Dis Res. 2017 Nov;14(6):534-539. doi: 10.1177/1479164117719827. Epub 2017 Aug 23.
386 Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E(0) mice.Atherosclerosis. 2018 Sep;276:155-162. doi: 10.1016/j.atherosclerosis.2018.07.026. Epub 2018 Jul 24.
387 Granulocyte macrophage-colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/macrophages in relation to arteriosclerosis.Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):430-5. doi: 10.1161/01.ATV.0000148705.13411.65. Epub 2004 Oct 28.
388 Histamine H(2) Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial).Am J Cardiol. 2018 Jan 15;121(2):256-261. doi: 10.1016/j.amjcard.2017.10.016. Epub 2017 Oct 20.
389 The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.J Clin Med. 2019 Oct 26;8(11):1793. doi: 10.3390/jcm8111793.
390 Protective effect of HSP27 in atherosclerosis and coronary heart disease by inhibiting reactive oxygen species.J Cell Biochem. 2019 Mar;120(3):2859-2868. doi: 10.1002/jcb.26575. Epub 2018 Dec 3.
391 Atorvastatin downregulates HSP22 expression inanatherosclerotic model in vitro and in vivo.Int J Mol Med. 2019 Feb;43(2):821-829. doi: 10.3892/ijmm.2018.4015. Epub 2018 Dec 3.
392 MicroRNA-10b Induces Vascular Muscle Cell Proliferation Through Akt Pathway by Targeting TIP30.Curr Vasc Pharmacol. 2015;13(5):679-86. doi: 10.2174/1570161113666150123112751.
393 A Novel Role of Id1 in Regulating Oscillatory Shear Stress-Mediated Lipid Uptake in Endothelial Cells.Ann Biomed Eng. 2018 Jun;46(6):849-863. doi: 10.1007/s10439-018-2000-3. Epub 2018 Mar 5.
394 Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis.Diabetes. 2012 Apr;61(4):915-24. doi: 10.2337/db11-0963. Epub 2012 Feb 22.
395 Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.Theranostics. 2018 Apr 30;8(11):3007-3021. doi: 10.7150/thno.21966. eCollection 2018.
396 Caprylic acid suppresses inflammation via TLR4/NF-B signaling and improves atherosclerosis in ApoE-deficient mice.Nutr Metab (Lond). 2019 Jun 6;16:40. doi: 10.1186/s12986-019-0359-2. eCollection 2019.
397 Genetic linkage of oxidative stress with cardiometabolic traits in an intercross derived from hyperlipidemic mouse strains.Atherosclerosis. 2020 Jan;293:1-10. doi: 10.1016/j.atherosclerosis.2019.11.034. Epub 2019 Dec 3.
398 Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.Arq Bras Cardiol. 2020 Jan;114(1):90-97. doi: 10.5935/abc.20190230.
399 The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.Pharmacol Ther. 2011 Aug;131(2):179-86. doi: 10.1016/j.pharmthera.2011.02.005. Epub 2011 Feb 26.
400 IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke.J Immunol. 2009 Apr 15;182(8):5003-12. doi: 10.4049/jimmunol.0803653.
401 IL-33 at the Crossroads of Metabolic Disorders and Immunity.Front Endocrinol (Lausanne). 2019 Jan 30;10:26. doi: 10.3389/fendo.2019.00026. eCollection 2019.
402 Potential role of IL-37 in atherosclerosis.Cytokine. 2019 Oct;122:154169. doi: 10.1016/j.cyto.2017.09.025. Epub 2017 Oct 5.
403 Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood.Int J Med Sci. 2019 Jun 2;16(6):882-892. doi: 10.7150/ijms.30082. eCollection 2019.
404 Evaluation of a new equation for LDL-c estimation and prediction of death by cardiovascular related events in a German population-based study cohort.Scand J Clin Lab Invest. 2018 May;78(3):187-196. doi: 10.1080/00365513.2018.1432070. Epub 2018 Mar 8.
405 Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases.J Innate Immun. 2009;1(4):350-7. doi: 10.1159/000200774. Epub 2009 Feb 11.
406 Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.Theranostics. 2019 Jul 9;9(16):4688-4703. doi: 10.7150/thno.36862. eCollection 2019.
407 Inhibiting Integrin 5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.J Am Heart Assoc. 2018 Jan 30;7(3):e007501. doi: 10.1161/JAHA.117.007501.
408 Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice.PLoS One. 2017 Aug 3;12(8):e0181947. doi: 10.1371/journal.pone.0181947. eCollection 2017.
409 Association between K469E polymorphism of ICAM-1 gene and susceptibility of ischemic stroke: An updated meta-analysis.Mol Genet Genomic Med. 2019 Jul;7(7):e00784. doi: 10.1002/mgg3.784. Epub 2019 Jun 3.
410 High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors.Cell Prolif. 2001 Aug;34(4):223-31. doi: 10.1046/j.0960-7722.2001.00207.x.
411 Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke.Thromb Res. 2019 Apr;176:18-26. doi: 10.1016/j.thromres.2019.01.014. Epub 2019 Feb 2.
412 Changes in IP3 Receptor Expression and Function in Aortic Smooth Muscle of Atherosclerotic Mice.J Vasc Res. 2017;54(2):68-78. doi: 10.1159/000461581. Epub 2017 Apr 1.
413 KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts.PLoS One. 2018 Aug 31;13(8):e0203213. doi: 10.1371/journal.pone.0203213. eCollection 2018.
414 Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL.Oncotarget. 2017 May 10;8(70):114442-114456. doi: 10.18632/oncotarget.17748. eCollection 2017 Dec 29.
415 Myeloid Kdm6b deficiency results in advanced atherosclerosis.Atherosclerosis. 2018 Aug;275:156-165. doi: 10.1016/j.atherosclerosis.2018.05.052. Epub 2018 Jun 1.
416 p62/SQSTM1 and Selective Autophagy in Cardiometabolic Diseases.Antioxid Redox Signal. 2019 Aug 20;31(6):458-471. doi: 10.1089/ars.2018.7649. Epub 2019 Feb 11.
417 Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.J Am Heart Assoc. 2017 Apr 14;6(4):e005790. doi: 10.1161/JAHA.117.005790.
418 Association of the KLK1 rs5516 G allele and the ACE D allele with aortic aneurysm and atherosclerotic stenosis.Medicine (Baltimore). 2016 Nov;95(44):e5120. doi: 10.1097/MD.0000000000005120.
419 Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice.Sci Rep. 2016 Apr 5;6:23912. doi: 10.1038/srep23912.
420 Lymphocyte activation gene 3 and coronary artery disease.JCI Insight. 2016 Oct 20;1(17):e88628. doi: 10.1172/jci.insight.88628.
421 Silencing LAIR-1 in human THP-1 macrophage increases foam cell formation by modulating PPAR and M2 polarization.Cytokine. 2018 Nov;111:194-205. doi: 10.1016/j.cyto.2018.08.028. Epub 2018 Aug 31.
422 Circulating lipopolysaccharide-binding protein and carotid intima-media thickness in obstructive sleep apnea.Physiol Res. 2018 Mar 16;67(1):69-78. doi: 10.33549/physiolres.933632. Epub 2017 Nov 10.
423 Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.Metabolism. 2018 Jun;83:245-255. doi: 10.1016/j.metabol.2018.03.003. Epub 2018 Mar 9.
424 Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women.J Am Heart Assoc. 2019 Jan 8;8(1):e011028. doi: 10.1161/JAHA.118.011028.
425 Increased Legumain/Smad3 expression in atherosclerotic plaque of rat thoracic aorta.Biomed Pharmacother. 2019 Nov;119:109353. doi: 10.1016/j.biopha.2019.109353. Epub 2019 Sep 12.
426 LILRB4 deficiency aggravates the development of atherosclerosis and plaque instability by increasing the macrophage inflammatory response via NF-B signaling.Clin Sci (Lond). 2017 Sep;131(17):2275-2288. doi: 10.1042/CS20170198. Epub 2017 Jul 25.
427 Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men.Nutr Metab Cardiovasc Dis. 2002 Aug;12(4):173-7.
428 Serum concentration of full-length- and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease.J Clin Lipidol. 2019 Sep-Oct;13(5):839-846. doi: 10.1016/j.jacl.2019.07.007. Epub 2019 Jul 29.
429 Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses.J Immunol. 2016 Dec 15;197(12):4651-4662. doi: 10.4049/jimmunol.1600206. Epub 2016 Nov 11.
430 Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis.Mol Ther Methods Clin Dev. 2018 Jun 27;10:17-28. doi: 10.1016/j.omtm.2018.05.003. eCollection 2018 Sep 21.
431 LPA receptor 4 deficiency attenuates experimental atherosclerosis.J Lipid Res. 2019 May;60(5):972-980. doi: 10.1194/jlr.M091066. Epub 2019 Feb 22.
432 Megalin: A bridge connecting kidney, the renin-angiotensin system, and atherosclerosis.Pharmacol Res. 2020 Jan;151:104537. doi: 10.1016/j.phrs.2019.104537. Epub 2019 Nov 7.
433 Low-density lipoprotein receptor-related protein 5 gene polymorphisms and genetic susceptibility to abdominal aortic aneurysm.J Vasc Surg. 2013 Oct;58(4):1062-8.e1. doi: 10.1016/j.jvs.2012.11.092. Epub 2013 Mar 13.
434 Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis.Sci Adv. 2019 Feb 6;5(2):eaav2309. doi: 10.1126/sciadv.aav2309. eCollection 2019 Feb.
435 Association between lymphotoxin alpha (-252 A/G and -804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study.Int J Neurosci. 2016 Dec;126(12):1127-35. doi: 10.3109/00207454.2015.1134527. Epub 2016 Jan 20.
436 Combined PET/DCE-MRI in a RabbitModelof Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):291-301. doi: 10.1016/j.jcmg.2017.11.030.
437 Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21093-7. doi: 10.1073/pnas.1015166107. Epub 2010 Nov 15.
438 Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms.Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75. doi: 10.1161/01.ATV.0000110503.16605.15. Epub 2003 Dec 1.
439 Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.Am J Pathol. 2006 Jul;169(1):303-13. doi: 10.2353/ajpath.2006.050885.
440 Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.J Biol Chem. 2018 Sep 7;293(36):14040-14064. doi: 10.1074/jbc.RA118.002321. Epub 2018 Jul 18.
441 Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10.PLoS One. 2012;7(11):e46551. doi: 10.1371/journal.pone.0046551. Epub 2012 Nov 26.
442 Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E303-E313. doi: 10.1152/ajpendo.00037.2017. Epub 2017 Jun 13.
443 Deletion of JNK2 prevents vitamin-D-deficiency-induced hypertension and atherosclerosis in mice.J Steroid Biochem Mol Biol. 2018 Mar;177:179-186. doi: 10.1016/j.jsbmb.2017.09.014. Epub 2017 Sep 23.
444 Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.J Thromb Thrombolysis. 2019 Apr;47(3):353-360. doi: 10.1007/s11239-018-1779-y.
445 Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on (18)F-fluorodeoxyglucose positron emission tomography.Atherosclerosis. 2017 Apr;259:12-19. doi: 10.1016/j.atherosclerosis.2017.02.010. Epub 2017 Feb 20.
446 DJ-1 is involved in epigenetic control of sphingosine-1-phosphate receptor expression in vascular neointima formation.Pflugers Arch. 2018 Jul;470(7):1103-1113. doi: 10.1007/s00424-018-2132-1. Epub 2018 Mar 6.
447 Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E(-/-) Mice.Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):313-323. doi: 10.1161/ATVBAHA.117.310418. Epub 2017 Dec 28.
448 Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study.Diabetes Obes Metab. 2007 Jul;9(4):548-57. doi: 10.1111/j.1463-1326.2006.00637.x.
449 CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment.J Mol Cell Cardiol. 2019 May;130:76-87. doi: 10.1016/j.yjmcc.2019.03.017. Epub 2019 Mar 27.
450 Immunoproteasome subunit 5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.J Pathol. 2020 Mar;250(3):275-287. doi: 10.1002/path.5368. Epub 2020 Jan 14.
451 Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid-dependent gut transit in ApoE-/- mice.Oncotarget. 2017 May 16;8(20):33122-33136. doi: 10.18632/oncotarget.16529.
452 Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification.Atherosclerosis. 2018 Nov;278:124-134. doi: 10.1016/j.atherosclerosis.2018.09.022. Epub 2018 Sep 19.
453 Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.J Exp Med. 1999 Mar 1;189(5):843-53. doi: 10.1084/jem.189.5.843.
454 MMP-12-Induced Pro-osteogenic Responses in Human Aortic Valve Interstitial Cells.J Surg Res. 2019 Mar;235:44-51. doi: 10.1016/j.jss.2018.09.005. Epub 2018 Oct 23.
455 FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13).Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):555-565. doi: 10.1161/ATVBAHA.117.310502. Epub 2018 Jan 11.
456 Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.J Am Heart Assoc. 2017 Jul 22;6(7):e003693. doi: 10.1161/JAHA.116.003693.
457 MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.Nat Commun. 2018 Mar 2;9(1):910. doi: 10.1038/s41467-018-03351-4.
458 Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.Atherosclerosis. 2017 Jun;261:90-98. doi: 10.1016/j.atherosclerosis.2017.02.012. Epub 2017 Feb 21.
459 Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026. doi: 10.1016/j.jcmg.2018.07.027. Epub 2018 Oct 17.
460 The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis.J Immunol. 2016 Jul 1;197(1):256-65. doi: 10.4049/jimmunol.1600450. Epub 2016 May 27.
461 Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.Kidney Int. 2019 Mar;95(3):506-517. doi: 10.1016/j.kint.2018.10.010. Epub 2018 Dec 28.
462 The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.Atherosclerosis. 2015 Jun;240(2):408-14. doi: 10.1016/j.atherosclerosis.2015.03.014. Epub 2015 Mar 14.
463 MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway.J Cell Mol Med. 2019 May;23(5):3696-3710. doi: 10.1111/jcmm.14274. Epub 2019 Mar 25.
464 Platelet-Derived Exosomal MicroRNA-25-3p Inhibits Coronary Vascular Endothelial Cell Inflammation Through Adam10 via the NF-B Signaling Pathway in ApoE(-/-) Mice.Front Immunol. 2019 Oct 2;10:2205. doi: 10.3389/fimmu.2019.02205. eCollection 2019.
465 NOX4 NADPH Oxidase-Dependent Mitochondrial Oxidative Stress in Aging-Associated Cardiovascular Disease.Antioxid Redox Signal. 2015 Dec 20;23(18):1389-409. doi: 10.1089/ars.2014.6221. Epub 2015 Jul 14.
466 Nedd4 Deficiency in Vascular Smooth Muscle Promotes Vascular Calcification by Stabilizing pSmad1.J Bone Miner Res. 2017 May;32(5):927-938. doi: 10.1002/jbmr.3073. Epub 2017 Feb 23.
467 Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis.Am J Pathol. 2007 Jul;171(1):326-37. doi: 10.2353/ajpath.2007.061196.
468 Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.Ann Epidemiol. 2003 Apr;13(4):211-7. doi: 10.1016/s1047-2797(02)00412-x.
469 CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells.Front Pharmacol. 2019 Jan 30;10:40. doi: 10.3389/fphar.2019.00040. eCollection 2019.
470 Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.J Vasc Res. 2018;55(2):98-110. doi: 10.1159/000486337. Epub 2018 Feb 16.
471 Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1.FASEB J. 2019 Mar;33(3):3912-3921. doi: 10.1096/fj.201801231RR. Epub 2018 Nov 29.
472 p120 inhibits LPS/TNF-induced endothelial Ang2 synthesis and release in an NF-B independent fashion.Cytokine. 2019 Nov;123:154786. doi: 10.1016/j.cyto.2019.154786. Epub 2019 Jul 26.
473 Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis.Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2258-65. doi: 10.1161/ATVBAHA.108.174995. Epub 2008 Sep 18.
474 MicroRNA-30e regulates TGF--mediated NADPH oxidase 4-dependent oxidative stress by Snai1 in atherosclerosis.Int J Mol Med. 2019 Apr;43(4):1806-1816. doi: 10.3892/ijmm.2019.4102. Epub 2019 Feb 20.
475 C-Type Natriuretic Peptide (CNP) Inhibition of Interferon--Mediated Gene Expression in Human Endothelial Cells In Vitro.Biosensors (Basel). 2018 Sep 14;8(3):86. doi: 10.3390/bios8030086.
476 Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPAR, LXR and ABCA1.Int J Mol Med. 2019 Sep;44(3):893-902. doi: 10.3892/ijmm.2019.4263. Epub 2019 Jul 3.
477 Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis. J Biol Chem. 2019 May 31;294(22):8732-8744. doi: 10.1074/jbc.RA119.008360. Epub 2019 Apr 17.
478 Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.Stem Cells. 2014 Sep;32(9):2419-29. doi: 10.1002/stem.1747.
479 SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport.Cell Metab. 2014 Oct 7;20(4):603-13. doi: 10.1016/j.cmet.2014.07.023. Epub 2014 Aug 28.
480 Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.Acta Diabetol. 2017 Dec;54(12):1091-1099. doi: 10.1007/s00592-017-1044-4. Epub 2017 Sep 16.
481 MicroRNA-9 overexpression suppresses vulnerable atherosclerotic plaque and enhances vascular remodeling through negative regulation of the p38MAPK pathway via OLR1 in acute coronary syndrome.J Cell Biochem. 2020 Jan;121(1):49-62. doi: 10.1002/jcb.27830. Epub 2019 Sep 30.
482 Evaluation of the effect of flavangenol on serum lipid peroxide levels and development of atherosclerosis in spontaneously hyperlipidemic B6.KOR-Apoeshl mice.Int J Mol Med. 2011 Jan;27(1):33-8. doi: 10.3892/ijmm.2010.554. Epub 2010 Nov 10.
483 Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.PLoS One. 2019 Aug 28;14(8):e0221477. doi: 10.1371/journal.pone.0221477. eCollection 2019.
484 Oncostatin M receptor deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.J Lipid Res. 2017 May;58(5):895-906. doi: 10.1194/jlr.M074112. Epub 2017 Mar 3.
485 Deletion of P2Y2 receptor reveals a role for lymphotoxin- in fatty streak formation.Vascul Pharmacol. 2016 Oct;85:11-20. doi: 10.1016/j.vph.2016.06.001. Epub 2016 Jun 26.
486 P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.Circulation. 2003 Dec 16;108(24):2971-3. doi: 10.1161/01.CIR.0000106904.80795.35. Epub 2003 Dec 8.
487 P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.PLoS One. 2014 Apr 25;9(4):e95807. doi: 10.1371/journal.pone.0095807. eCollection 2014.
488 Double bond configuration of palmitoleate is critical for atheroprotection.Mol Metab. 2019 Oct;28:58-72. doi: 10.1016/j.molmet.2019.08.004. Epub 2019 Aug 7.
489 NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis.Cardiovasc Res. 2012 Mar 1;93(3):414-23. doi: 10.1093/cvr/cvr309. Epub 2011 Nov 23.
490 Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.Sci Adv. 2016 Jul 22;2(7):e1600224. doi: 10.1126/sciadv.1600224. eCollection 2016 Jul.
491 Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL.Atherosclerosis. 2011 Dec;219(2):799-806. doi: 10.1016/j.atherosclerosis.2011.08.011. Epub 2011 Aug 22.
492 B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.Vascul Pharmacol. 2018 Dec;111:54-61. doi: 10.1016/j.vph.2018.09.002. Epub 2018 Sep 19.
493 Phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a rat model.Prostate. 2019 Apr;79(5):536-543. doi: 10.1002/pros.23759. Epub 2018 Dec 28.
494 PDGF-D is a potent transforming and angiogenic growth factor.Oncogene. 2003 Mar 13;22(10):1501-10. doi: 10.1038/sj.onc.1206223.
495 PDGF-C and PDGF-D signaling in vascular diseases and animal models. Mol Aspects Med. 2018 Aug;62:1-11.
496 PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.Atherosclerosis. 2018 Sep;276:171-181. doi: 10.1016/j.atherosclerosis.2018.05.009. Epub 2018 May 16.
497 Decreased frequencies and impaired functions of the CD31(+) subpopulation in T(reg) cells associated with decreased FoxP3 expression and enhanced T(reg) cell defects in patients with coronary heart disease.Clin Exp Immunol. 2017 Mar;187(3):441-454. doi: 10.1111/cei.12897. Epub 2016 Dec 20.
498 Hepatic Expression of PEMT, but Not Dietary Choline Supplementation, Reverses the Protection against Atherosclerosis in Pemt-/-/Ldlr-/- Mice.J Nutr. 2018 Oct 1;148(10):1513-1520. doi: 10.1093/jn/nxy165.
499 CXCL4-induced macrophages in human atherosclerosis.Cytokine. 2019 Oct;122:154141. doi: 10.1016/j.cyto.2017.08.021. Epub 2017 Sep 10.
500 Scutellarin exerts protective effects against atherosclerosis in rats by regulating the Hippo-FOXO3A and PI3K/AKT signaling pathways.J Cell Physiol. 2019 Aug;234(10):18131-18145. doi: 10.1002/jcp.28446. Epub 2019 Mar 19.
501 Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity.Haematologica. 2018 Jun;103(6):1073-1082. doi: 10.3324/haematol.2017.183087. Epub 2018 Mar 15.
502 Group 1B phospholipase A(2) in metabolic and inflammatory disease modulation.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):784-788. doi: 10.1016/j.bbalip.2018.07.001. Epub 2018 Jul 9.
503 Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.Exp Ther Med. 2018 Nov;16(5):4119-4123. doi: 10.3892/etm.2018.6669. Epub 2018 Aug 30.
504 Participation of ATP7A in macrophage mediated oxidation of LDL.J Lipid Res. 2010 Jun;51(6):1471-7. doi: 10.1194/jlr.M003426. Epub 2009 Nov 23.
505 Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1090-100. doi: 10.1161/ATVBAHA.115.306964. Epub 2016 Apr 28.
506 Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans.J Am Heart Assoc. 2018 Aug 7;7(15):e009881. doi: 10.1161/JAHA.118.009881.
507 Overexpression of perilipin1 protects against atheroma progression in apolipoprotein E knockout mice.Atherosclerosis. 2018 Feb;269:192-196. doi: 10.1016/j.atherosclerosis.2018.01.019. Epub 2018 Jan 17.
508 Identification of Novel Phospholipid Transfer Protein Inhibitors by High-Throughput Screening.SLAS Discov. 2019 Jun;24(5):579-586. doi: 10.1177/2472555219842210. Epub 2019 Apr 24.
509 Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes.Environ Res. 2011 Aug;111(6):804-10. doi: 10.1016/j.envres.2011.05.003. Epub 2011 May 24.
510 Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.Liver Int. 2011 Mar;31(3):412-6. doi: 10.1111/j.1478-3231.2010.02444.x. Epub 2011 Jan 13.
511 Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.Pathol Int. 2018 Feb;68(2):91-101. doi: 10.1111/pin.12634. Epub 2018 Jan 17.
512 PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.J Transl Med. 2015 Sep 26;13:316. doi: 10.1186/s12967-015-0677-8.
513 Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1402-1409. doi: 10.1016/j.bbadis.2019.02.012. Epub 2019 Feb 15.
514 Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis.PLoS One. 2014 Jul 17;9(7):e101446. doi: 10.1371/journal.pone.0101446. eCollection 2014.
515 Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.
516 Immunoproteasome subunit 5i/LMP7-deficiency in atherosclerosis.Sci Rep. 2017 Oct 17;7(1):13342. doi: 10.1038/s41598-017-13592-w.
517 Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.PLoS One. 2014 Oct 21;9(10):e110828. doi: 10.1371/journal.pone.0110828. eCollection 2014.
518 Membrane prostaglandin E synthase-1: a novel therapeutic target.Pharmacol Rev. 2007 Sep;59(3):207-24. doi: 10.1124/pr.59.3.1.
519 Association of circulating 25-hydroxyvitamin D and parathyroid hormone with carotid intima media thickness in children and adolescents with excess weight.J Steroid Biochem Mol Biol. 2019 Apr;188:117-123. doi: 10.1016/j.jsbmb.2018.12.015. Epub 2018 Dec 31.
520 Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(-/-) mouse model of atherosclerosis.Clin Sci (Lond). 2017 Sep 28;131(20):2489-2501. doi: 10.1042/CS20171066. Print 2017 Oct 1.
521 Hemodynamics-Based Strategy of Using Retinoic Acid Receptor and Retinoid X Receptor Agonists to Induce MicroRNA-10a and Inhibit Atherosclerotic Lesion.Methods Mol Biol. 2019;2019:143-169. doi: 10.1007/978-1-4939-9585-1_11.
522 Comparison of remnant cholesterol levels estimated by calculated and measured LDL-C levels in Chinese patients with coronary heart disease.Clin Chim Acta. 2020 Jan;500:75-80. doi: 10.1016/j.cca.2019.09.020. Epub 2019 Oct 23.
523 A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.Drug Des Devel Ther. 2019 Nov 28;13:3989-4005. doi: 10.2147/DDDT.S216644. eCollection 2019.
524 Association of intima-media thickening of carotid artery with genetic polymorphisms of the regulator of G-protein signaling 2 gene in patients with hypertension and in the general population.Hypertens Res. 2011 Jun;34(6):740-6. doi: 10.1038/hr.2011.25. Epub 2011 Mar 31.
525 iRhom2 promotes atherosclerosis through macrophage inflammation and induction of oxidative stress.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1897-1904. doi: 10.1016/j.bbrc.2018.07.133. Epub 2018 Aug 7.
526 Receptor-interacting protein 2 (RIP2) gene polymorphisms are associated with increased risk of subclinical atherosclerosis and clinical and metabolic parameters. The Genetics of Atherosclerotic Disease (GEA) Mexican study.Exp Mol Pathol. 2017 Feb;102(1):1-6. doi: 10.1016/j.yexmp.2016.12.003. Epub 2016 Dec 7.
527 Identification and characterization of the druggable kinase targets of olmesartan and its analogues from a systematic kinase-chemical interaction profile in atherosclerosis.J Mol Graph Model. 2018 Mar;80:211-216. doi: 10.1016/j.jmgm.2018.01.016.
528 lncRNA 430945 promotes the proliferation and migration of vascular smooth muscle cells via the ROR2/RhoA signaling pathway in atherosclerosis.Mol Med Rep. 2019 Jun;19(6):4663-4672. doi: 10.3892/mmr.2019.10137. Epub 2019 Apr 5.
529 CYP19A1, MIF and ABCA1 genes are targets of the ROR in monocyte and endothelial cells.Cell Biol Int. 2017 Feb;41(2):163-176. doi: 10.1002/cbin.10712.
530 Risk factors between intracranial-extracranial atherosclerosis and anterior-posterior circulation stroke in ischaemic stroke.Neurol Res. 2017 Jan;39(1):30-35. doi: 10.1080/01616412.2016.1250856. Epub 2016 Oct 31.
531 Sulindac-derived retinoid X receptor- modulator attenuates atherosclerotic plaque progression and destabilization in ApoE(-/-) mice.Br J Pharmacol. 2019 Jul;176(14):2559-2572. doi: 10.1111/bph.14682. Epub 2019 May 23.
532 S100A12-CD36 axis: A novel player in the pathogenesis of atherosclerosis?.Cytokine. 2019 Oct;122:154104. doi: 10.1016/j.cyto.2017.07.010. Epub 2017 Jul 26.
533 S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2496-507. doi: 10.1161/ATVBAHA.115.302072. Epub 2015 Oct 29.
534 SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE(-/-) mice.FASEB J. 2019 Mar;33(3):3437-3450. doi: 10.1096/fj.201800975RRR. Epub 2018 Nov 21.
535 Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway.J Mol Cell Cardiol. 2020 Jan;138:34-48. doi: 10.1016/j.yjmcc.2019.11.145. Epub 2019 Nov 14.
536 The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.Br J Dermatol. 2019 Oct;181(4):733-742. doi: 10.1111/bjd.17932. Epub 2019 May 6.
537 Effect of Autophagy Regulated by Sirt1/FoxO1 Pathway on the Release of Factors Promoting Thrombosis from Vascular Endothelial Cells.Int J Mol Sci. 2019 Aug 24;20(17):4132. doi: 10.3390/ijms20174132.
538 The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway.Cell Death Dis. 2019 Jul 1;10(7):507. doi: 10.1038/s41419-019-1736-5.
539 CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis.Mol Immunol. 2015 Oct;67(2 Pt B):559-67. doi: 10.1016/j.molimm.2015.07.028. Epub 2015 Aug 12.
540 The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis.Nat Commun. 2017 Jun 1;8:15426. doi: 10.1038/ncomms15426.
541 Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.Arterioscler Thromb Vasc Biol. 2016 May;36(5):e41-50. doi: 10.1161/ATVBAHA.115.306973. Epub 2016 Mar 31.
542 The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease.Front Immunol. 2019 Sep 20;10:2264. doi: 10.3389/fimmu.2019.02264. eCollection 2019.
543 -Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice.J Vasc Res. 2017;54(4):235-245. doi: 10.1159/000478014. Epub 2017 Jul 29.
544 Fabrication of 3D continuous-flow reverse-transcription polymerase chain reaction microdevice integrated with on-chip fluorescence detection for semi-quantitative assessment of gene expression.Analyst. 2018 Nov 19;143(23):5692-5701. doi: 10.1039/c8an01739e.
545 miR-378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47-SIRP Axis in Atherosclerosis.Scand J Immunol. 2019 Jul;90(1):e12766. doi: 10.1111/sji.12766. Epub 2019 Apr 22.
546 Integrated DNA methylation and gene expression analysis identifies SLAMF7 as a key regulator of atherosclerosis.Aging (Albany NY). 2018 Jun 13;10(6):1324-1337. doi: 10.18632/aging.101470.
547 ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions.Basic Res Cardiol. 2007 Jul;102(4):298-307. doi: 10.1007/s00395-007-0652-5. Epub 2007 Apr 30.
548 Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis.Circulation. 2005 Aug 30;112(9):1353-61. doi: 10.1161/CIRCULATIONAHA.104.519025. Epub 2005 Aug 22.
549 AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.Sci Rep. 2019 Oct 30;9(1):15571. doi: 10.1038/s41598-019-51292-9.
550 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.Biochem J. 2006 Jan 1;393(Pt 1):255-65. doi: 10.1042/BJ20050845.
551 A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study.Am J Kidney Dis. 2015 Feb;65(2):294-302. doi: 10.1053/j.ajkd.2014.07.021. Epub 2014 Oct 7.
552 CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis.Atherosclerosis. 2017 Jan;256:105-114. doi: 10.1016/j.atherosclerosis.2016.11.017. Epub 2016 Nov 16.
553 Conventional and electronic cigarettes dysregulate the expression of iron transporters and detoxifying enzymes at the brain vascular endothelium: In vivo evidence of a gender-specific cellular response to chronic cigarette smoke exposure.Neurosci Lett. 2018 Aug 24;682:1-9. doi: 10.1016/j.neulet.2018.05.045. Epub 2018 Jun 4.
554 Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies.Cardiovasc Res. 2019 Feb 1;115(2):266-276. doi: 10.1093/cvr/cvy295.
555 Ca(2+) Entry Through Reverse Mode Na(+)/Ca(2+) Exchanger Contributes to Store Operated Channel-Mediated Neointima Formation After Arterial Injury.Can J Cardiol. 2018 Jun;34(6):791-799. doi: 10.1016/j.cjca.2018.01.012. Epub 2018 Jan 31.
556 The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells.J Immunol. 2015 Oct 1;195(7):3334-44. doi: 10.4049/jimmunol.1500640. Epub 2015 Aug 21.
557 Modulation of the Proliferation/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a/Smad1 Axis.Int Heart J. 2019 Mar 20;60(2):444-450. doi: 10.1536/ihj.18-195. Epub 2019 Feb 8.
558 nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe(-/-) Mice.Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1479-1492. doi: 10.1161/ATVBAHA.118.311208. Epub 2018 May 24.
559 Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.Dig Liver Dis. 2019 Jul;51(7):1016-1022. doi: 10.1016/j.dld.2018.12.007. Epub 2018 Dec 23.
560 M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.Vasc Med. 2019 Dec;24(6):484-492. doi: 10.1177/1358863X19878495. Epub 2019 Oct 17.
561 Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):471-483. doi: 10.1093/abbs/gmz029.
562 Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation.Sci Rep. 2019 Dec 4;9(1):18329. doi: 10.1038/s41598-019-54877-6.
563 Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis.Vascul Pharmacol. 2018 Mar;102:29-36. doi: 10.1016/j.vph.2018.01.006. Epub 2018 Feb 2.
564 MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.Clin Sci (Lond). 2019 Feb 22;133(4):583-595. doi: 10.1042/CS20180980. Print 2019 Feb 28.
565 Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.Acta Pharmacol Sin. 2013 Jun;34(6):830-6. doi: 10.1038/aps.2013.8. Epub 2013 Apr 8.
566 Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.Diabetes. 2009 Jun;58(6):1457-62. doi: 10.2337/db08-0189. Epub 2009 Mar 26.
567 Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):769-75. doi: 10.1161/01.ATV.0000258862.61067.14. Epub 2007 Jan 25.
568 Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.Atherosclerosis. 2019 Feb;281:47-55. doi: 10.1016/j.atherosclerosis.2018.12.020. Epub 2018 Dec 30.
569 Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis.Lipids. 2010 Jan;45(1):29-36. doi: 10.1007/s11745-009-3375-6. Epub 2009 Nov 28.
570 Myeloid -Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1468-1478. doi: 10.1161/ATVBAHA.118.311059. Epub 2018 May 3.
571 Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.J Clin Invest. 2017 Aug 1;127(8):2904-2915. doi: 10.1172/JCI75005. Epub 2017 Jun 26.
572 Effect of STC2 gene silencing on colorectal cancer cells.Mol Med Rep. 2019 Aug;20(2):977-984. doi: 10.3892/mmr.2019.10332. Epub 2019 Jun 4.
573 Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors.Nature. 2004 May 13;429(6988):188-93. doi: 10.1038/nature02488.
574 MiR-377 mediates the expression of Syk to attenuate atherosclerosis lesion development in ApoE(-/-) mice.Biomed Pharmacother. 2019 Oct;118:109332. doi: 10.1016/j.biopha.2019.109332. Epub 2019 Aug 22.
575 SM22 (Smooth Muscle Protein 22-) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2306-2317. doi: 10.1161/ATVBAHA.118.311134.
576 A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene.J Vis Exp. 2019 Apr 1;(146). doi: 10.3791/57289.
577 Associations between thromboxane A synthase 1 gene polymorphisms and the risk of ischemic stroke in a Chinese Han population.Neural Regen Res. 2018 Mar;13(3):463-469. doi: 10.4103/1673-5374.228729.
578 Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis.PLoS One. 2011 Mar 15;6(3):e17978. doi: 10.1371/journal.pone.0017978.
579 Association Between Absolute Neutrophil Count and Variation at TCIRG1: The NHLBI Exome Sequencing Project.Genet Epidemiol. 2016 Sep;40(6):470-4. doi: 10.1002/gepi.21976. Epub 2016 May 27.
580 Identification of key transcription factors associated with cerebral ischemiareperfusion injury based on geneset enrichment analysis.Int J Mol Med. 2019 Jun;43(6):2429-2439. doi: 10.3892/ijmm.2019.4159. Epub 2019 Apr 9.
581 Tissue factor pathway inhibitor in atherosclerosis.Clin Chim Acta. 2019 Apr;491:97-102. doi: 10.1016/j.cca.2019.01.024. Epub 2019 Jan 26.
582 Systematic analysis of lncRNA expression profiles and atherosclerosis-associated lncRNA-mRNA network revealing functional lncRNAs in carotid atherosclerotic rabbit models.Funct Integr Genomics. 2020 Jan;20(1):103-115. doi: 10.1007/s10142-019-00705-z. Epub 2019 Aug 7.
583 Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis.J Clin Invest. 2018 Feb 1;128(2):834-845. doi: 10.1172/JCI94674. Epub 2018 Jan 22.
584 Oscillating flow promotes inflammation through the TLR2-TAK1-IKK2 signalling pathway in human umbilical vein endothelial cell (HUVECs).Life Sci. 2019 May 1;224:212-221. doi: 10.1016/j.lfs.2019.03.033. Epub 2019 Mar 23.
585 The flagellin-TLR5-Nox4 axis promotes the migration of smooth muscle cells in atherosclerosis.Exp Mol Med. 2019 Jul 10;51(7):1-13. doi: 10.1038/s12276-019-0275-6.
586 The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.Scand J Immunol. 2017 Jul;86(1):50-58. doi: 10.1111/sji.12560.
587 Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.J Vasc Res. 2017;54(3):156-169. doi: 10.1159/000457797. Epub 2017 May 5.
588 Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.Hum Mol Genet. 2017 Jul 15;26(14):2719-2731. doi: 10.1093/hmg/ddx159.
589 Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis.J Atheroscler Thromb. 2019 Jan 1;26(1):31-38. doi: 10.5551/jat.42887. Epub 2018 May 17.
590 Effects of 12-months treatment with zoledronate or teriparatide on intima-media thickness of carotid artery in women with postmenopausal osteoporosis: A pilot study.Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738418822439. doi: 10.1177/2058738418822439.
591 Association of OX40 and OX40L gene polymorphisms with acute coronary syndrome in a Han Chinese population.DNA Cell Biol. 2011 Aug;30(8):597-602. doi: 10.1089/dna.2010.1201. Epub 2011 Apr 10.
592 The rs3850641 polymorphism of the TNFSF4 gene increases the risk of myocardial infarction in a Chinese Han population.Biosci Rep. 2018 Jul 12;38(4):BSR20180526. doi: 10.1042/BSR20180526. Print 2018 Aug 31.
593 Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 May;38(5):1007-1019. doi: 10.1161/ATVBAHA.117.310536. Epub 2018 Mar 22.
594 Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.Adv Clin Chem. 2017;82:265-300. doi: 10.1016/bs.acc.2017.06.006. Epub 2017 Aug 7.
595 Research on mechanism of PCS in damaging vascular endothelial cells and promoting formation of atherosclerosis via TLR4/TREM-1.Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7533-7542. doi: 10.26355/eurrev_201811_16295.
596 Knockdown of TRIM28 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration.Chem Biol Interact. 2019 Sep 25;311:108772. doi: 10.1016/j.cbi.2019.108772. Epub 2019 Jul 24.
597 The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges.Front Pharmacol. 2019 Oct 18;10:1253. doi: 10.3389/fphar.2019.01253. eCollection 2019.
598 Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs.Basic Res Cardiol. 2017 Sep;112(5):54. doi: 10.1007/s00395-017-0643-0. Epub 2017 Jul 29.
599 miR-26a inhibits atherosclerosis progression by targeting TRPC3.Cell Biosci. 2018 Jan 19;8:4. doi: 10.1186/s13578-018-0203-9. eCollection 2018.
600 Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study.BMC Genet. 2015 May 29;16:56. doi: 10.1186/s12863-015-0219-7.
601 Oxygenized low density lipoprotein down-regulates the TRPV4 protein expression of macrophage through activation of peroxisome proliferator-activated receptor .Minerva Med. 2017 Feb;108(1):1-12. doi: 10.23736/S0026-4806.16.04645-0. Epub 2016 Oct 5.
602 Thymic stromal lymphopoietin-induced HOTAIR activation promotes endothelial cell proliferation and migration in atherosclerosis.Biosci Rep. 2017 Jul 12;37(4):BSR20170351. doi: 10.1042/BSR20170351. Print 2017 Aug 31.
603 TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation.Acta Pharmacol Sin. 2020 Jan;41(1):34-46. doi: 10.1038/s41401-019-0293-x. Epub 2019 Sep 12.
604 Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.Int J Mol Sci. 2019 May 10;20(9):2322. doi: 10.3390/ijms20092322.
605 Evaluation on the effect of hydrogen sulfide on the NLRP3 signaling pathway and its involvement in the pathogenesis of atherosclerosis.J Cell Biochem. 2019 Jan;120(1):481-492. doi: 10.1002/jcb.27404. Epub 2018 Sep 23.
606 Selenium in the prevention of atherosclerosis and its underlying mechanisms.Metallomics. 2017 Jan 25;9(1):21-37. doi: 10.1039/c6mt00195e.
607 Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation.Exp Mol Med. 2019 Sep 30;51(10):1-12. doi: 10.1038/s12276-019-0315-2.
608 Uncoupling Protein 2 in Cardiovascular Health and Disease.Front Physiol. 2018 Aug 2;9:1060. doi: 10.3389/fphys.2018.01060. eCollection 2018.
609 USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2295-2305. doi: 10.1161/ATVBAHA.118.311071.
610 Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?.J Endocrinol Invest. 2019 Feb;42(2):207-215. doi: 10.1007/s40618-018-0905-1. Epub 2018 May 26.
611 Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics.Biol Chem. 2019 Feb 25;400(3):323-332. doi: 10.1515/hsz-2018-0330.
612 Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.Circulation. 2005 Aug 30;112(9):1347-52. doi: 10.1161/CIRCULATIONAHA.105.534107.
613 Leptin and the vasculature in young adults: The African-PREDICT study.Eur J Clin Invest. 2019 Jan;49(1):e13039. doi: 10.1111/eci.13039. Epub 2018 Nov 16.
614 Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158547. doi: 10.1016/j.bbalip.2019.158547. Epub 2019 Oct 31.
615 Novel LMNA mutation in atypical Werner syndrome presenting with ischemic disease.Stroke. 2009 Feb;40(2):e11-4. doi: 10.1161/STROKEAHA.108.531780. Epub 2008 Dec 18.
616 Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development.Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):291-8. doi: 10.1161/ATVBAHA.111.234559. Epub 2011 Nov 17.
617 Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.J Am Coll Cardiol. 2008 Jul 29;52(5):369-77. doi: 10.1016/j.jacc.2008.03.059.
618 Adrenomedullin and arterial stiffness: integrative approach combining monocyte ADM expression, plasma MR-Pro-ADM, and genome-wide association study.Circ Cardiovasc Genet. 2014 Oct;7(5):634-41. doi: 10.1161/CIRCGENETICS.113.000456. Epub 2014 Jul 22.
619 The association between local arteriosclerosis of the prostatic arteries and chronic inflammation in human benign prostatic enlargement.Prostate. 2019 May;79(6):574-582. doi: 10.1002/pros.23763. Epub 2019 Jan 13.
620 Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.Theranostics. 2018 Jan 1;8(3):749-766. doi: 10.7150/thno.20183. eCollection 2018.
621 Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-B p65 phosphorylation in senescent endothelial cells.Int J Mol Med. 2019 Oct;44(4):1187-1196. doi: 10.3892/ijmm.2019.4294. Epub 2019 Jul 31.
622 Impact of Tag Single Nucleotide Polymorphisms (SNPs) in CCL11 Gene on Risk of Subtypes of Ischemic Stroke in Xinjiang Han Populations.Med Sci Monit. 2017 Sep 5;23:4291-4298. doi: 10.12659/msm.905942.
623 mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway.Mol Med Rep. 2017 Sep;16(3):3315-3323. doi: 10.3892/mmr.2017.7032. Epub 2017 Jul 18.
624 Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.Thromb Res. 2018 Nov;171:171-176. doi: 10.1016/j.thromres.2018.10.001. Epub 2018 Oct 3.
625 Altered Gene Response to Aflatoxin B(1) in the Spleens of Susceptible and Resistant Turkeys.Toxins (Basel). 2019 Apr 28;11(5):242. doi: 10.3390/toxins11050242.
626 Intestinal fatty acid binding protein Ala54Thr polymorphism is associated with peripheral atherosclerosis combined with type 2 diabetes mellitus.J Diabetes. 2017 Sep;9(9):821-826. doi: 10.1111/1753-0407.12496. Epub 2016 Dec 9.
627 Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?.Antioxid Redox Signal. 2017 Dec 10;27(17):1439-1445. doi: 10.1089/ars.2017.7122. Epub 2017 Jun 2.
628 Progranulin in the hematopoietic compartment protects mice from atherosclerosis.Atherosclerosis. 2018 Oct;277:145-154. doi: 10.1016/j.atherosclerosis.2018.08.042. Epub 2018 Aug 30.
629 Protein corona and phospholipase activity drive selective accumulation of nanomicelles in atherosclerotic plaques.Nanomedicine. 2018 Apr;14(3):643-650. doi: 10.1016/j.nano.2017.12.021. Epub 2018 Jan 6.
630 Muramyl Dipeptide Induces Reactive Oxygen Species Generation Through the NOD2/COX-2/NOX4 Signaling Pathway in Human Umbilical Vein Endothelial Cells.J Cardiovasc Pharmacol. 2018 Jun;71(6):352-358. doi: 10.1097/FJC.0000000000000581.
631 CD73 Promotes Age-Dependent Accretion of Atherosclerosis.Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):61-71. doi: 10.1161/ATVBAHA.119.313002. Epub 2019 Oct 17.
632 Netrin-1 and the Grade of Atherosclerosis Are Inversely Correlated in Humans.Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):462-472. doi: 10.1161/ATVBAHA.119.313624. Epub 2019 Dec 5.
633 IL-1/MMP9 activation in primary human vascular smooth muscle-like cells: Exploring the role of TNF and P2X7.Int J Cardiol. 2019 Mar 1;278:202-209. doi: 10.1016/j.ijcard.2018.12.047. Epub 2018 Dec 18.
634 Association of G-protein coupled purinergic receptor P2Y2 with ischemic stroke in a Han Chinese population of North China.Neural Regen Res. 2019 Mar;14(3):506-512. doi: 10.4103/1673-5374.245472.
635 A study on the association of rs7950273 polymorphism in the PDGFD with ischaemic stroke in the Chinese Han population.Ann Hum Biol. 2016;43(1):78-80. doi: 10.3109/03014460.2015.1016552. Epub 2015 Sep 11.
636 Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.J Cardiovasc Transl Res. 2017 Aug;10(4):348-358. doi: 10.1007/s12265-017-9742-4. Epub 2017 Apr 10.
637 Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies.Eur J Hum Genet. 2004 Mar;12(3):213-9. doi: 10.1038/sj.ejhg.5201143.
638 Intermittent Hypoxia Composite Abnormal Glucose Metabolism-Mediated Atherosclerosis In Vitro and In Vivo: The Role of SREBP-1.Oxid Med Cell Longev. 2019 Feb 4;2019:4862760. doi: 10.1155/2019/4862760. eCollection 2019.
639 ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. Cell Metab. 2013 Aug 6;18(2):225-38.
640 Structural snapshot of the cholesterol-transport ATP-binding cassette proteins (1).Biochem Cell Biol. 2019 Jun;97(3):224-233. doi: 10.1139/bcb-2018-0151. Epub 2018 Jul 30.
641 Association of ATP2B1 common variants with asymptomatic intracranial and extracranial large artery stenosis in hypertension patients.Clin Exp Hypertens. 2019;41(4):323-329. doi: 10.1080/10641963.2018.1481421. Epub 2018 Jun 14.
642 Sequencing of 2 subclinical atherosclerosis candidate regions in 3669 individuals: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.Circ Cardiovasc Genet. 2014 Jun;7(3):359-64. doi: 10.1161/CIRCGENETICS.113.000116.
643 Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.Atherosclerosis. 2019 Feb;281:78-88. doi: 10.1016/j.atherosclerosis.2018.12.025. Epub 2018 Dec 24.
644 Graphical modeling of gene expression in monocytes suggests molecular mechanisms explaining increased atherosclerosis in smokers.PLoS One. 2013;8(1):e50888. doi: 10.1371/journal.pone.0050888. Epub 2013 Jan 23.
645 PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1271-1282. doi: 10.1161/ATVBAHA.117.310082. Epub 2018 Mar 29.
646 Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study.Sci Rep. 2019 Apr 11;9(1):5941. doi: 10.1038/s41598-019-42202-0.
647 Mutation in CYP27A1 identified in family with coronary artery disease.Eur J Med Genet. 2013 Dec;56(12):655-60. doi: 10.1016/j.ejmg.2013.09.008. Epub 2013 Sep 28.
648 A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness).Diabetologia. 2014 Jun;57(6):1159-72. doi: 10.1007/s00125-014-3215-y. Epub 2014 Mar 25.
649 Association between frailty and the cardio-ankle vascular index.Clin Interv Aging. 2019 Apr 26;14:735-742. doi: 10.2147/CIA.S195109. eCollection 2019.
650 Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allografts.Transplantation. 2010 Feb 27;89(4):409-16. doi: 10.1097/TP.0b013e3181c69838.
651 Vascular extracellular adenosine metabolism in mice correlates with susceptibility to atherosclerosis.Nucleosides Nucleotides Nucleic Acids. 2018;37(11):653-662. doi: 10.1080/15257770.2018.1489051. Epub 2018 Dec 27.
652 Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5.Front Neurol. 2019 Feb 4;10:32. doi: 10.3389/fneur.2019.00032. eCollection 2019.
653 Association of Serum Cholesterol Ester Transfer Protein Levels with Taq IB Polymorphism in Acute Coronary Syndrome.Lab Med. 2020 Mar 10;51(2):199-210. doi: 10.1093/labmed/lmz043.
654 GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.Redox Biol. 2018 Jul;17:386-399. doi: 10.1016/j.redox.2018.04.021. Epub 2018 May 1.
655 A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase.Sci China Life Sci. 2018 Sep;61(9):1024-1029. doi: 10.1007/s11427-017-9285-1. Epub 2018 Apr 16.
656 Effects of Inorganic Arsenic, Methylated Arsenicals, and Arsenobetaine on Atherosclerosis in the Mouse Model and the Role of As3mt-Mediated Methylation.Environ Health Perspect. 2017 Jul 5;125(7):077001. doi: 10.1289/EHP806.
657 Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1795-802. doi: 10.1161/ATVBAHA.113.301634. Epub 2013 Jun 6.
658 3beta-Hydroxysteroid dehydrogenase in human aorta.Endocr J. 2005 Feb;52(1):111-5. doi: 10.1507/endocrj.52.111.
659 CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.Pharmacogenet Genomics. 2007 May;17(5):349-58. doi: 10.1097/FPC.0b013e32809913ea.
660 New potential modulators of CYP4F2 enzyme activity in angina pectoris: hsa-miR-24-3p and hsa-miR-34a-5p.Biomarkers. 2020 Feb;25(1):40-47. doi: 10.1080/1354750X.2019.1690580. Epub 2019 Nov 14.
661 Prostaglandin E(2) promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4/cholesterol 7-hydroxylase pathway in mice.Hepatology. 2017 Mar;65(3):999-1014. doi: 10.1002/hep.28928. Epub 2016 Dec 31.
662 FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis.Atherosclerosis. 2015 Sep;242(1):230-5. doi: 10.1016/j.atherosclerosis.2015.07.026. Epub 2015 Jul 16.
663 A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice.J Pharmacol Exp Ther. 2019 Nov;371(2):290-298. doi: 10.1124/jpet.119.259846. Epub 2019 Sep 5.
664 Combined GSTM1 and GSTT1 null genotypes are strong risk factors for atherogenesis in a Serbian population.Genet Mol Biol. 2018 Jan-Mar;41(1):35-40. doi: 10.1590/1678-4685-GMB-2017-0034.
665 Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.J Lipid Res. 2015 Oct;56(10):1891-900. doi: 10.1194/jlr.M058776. Epub 2015 Aug 28.
666 The beneficial effects of rosuvastatin are independent of zinc supplementation in patients with atherosclerosis.J Trace Elem Med Biol. 2014 Apr;28(2):194-199. doi: 10.1016/j.jtemb.2014.01.003. Epub 2014 Jan 29.
667 Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.J Am Heart Assoc. 2017 Feb 7;6(2):e004328. doi: 10.1161/JAHA.116.004328.
668 PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity.Antioxidants (Basel). 2019 Jan 11;8(1):19. doi: 10.3390/antiox8010019.
669 Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans.Nephrol Dial Transplant. 2013 Jun;28(6):1497-504. doi: 10.1093/ndt/gfs591. Epub 2013 Jan 16.
670 Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family Study.J Clin Endocrinol Metab. 2012 Sep;97(9):3285-91. doi: 10.1210/jc.2012-1318. Epub 2012 Jul 3.
671 Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.Arch Med Res. 2018 Apr;49(3):182-190. doi: 10.1016/j.arcmed.2018.07.002. Epub 2018 Jul 18.
672 Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief Report.Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1045-1054. doi: 10.1161/ATVBAHA.119.312592.
673 High expression of long chain acyl-coenzyme A synthetase 1 in peripheral blood may be a molecular marker for assessing the risk of acute myocardial infarction.Exp Ther Med. 2017 Nov;14(5):4065-4072. doi: 10.3892/etm.2017.5091. Epub 2017 Sep 1.
674 miR-449a induces EndMT, promotes the development of atherosclerosis by targeting the interaction between AdipoR2 and E-cadherin in Lipid Rafts.Biomed Pharmacother. 2019 Jan;109:2293-2304. doi: 10.1016/j.biopha.2018.11.114. Epub 2018 Nov 28.
675 Identification of a molecular signaling gene-gene regulatory network between GWAS susceptibility genes ADTRP and MIA3/TANGO1 for coronary artery disease.Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1640-1653. doi: 10.1016/j.bbadis.2017.03.010. Epub 2017 Mar 21.
676 Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease.J Atheroscler Thromb. 2019 Jun 1;26(6):573-581. doi: 10.5551/jat.46508. Epub 2018 Dec 4.
677 Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells.Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1161-C1171. doi: 10.1152/ajpcell.00264.2019. Epub 2019 Sep 25.
678 Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.Circulation. 2002 Mar 5;105(9):1044-8. doi: 10.1161/hc0902.104676.
679 Serum Resistin, Adenylate Cyclase-Associated Protein 1 Gene Expression, and Carotid Intima-Media Thickness in Patients with End-Stage Renal Disease and Healthy Controls.Cardiorenal Med. 2020;10(1):51-60. doi: 10.1159/000503416. Epub 2019 Nov 13.
680 Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.Sci Signal. 2017 May 23;10(480):eaai8529. doi: 10.1126/scisignal.aai8529.
681 Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.Stroke. 2019 Nov;50(11):3289-3292. doi: 10.1161/STROKEAHA.119.026457. Epub 2019 Sep 9.
682 Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study.J Thromb Haemost. 2019 May;17(5):818-826. doi: 10.1111/jth.14420. Epub 2019 Mar 18.
683 Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease.Am J Cardiovasc Drugs. 2018 Apr;18(2):109-115. doi: 10.1007/s40256-017-0250-3.
684 Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study).Eur J Clin Invest. 2000 Jul;30(7):578-85. doi: 10.1046/j.1365-2362.2000.00674.x.
685 TPM2 as a potential predictive biomarker for atherosclerosis.Aging (Albany NY). 2019 Sep 5;11(17):6960-6982. doi: 10.18632/aging.102231. Epub 2019 Sep 5.
686 HHIPL1, a Gene at the 14q32 Coronary Artery Disease Locus, Positively Regulates Hedgehog Signaling and Promotes Atherosclerosis.Circulation. 2019 Aug 6;140(6):500-513. doi: 10.1161/CIRCULATIONAHA.119.041059. Epub 2019 Jun 5.
687 Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway.Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Aug;1863(8):806-822. doi: 10.1016/j.bbalip.2018.04.011. Epub 2018 Apr 17.
688 Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis.Clin Chim Acta. 1996 Nov 29;255(2):165-71. doi: 10.1016/0009-8981(96)06404-2.
689 Krppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.Atherosclerosis. 2019 Oct;289:143-161. doi: 10.1016/j.atherosclerosis.2019.08.012. Epub 2019 Aug 26.
690 Lim domain binding 2: a key driver of transendothelial migration of leukocytes and atherosclerosis.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2068-77. doi: 10.1161/ATVBAHA.113.302709. Epub 2014 Jun 12.
691 Expression of Mac-2 binding protein in human carotid atheroma is associated with plaque instability and clinical manifestations.Biomed Pharmacother. 2019 Feb;110:465-472. doi: 10.1016/j.biopha.2018.12.015. Epub 2018 Dec 6.
692 The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.Hum Mol Genet. 2018 Apr 15;27(8):1447-1459. doi: 10.1093/hmg/ddy055.
693 A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.FEBS Open Bio. 2019 Oct;9(10):1734-1743. doi: 10.1002/2211-5463.12712. Epub 2019 Aug 30.
694 Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease.Ann Hum Genet. 2008 Jul;72(Pt 4):443-53. doi: 10.1111/j.1469-1809.2008.00433.x. Epub 2008 Jul 3.
695 Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin.J Ethnopharmacol. 2020 Jan 10;246:112207. doi: 10.1016/j.jep.2019.112207. Epub 2019 Aug 30.
696 Operational Differences in Plant-Based Diet Indices Affect the Ability to Detect Associations with Incident Hypertension in Middle-Aged US Adults.J Nutr. 2020 Apr 1;150(4):842-850. doi: 10.1093/jn/nxz275.
697 Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium.Proc Natl Acad Sci U S A. 2018 May 1;115(18):4672-4677. doi: 10.1073/pnas.1712918115. Epub 2018 Mar 27.
698 PHACTR1 haplotypes are associated with carotid plaque presence and affect PHACTR1 mRNA expression in carotid plaque tissue.Gene. 2019 Aug 20;710:273-278. doi: 10.1016/j.gene.2019.06.020. Epub 2019 Jun 12.
699 A RTK-based functional RNAi screen reveals determinants of PTX-3 expression.Int J Clin Exp Pathol. 2013;6(4):660-8. Epub 2013 Mar 15.
700 Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy.J Intern Med. 2019 Dec;286(6):660-675. doi: 10.1111/joim.12951. Epub 2019 Jul 29.
701 RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).Atherosclerosis. 2014 Apr;233(2):666-672. doi: 10.1016/j.atherosclerosis.2014.01.035. Epub 2014 Jan 30.
702 Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.BMC Cancer. 2015 Oct 29;15:819. doi: 10.1186/s12885-015-1832-6.
703 The interleukin-33-mediated inhibition of expression of two key genes implicated in atherosclerosis in human macrophages requires MAP kinase, phosphoinositide 3-kinase and nuclear factor-B signaling pathways.Sci Rep. 2019 Aug 5;9(1):11317. doi: 10.1038/s41598-019-47620-8.
704 The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease.Clin Cardiol. 2010 Sep;33(9):548-52. doi: 10.1002/clc.20761.
705 SOX6 gene polymorphism (rs16933090) and markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus.Int Angiol. 2016 Dec;35(6):552-556. Epub 2016 Feb 11.
706 Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.RNA. 2015 Jun;21(6):1187-202. doi: 10.1261/rna.049890.115. Epub 2015 Apr 22.
707 MicroRNA-30-3p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21.Mediators Inflamm. 2019 Jul 2;2019:1342190. doi: 10.1155/2019/1342190. eCollection 2019.
708 Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.Hum Mol Genet. 2012 Mar 15;21(6):1364-73. doi: 10.1093/hmg/ddr574. Epub 2011 Dec 12.
709 MicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and Elastin.Circ Res. 2017 Jan 6;120(1):49-65. doi: 10.1161/CIRCRESAHA.116.309321. Epub 2016 Oct 18.
710 Inhibition of IL-8-mediated endothelial adhesion, VSMCs proliferation and migration by siRNA-TMEM98 suggests TMEM98's emerging role in atherosclerosis.Oncotarget. 2017 Sep 30;8(50):88043-88058. doi: 10.18632/oncotarget.21408. eCollection 2017 Oct 20.
711 CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.Cell Signal. 2013 Jan;25(1):359-71. doi: 10.1016/j.cellsig.2012.10.009. Epub 2012 Oct 17.
712 A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 2006 Oct;79(4):759-64. doi: 10.1086/508069. Epub 2006 Aug 24.
713 ACP1 genetic polymorphism and coronary artery disease: an association study.Cardiology. 2009;113(4):236-42. doi: 10.1159/000203405. Epub 2009 Feb 25.
714 A functional variant in the CARD4 gene and risk of premature coronary heart disease.Int J Immunogenet. 2006 Aug;33(4):307-11. doi: 10.1111/j.1744-313X.2006.00618.x.
715 The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways.Curr Med Sci. 2019 Apr;39(2):185-189. doi: 10.1007/s11596-019-2017-3. Epub 2019 Apr 23.
716 The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR(-/-)/ApoBec(-/-) Mice.Cell Physiol Biochem. 2019;52(4):681-695. doi: 10.33594/000000048.
717 Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases.Sci Transl Med. 2019 Sep 18;11(510):eaav5055. doi: 10.1126/scitranslmed.aav5055.
718 An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor- mediated apolipoprotein A-I, A-II and C-III.Eur J Pharmacol. 2015 Aug 15;761:362-74. doi: 10.1016/j.ejphar.2015.04.015. Epub 2015 May 12.
719 Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.Neurobiol Aging. 2014 Jun;35(6):1510.e7-18. doi: 10.1016/j.neurobiolaging.2013.12.007. Epub 2013 Dec 19.
720 Interleukin-6 "Trans-Signaling" and Ischemic Vascular Disease: The Important Role of Soluble gp130.Mediators Inflamm. 2017;2017:1396398. doi: 10.1155/2017/1396398. Epub 2017 Jan 31.
721 Impaired Autophagy in CD11b(+) Dendritic Cells Expands CD4(+) Regulatory T Cells and Limits Atherosclerosis in Mice.Circ Res. 2019 Nov 8;125(11):1019-1034. doi: 10.1161/CIRCRESAHA.119.315248. Epub 2019 Oct 15.
722 ApoER2 (Apolipoprotein E Receptor-2) Deficiency Accelerates Smooth Muscle Cell Senescence via Cytokinesis Impairment and Promotes Fibrotic Neointima After Vascular Injury.Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2132-2144. doi: 10.1161/ATVBAHA.119.313194. Epub 2019 Aug 15.
723 Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).Ann Noninvasive Electrocardiol. 2013 Jan;18(1):29-40. doi: 10.1111/anec.12028.
724 Novel DNA methylation sites associated with cigarette smoking among African Americans.Epigenetics. 2019 Apr;14(4):383-391. doi: 10.1080/15592294.2019.1588683. Epub 2019 Mar 27.
725 Gypenoside XVII prevents atherosclerosis by attenuating endothelial apoptosis and oxidative stress: insight into the ERalpha-mediated PI3K/Akt pathway. Int J Mol Sci. 2017 Feb 9;18(2). pii: E77.
726 LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.Atherosclerosis. 2015 Dec;243(2):429-37. doi: 10.1016/j.atherosclerosis.2015.10.009. Epub 2015 Oct 13.
727 Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.Inflamm Res. 2012 Dec;61(12):1347-54. doi: 10.1007/s00011-012-0535-6. Epub 2012 Jul 31.
728 Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.Haematologica. 2018 Jul;103(7):1136-1142. doi: 10.3324/haematol.2018.187815. Epub 2018 Mar 15.
729 Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.Diabetes Care. 2017 Apr;40(4):591-598. doi: 10.2337/dc16-1875. Epub 2017 Feb 1.
730 Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE nullmice.Atherosclerosis. 2013 May;228(1):69-79. doi: 10.1016/j.atherosclerosis.2013.02.023. Epub 2013 Feb 28.
731 Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells.BMB Rep. 2019 Feb;52(2):145-150. doi: 10.5483/BMBRep.2019.52.2.282.
732 Adipocyte Hypoxia-Inducible Factor 2 Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism.Cell Metab. 2019 Nov 5;30(5):937-951.e5. doi: 10.1016/j.cmet.2019.09.016. Epub 2019 Oct 24.
733 Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.Scand J Clin Lab Invest. 2012 Dec;72(8):648-56. doi: 10.3109/00365513.2012.734394. Epub 2012 Oct 29.
734 A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity.Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2444-51. doi: 10.1161/ATVBAHA.112.252205. Epub 2012 Aug 16.
735 A Disintegrin and Metalloproteinase with Thrombospondin Motifs 18 Deficiency Leads to Visceral Adiposity and Associated Metabolic Syndrome in Mice.Am J Pathol. 2018 Feb;188(2):461-473. doi: 10.1016/j.ajpath.2017.10.020. Epub 2017 Nov 21.
736 The expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the anti-atherogenic cytokine transforming growth factor- and requires Smads, p38 mitogen-activated protein kinase and c-Jun.Int J Biochem Cell Biol. 2011 May;43(5):805-11. doi: 10.1016/j.biocel.2011.02.005. Epub 2011 Feb 18.
737 Association between ADAMTS7 polymorphism and carotid artery plaque vulnerability.Medicine (Baltimore). 2019 Oct;98(43):e17438. doi: 10.1097/MD.0000000000017438.
738 The Notch pathway attenuates interleukin 1 (IL1)-mediated induction of adenylyl cyclase 8 (AC8) expression during vascular smooth muscle cell (VSMC) trans-differentiation.J Biol Chem. 2012 Jul 20;287(30):24978-89. doi: 10.1074/jbc.M111.292516. Epub 2012 May 21.
739 ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).Circulation. 2018 Oct 16;138(16):1677-1692. doi: 10.1161/CIRCULATIONAHA.117.031134.
740 ACE and ADD1 gene in extra and intracranial atherosclerosis in ischaemic stroke.Neurol Res. 2013 May;35(4):429-34. doi: 10.1179/1743132813Y.0000000161.
741 Endothelial GPR124 Exaggerates the Pathogenesis of Atherosclerosis by Activating Inflammation.Cell Physiol Biochem. 2018;45(2):547-557. doi: 10.1159/000487032. Epub 2018 Jan 25.
742 Missense variants of the alanine: glyoxylate aminotransferase 2 gene correlated with carotid atherosclerosis in the Japanese population.J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):605-14.
743 AIM2 accelerates the atherosclerotic plaque progressions in ApoE-/- mice.Biochem Biophys Res Commun. 2018 Apr 6;498(3):487-494. doi: 10.1016/j.bbrc.2018.03.005. Epub 2018 Mar 3.
744 Cell death-mediated cleavage of the attraction signal p43 in human atherosclerosis: implications for plaque destabilization.Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1415-22. doi: 10.1161/ATVBAHA.110.206029. Epub 2010 Apr 22.
745 Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H793-H810. doi: 10.1152/ajpheart.00215.2019. Epub 2019 Aug 23.
746 PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells.Sci Rep. 2019 Nov 14;9(1):16787. doi: 10.1038/s41598-019-53098-1.
747 Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts.Cell Death Dis. 2019 Dec 4;10(12):909. doi: 10.1038/s41419-019-2152-6.
748 Association of serum angiopoietin-like protein 2 with elevated risk of cardiovascular diseases in subjects with type 2 diabetes.J Diabetes Complications. 2019 Nov;33(11):107421. doi: 10.1016/j.jdiacomp.2019.107421. Epub 2019 Aug 22.
749 Association of frequent genetic variants in platelet activation pathway genes with large-vessel ischemic stroke in Polish population.Platelets. 2017 Jan;28(1):66-73. doi: 10.1080/09537104.2016.1203404. Epub 2016 Aug 17.
750 Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo.Oncotarget. 2016 Aug 16;7(33):52729-52739. doi: 10.18632/oncotarget.10400.
751 Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.PLoS One. 2018 Feb 9;13(2):e0192740. doi: 10.1371/journal.pone.0192740. eCollection 2018.
752 Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel.PLoS One. 2019 Jun 26;14(6):e0218934. doi: 10.1371/journal.pone.0218934. eCollection 2019.
753 Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism.Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):424-9. doi: 10.1161/01.ATV.0000152632.48937.2d. Epub 2004 Dec 9.
754 Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells.J Leukoc Biol. 2001 Apr;69(4):645-50.
755 Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells.J Biol Chem. 2011 Aug 5;286(31):27389-98. doi: 10.1074/jbc.M110.210245. Epub 2011 Jun 6.
756 ApoM-S1P Modulates Ox-LDL-Induced Inflammation Through the PI3K/Akt Signaling Pathway in HUVECs.Inflammation. 2019 Apr;42(2):606-617. doi: 10.1007/s10753-018-0918-0.
757 Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.Atherosclerosis. 2012 Mar;221(1):66-75. doi: 10.1016/j.atherosclerosis.2011.12.014. Epub 2011 Dec 22.
758 ARHGAP18: A Flow-Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis.J Am Heart Assoc. 2019 Jan 22;8(2):e010057. doi: 10.1161/JAHA.118.010057.
759 Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.J Clin Invest. 2017 Dec 1;127(12):4516-4526. doi: 10.1172/JCI92702. Epub 2017 Nov 13.
760 The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis.PLoS One. 2013;8(1):e55202. doi: 10.1371/journal.pone.0055202. Epub 2013 Jan 25.
761 Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation.Circ Res. 2011 Nov 11;109(11):1210-8. doi: 10.1161/CIRCRESAHA.111.246702. Epub 2011 Sep 29.
762 Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.J Am Heart Assoc. 2018 Jun 23;7(13):e008447. doi: 10.1161/JAHA.117.008447.
763 Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis.Nat Commun. 2017 Aug 30;8(1):393. doi: 10.1038/s41467-017-00517-4.
764 Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure.ESC Heart Fail. 2019 Aug;6(4):747-757. doi: 10.1002/ehf2.12449. Epub 2019 May 15.
765 Triggers of histologically suspected drug-induced colitis.World J Gastroenterol. 2019 Feb 28;25(8):967-979. doi: 10.3748/wjg.v25.i8.967.
766 Protein Kinase C Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6C(hi) Cells Contributes to Atherosclerosis.Circulation. 2018 Nov 20;138(21):2395-2412. doi: 10.1161/CIRCULATIONAHA.118.034083.
767 Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice.Sci Rep. 2017 Jun 12;7(1):3284. doi: 10.1038/s41598-017-03443-z.
768 ATG16L1 Expression in Carotid Atherosclerotic Plaques Is Associated With Plaque Vulnerability.Arterioscler Thromb Vasc Biol. 2015 May;35(5):1226-35. doi: 10.1161/ATVBAHA.114.304840. Epub 2015 Mar 12.
769 3D time-varying simulations of Ca(2+) dynamics in arterial coupled cells: A massively parallel implementation.Int J Numer Method Biomed Eng. 2017 Feb;33(2):e02786. doi: 10.1002/cnm.2786. Epub 2016 Jul 1.
770 Functional modulation of smooth muscle cells by the inflammatory mediator CAP37.Microvasc Res. 2004 Mar;67(2):168-81. doi: 10.1016/j.mvr.2003.12.007.
771 microRNA-338-3p promotes ox-LDL-induced endothelial cell injury through targeting BAMBI and activating TGF-/Smad pathway.J Cell Physiol. 2019 Jul;234(7):11577-11586. doi: 10.1002/jcp.27814. Epub 2018 Dec 17.
772 An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.Thromb Haemost. 2015 Mar;113(3):655-63. doi: 10.1160/TH14-05-0466. Epub 2014 Nov 6.
773 Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease.J Diabetes Complications. 2019 May;33(5):390-397. doi: 10.1016/j.jdiacomp.2019.01.003. Epub 2019 Jan 17.
774 Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.JAMA Cardiol. 2016 Apr 1;1(1):15-25. doi: 10.1001/jamacardio.2015.0300.
775 Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism.Eur Heart J. 2020 Jul 7;41(26):2487-2497. doi: 10.1093/eurheartj/ehz459.
776 Lack of association between a functional variant of the BRCA-1 related associated protein (BRAP) gene and ischemic stroke.BMC Med Genet. 2013 Jan 28;14:17. doi: 10.1186/1471-2350-14-17.
777 Deleted in breast cancer 1 limits adipose tissue fat accumulation and plays a key role in the development of metabolic syndrome phenotype.Diabetes. 2015 Jan;64(1):12-22. doi: 10.2337/db14-0192. Epub 2014 Jul 22.
778 Genetic and functional association of FAM5C with myocardial infarction.BMC Med Genet. 2008 Apr 22;9:33. doi: 10.1186/1471-2350-9-33.
779 Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.Circ Res. 2019 Feb 15;124(4):e6-e19. doi: 10.1161/CIRCRESAHA.118.313028.
780 CTRP13 Preserves Endothelial Function by Targeting GTP Cyclohydrolase 1 in Diabetes.Diabetes. 2020 Jan;69(1):99-111. doi: 10.2337/db19-0635. Epub 2019 Nov 1.
781 C1q/TNF-related protein 1 promotes endothelial barrier dysfunction under disturbed flow.Biochem Biophys Res Commun. 2017 Aug 19;490(2):580-586. doi: 10.1016/j.bbrc.2017.06.081. Epub 2017 Jun 15.
782 Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.Cytokine. 2019 Jan;113:326-331. doi: 10.1016/j.cyto.2018.09.019. Epub 2018 Oct 15.
783 Flavone of Hippophae (H-flavone) lowers atherosclerotic risk factors via upregulation of the adipokine C1q/tumor necrosis factor-related protein 6 (CTRP6) in macrophages.Biosci Biotechnol Biochem. 2019 Nov;83(11):2000-2007. doi: 10.1080/09168451.2019.1634997. Epub 2019 Jun 28.
784 circRNA/lncRNA-miRNA-mRNA Network in Oxidized, Low-Density, Lipoprotein-Induced Foam Cells.DNA Cell Biol. 2019 Dec;38(12):1499-1511. doi: 10.1089/dna.2019.4865.
785 CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.Ann Med. 2010 Sep;42(6):439-46. doi: 10.3109/07853890.2010.499131.
786 Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.Exp Gerontol. 2019 Sep;124:110624. doi: 10.1016/j.exger.2019.05.013. Epub 2019 May 29.
787 Replication of calpain-10 genetic association with carotid intima-media thickness.Atherosclerosis. 2009 Aug;205(2):503-5. doi: 10.1016/j.atherosclerosis.2008.12.038. Epub 2009 Jan 9.
788 CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation.Clin Sci (Lond). 2013 Oct;125(8):401-7. doi: 10.1042/CS20120572.
789 miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.Sci Rep. 2016 Feb 22;6:21789. doi: 10.1038/srep21789.
790 Calpain inhibitor I attenuates atherosclerosis and inflammation in atherosclerotic rats through eNOS/NO/NF-B pathway.Can J Physiol Pharmacol. 2018 Jan;96(1):60-67. doi: 10.1139/cjpp-2016-0652. Epub 2017 Jul 30.
791 Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.Eur J Pharmacol. 2019 Jan 15;843:177-189. doi: 10.1016/j.ejphar.2018.11.009. Epub 2018 Nov 12.
792 Tumor Necrosis Factor- and C-C Motif Chemokine Ligand 18 Associate with Atherosclerotic Lipid Accumulation In situ and In vitro.Curr Pharm Des. 2018;24(24):2883-2889. doi: 10.2174/1381612824666180911120726.
793 Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis.Ann Allergy Asthma Immunol. 2020 Jan;124(1):70-78. doi: 10.1016/j.anai.2019.10.013. Epub 2019 Oct 14.
794 Chemokine receptor CCR5: from AIDS to atherosclerosis.Br J Pharmacol. 2011 Apr;162(7):1453-69. doi: 10.1111/j.1476-5381.2010.01147.x.
795 CCN3 Regulates Macrophage Foam Cell Formation and Atherosclerosis.Am J Pathol. 2017 Jun;187(6):1230-1237. doi: 10.1016/j.ajpath.2017.01.020.
796 Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells.Aging Cell. 2019 Feb;18(1):e12844. doi: 10.1111/acel.12844. Epub 2018 Dec 12.
797 Distorted leukocyte migration, angiogenesis, wound repair and metastasis in Tspan8 and Tspan8/CD151 double knockout mice indicate complementary activities of Tspan8 and CD51.Biochim Biophys Acta Mol Cell Res. 2018 Feb;1865(2):379-391. doi: 10.1016/j.bbamcr.2017.11.007. Epub 2017 Nov 11.
798 Erratum to "Magnetic Resonance Imaging of Atherosclerosis Using CD81-Targeted Microparticles of Iron Oxide in Mice".Biomed Res Int. 2018 Oct 18;2018:8093438. doi: 10.1155/2018/8093438. eCollection 2018.
799 Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):558-65. doi: 10.1158/1055-9965.EPI-09-0902.
800 CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation. Nat Genet. 2019 Aug;51(8):1233-1243. doi: 10.1038/s41588-019-0470-3. Epub 2019 Jul 29.
801 Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.Thromb Haemost. 2018 Jan;118(1):182-194. doi: 10.1160/TH17-05-0349. Epub 2018 Jan 5.
802 YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E(-/-) mice fed a high-fat diet.Heart Vessels. 2019 Nov;34(11):1874-1881. doi: 10.1007/s00380-019-01434-w. Epub 2019 May 21.
803 Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(-/-) mice.Atherosclerosis. 2018 Aug;275:43-49. doi: 10.1016/j.atherosclerosis.2018.05.045. Epub 2018 May 24.
804 MitoNEET in Perivascular Adipose Tissue Blunts Atherosclerosis under Mild Cold Condition in Mice.Front Physiol. 2017 Dec 19;8:1032. doi: 10.3389/fphys.2017.01032. eCollection 2017.
805 Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.Int J Mol Med. 2013 May;31(5):1066-74. doi: 10.3892/ijmm.2013.1323. Epub 2013 Mar 27.
806 Monocytic cell junction proteins serve important roles in atherosclerosis via the endoglin pathway.Mol Med Rep. 2017 Nov;16(5):6750-6756. doi: 10.3892/mmr.2017.7444. Epub 2017 Sep 8.
807 Necrotic Cell Sensor Clec4e Promotes a Proatherogenic Macrophage Phenotype Through Activation of the Unfolded Protein Response.Circulation. 2016 Oct 4;134(14):1039-1051. doi: 10.1161/CIRCULATIONAHA.116.022668. Epub 2016 Sep 1.
808 The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival.J Transl Med. 2017 Nov 10;15(1):234. doi: 10.1186/s12967-017-1336-z.
809 MicroRNA-217-5p ameliorates endothelial cell apoptosis induced by ox-LDL by targeting CLIC4.Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):523-533. doi: 10.1016/j.numecd.2019.09.027. Epub 2019 Oct 1.
810 Angiotensin II Suppresses Rev-erb Expression in THP-1 Macrophages via the Ang II Type 1 Receptor/Liver X Receptor Pathway.Cell Physiol Biochem. 2018;46(1):303-313. doi: 10.1159/000488431. Epub 2018 Mar 22.
811 Downregulation of calponin 2 contributes to the quiescence of lung macrophages.Am J Physiol Cell Physiol. 2019 Oct 1;317(4):C749-C761. doi: 10.1152/ajpcell.00036.2019. Epub 2019 Jul 31.
812 Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.Am J Physiol Heart Circ Physiol. 2017 May 1;312(5):H943-H958. doi: 10.1152/ajpheart.00029.2017. Epub 2017 Mar 10.
813 A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis.Atherosclerosis. 2018 Apr;271:92-101. doi: 10.1016/j.atherosclerosis.2017.11.024. Epub 2017 Nov 26.
814 The induction of human CL-P1 expression in hypoxia/reoxygenation culture condition and rat CL-P1 after ischemic/reperfusion treatment.Biochim Biophys Acta. 2011 Sep;1810(9):836-42. doi: 10.1016/j.bbagen.2011.06.013. Epub 2011 Jun 24.
815 Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.Am J Physiol Heart Circ Physiol. 2017 Apr 1;312(4):H781-H790. doi: 10.1152/ajpheart.00798.2016. Epub 2017 Jan 13.
816 Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea.J Clin Sleep Med. 2017 Mar 15;13(3):393-400. doi: 10.5664/jcsm.6488.
817 Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells.Sci Rep. 2017 Apr 13;7:46444. doi: 10.1038/srep46444.
818 Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE(-/-) mice and lipopolysaccharide-stimulated RAW264.7 macrophages.Atherosclerosis. 2019 May;284:50-58. doi: 10.1016/j.atherosclerosis.2019.02.017. Epub 2019 Mar 1.
819 Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs.PLoS One. 2017 Jan 25;12(1):e0170307. doi: 10.1371/journal.pone.0170307. eCollection 2017.
820 Macrophage fatty acid oxidation inhibits atherosclerosis progression.J Mol Cell Cardiol. 2019 Feb;127:270-276. doi: 10.1016/j.yjmcc.2019.01.003. Epub 2019 Jan 9.
821 Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration.FASEB J. 2014 Nov;28(11):5010-21. doi: 10.1096/fj.14-259218. Epub 2014 Jul 30.
822 CREBH Regulates Systemic Glucose and Lipid Metabolism.Int J Mol Sci. 2018 May 8;19(5):1396. doi: 10.3390/ijms19051396.
823 Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis.Curr Drug Targets. 2017;18(15):1800-1804. doi: 10.2174/1389450117666161026111250.
824 Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE(-/-) mice.Sci Rep. 2017 Mar 27;7:45279. doi: 10.1038/srep45279.
825 Chondroitin sulfate N-acetylgalactosaminyltransferase-2 deletion alleviates lipoprotein retention in early atherosclerosis and attenuates aortic smooth muscle cell migration.Biochem Biophys Res Commun. 2019 Jan 29;509(1):89-95. doi: 10.1016/j.bbrc.2018.12.068. Epub 2018 Dec 20.
826 Serum cystatin C level is associated with carotid arterial wall elasticity in subjects with type 2 diabetes mellitus: A potential marker of early-stage atherosclerosis.Diabetes Res Clin Pract. 2018 May;139:43-51. doi: 10.1016/j.diabres.2018.02.003. Epub 2018 Feb 15.
827 Coxsackievirus and adenovirus receptor mediates the responses of endothelial cells to fluid shear stress.Exp Mol Med. 2019 Nov 27;51(11):1-15. doi: 10.1038/s12276-019-0347-7.
828 Foam Cell-Derived CXCL14 Muti-Functionally Promotes Atherogenesis and Is a Potent Therapeutic Target in Atherosclerosis.J Cardiovasc Transl Res. 2020 Apr;13(2):215-224. doi: 10.1007/s12265-019-09915-z. Epub 2019 Nov 14.
829 An Inhibitor of Activated Blood Coagulation Factor X Shows Anti-Endothelial Senescence and Anti-Atherosclerotic Effects.J Vasc Res. 2019;56(4):181-190. doi: 10.1159/000499975. Epub 2019 Jul 2.
830 Recombinant Human Cytoglobin Prevents Atherosclerosis by Regulating Lipid Metabolism and Oxidative Stress.J Cardiovasc Pharmacol Ther. 2018 Mar;23(2):162-173. doi: 10.1177/1074248417724870. Epub 2017 Sep 27.
831 Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease.Atherosclerosis. 2013 Apr;227(2):283-8. doi: 10.1016/j.atherosclerosis.2013.01.006. Epub 2013 Jan 25.
832 Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.Arterioscler Thromb Vasc Biol. 2018 May;38(5):1020-1029. doi: 10.1161/ATVBAHA.117.310467. Epub 2018 Mar 29.
833 The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.Arterioscler Thromb Vasc Biol. 2016 May;36(5):984-93. doi: 10.1161/ATVBAHA.115.306140. Epub 2016 Mar 24.
834 Prehypertension increases the risk of atherosclerosis in drug-nave Japanese patients with type 2 diabetes mellitus.PLoS One. 2018 Jul 20;13(7):e0201055. doi: 10.1371/journal.pone.0201055. eCollection 2018.
835 ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis.Am J Transplant. 2007 Sep;7(9):2098-105. doi: 10.1111/j.1600-6143.2007.01919.x.
836 Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients.J Transl Med. 2014 Jun 16;12:170. doi: 10.1186/1479-5876-12-170.
837 Human -Defensin 3 Reduces TNF--Induced Inflammation and Monocyte Adhesion in Human Umbilical Vein Endothelial Cells.Mediators Inflamm. 2017;2017:8529542. doi: 10.1155/2017/8529542. Epub 2017 Feb 28.
838 Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.Diabetes. 2017 Jan;66(1):193-205. doi: 10.2337/db16-0915. Epub 2016 Oct 13.
839 Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 Adhesome.Cell Rep. 2018 Sep 18;24(12):3115-3124. doi: 10.1016/j.celrep.2018.08.045.
840 pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet.Sci Rep. 2017 Mar 15;7(1):193. doi: 10.1038/s41598-017-00306-5.
841 SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.Nature. 2019 May;569(7757):565-569. doi: 10.1038/s41586-019-1140-4. Epub 2019 Apr 24.
842 HDLs and the pathogenesis of atherosclerosis.Curr Opin Cardiol. 2018 May;33(3):311-316. doi: 10.1097/HCO.0000000000000508.
843 Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice.Int J Endocrinol. 2017;2017:1365209. doi: 10.1155/2017/1365209. Epub 2017 Mar 19.
844 Loss of apoptosis regulator through modulating IAP expression (ARIA) protects blood vessels from atherosclerosis.J Biol Chem. 2015 Feb 6;290(6):3784-92. doi: 10.1074/jbc.M114.605287. Epub 2014 Dec 22.
845 Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):500-508. doi: 10.1161/ATVBAHA.117.310345. Epub 2018 Jan 11.
846 SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.PLoS One. 2017 Sep 7;12(9):e0184154. doi: 10.1371/journal.pone.0184154. eCollection 2017.
847 Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.Clin Sci (Lond). 2008 May;114(10):643-50. doi: 10.1042/CS20070339.
848 Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?.Adv Rheumatol. 2019 Nov 14;59(1):49. doi: 10.1186/s42358-019-0096-2.
849 Fractal dimension and directional analysis of elastic and collagen fiber arrangement in unsectioned arterial tissues affected by atherosclerosis and aging.J Appl Physiol (1985). 2019 Mar 1;126(3):638-646. doi: 10.1152/japplphysiol.00497.2018. Epub 2019 Jan 10.
850 Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krppel-Like Factor 4 (AMPK/KLF4) Signaling.J Am Heart Assoc. 2016 Nov 23;5(12):e004014. doi: 10.1161/JAHA.116.004014.
851 A newly synthesized Ligustrazine stilbene derivative inhibits PDGF-BB induced vascular smooth muscle cell phenotypic switch and proliferation via delaying cell cycle progression.Eur J Pharmacol. 2017 Nov 5;814:106-113. doi: 10.1016/j.ejphar.2017.08.008. Epub 2017 Aug 12.
852 Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation.Int J Mol Sci. 2018 Apr 26;19(5):1293. doi: 10.3390/ijms19051293.
853 Alkaline sphingomyelinase: an old enzyme with novel implications.Biochim Biophys Acta. 2006 Mar;1761(3):281-91. doi: 10.1016/j.bbalip.2006.03.007. Epub 2006 Mar 30.
854 A non-coding genetic variant associated with abdominal aortic aneurysm alters ERG gene regulation.Hum Mol Genet. 2020 Mar 13;29(4):554-565. doi: 10.1093/hmg/ddz256.
855 Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population.Am Heart J. 2017 Sep;191:55-61. doi: 10.1016/j.ahj.2017.06.008. Epub 2017 Jun 23.
856 Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.Angiology. 2018 Nov;69(10):878-883. doi: 10.1177/0003319718775283. Epub 2018 May 10.
857 The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling.Cell Death Differ. 2019 Sep;26(9):1670-1687. doi: 10.1038/s41418-018-0235-z. Epub 2019 Jan 25.
858 Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects.Redox Biol. 2017 Aug;12:787-797. doi: 10.1016/j.redox.2017.04.017. Epub 2017 Apr 13.
859 Analysis of gene expression profile identifies potential biomarkers for atherosclerosis.Mol Med Rep. 2016 Oct;14(4):3052-8. doi: 10.3892/mmr.2016.5650. Epub 2016 Aug 19.
860 Healthy Lifestyle During the Midlife Is Prospectively Associated With Less Subclinical Carotid Atherosclerosis: The Study of Women's Health Across the Nation.J Am Heart Assoc. 2018 Dec 4;7(23):e010405. doi: 10.1161/JAHA.118.010405.
861 Different Lifestyle Interventions in AdultsFrom Underserved Communities: The FAMILIA Trial.J Am Coll Cardiol. 2020 Jan 7;75(1):42-56. doi: 10.1016/j.jacc.2019.10.021. Epub 2019 Nov 11.
862 Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner.J Biol Chem. 2007 Jun 29;282(26):19167-76. doi: 10.1074/jbc.M701642200. Epub 2007 Apr 23.
863 Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.J Atheroscler Thromb. 2020 May 1;27(5):418-428. doi: 10.5551/jat.49619. Epub 2019 Sep 13.
864 Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study.J Am Coll Cardiol. 2008 Sep 9;52(11):941-52. doi: 10.1016/j.jacc.2008.06.016.
865 Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1928-36. doi: 10.1161/ATVBAHA.116.308017. Epub 2016 Jul 28.
866 Knockout of Low Molecular Weight FGF2 Attenuates Atherosclerosis by Reducing Macrophage Infiltration and Oxidative Stress in Mice.Cell Physiol Biochem. 2018;45(4):1434-1443. doi: 10.1159/000487569. Epub 2018 Feb 16.
867 Deletion of the FHL2 gene attenuates intima-media thickening in a partially ligated carotid artery ligated mouse model.J Cell Mol Med. 2020 Jan;24(1):160-173. doi: 10.1111/jcmm.14687. Epub 2019 Nov 12.
868 Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease.Gene Ther. 2009 Sep;16(9):1154-62. doi: 10.1038/gt.2009.63. Epub 2009 May 28.
869 Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis.Front Pharmacol. 2019 May 28;10:548. doi: 10.3389/fphar.2019.00548. eCollection 2019.
870 Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1574-1587. doi: 10.1161/ATVBAHA.119.312610. Epub 2019 Jul 11.
871 Endothelial-to-mesenchymal transition drives atherosclerosis progression.J Clin Invest. 2015 Oct 26;125(12):4514-28. doi: 10.1172/JCI82719.
872 The 1,3-fucosyltransferase FUT7 regulates IL-1-induced monocyte-endothelial adhesion via fucosylation of endomucin.Life Sci. 2018 Jan 1;192:231-237. doi: 10.1016/j.lfs.2017.11.017. Epub 2017 Nov 11.
873 Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1.Atherosclerosis. 2019 Nov;290:19-30. doi: 10.1016/j.atherosclerosis.2019.09.001. Epub 2019 Sep 11.
874 Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases.Front Pharmacol. 2019 Apr 12;10:382. doi: 10.3389/fphar.2019.00382. eCollection 2019.
875 Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study.JACC Heart Fail. 2015 May;3(5):347-356. doi: 10.1016/j.jchf.2014.11.013. Epub 2015 Apr 8.
876 Why do temporal arteries go wrong? Principles and pearls from a clinician and a pathologist.Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii3-ii10. doi: 10.1093/rheumatology/kex524.
877 GCKR and PPP1R3B identified as genome-wide significant loci for plasma lactate: the Atherosclerosis Risk in Communities (ARIC) study.Diabet Med. 2016 Jul;33(7):968-75. doi: 10.1111/dme.12971. Epub 2015 Oct 30.
878 Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.Am J Physiol Gastrointest Liver Physiol. 2018 Dec 1;315(6):G909-G920. doi: 10.1152/ajpgi.00159.2018. Epub 2018 Sep 6.
879 ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.Circulation. 2018 Oct 16;138(16):1693-1705. doi: 10.1161/CIRCULATIONAHA.117.032801.
880 Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.Acta Biomater. 2019 May;90:324-336. doi: 10.1016/j.actbio.2019.04.014. Epub 2019 Apr 4.
881 Gamma-glutamyl transpeptidase (-GTP) has an ambivalent association with hypertension and atherosclerosis among elderly Japanese men: a cross-sectional study.Environ Health Prev Med. 2019 Nov 30;24(1):69. doi: 10.1186/s12199-019-0828-2.
882 GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study.Atherosclerosis. 2014 Dec;237(2):437-42. doi: 10.1016/j.atherosclerosis.2014.08.025. Epub 2014 Aug 28.
883 Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.J Pharmacol Exp Ther. 2019 Sep;370(3):447-458. doi: 10.1124/jpet.119.258343. Epub 2019 Jul 3.
884 Polymorphisms in three genes are associated with hemorrhagic stroke.Brain Behav. 2015 Oct 1;5(11):e00395. doi: 10.1002/brb3.395. eCollection 2015 Nov.
885 GOSR2 Lys67Arg is associated with hypertension in whites.Am J Hypertens. 2009 Feb;22(2):163-8. doi: 10.1038/ajh.2008.336. Epub 2008 Dec 4.
886 Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-/-) mice.Atherosclerosis. 2019 Mar;282:100-109. doi: 10.1016/j.atherosclerosis.2019.01.025. Epub 2019 Jan 29.
887 Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice.Free Radic Biol Med. 2008 Feb 1;44(3):343-52. doi: 10.1016/j.freeradbiomed.2007.09.009. Epub 2007 Oct 2.
888 Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study.Obesity (Silver Spring). 2010 Sep;18(9):1812-20. doi: 10.1038/oby.2009.496. Epub 2010 Jan 28.
889 Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.Basic Res Cardiol. 2016 Jul;111(4):51. doi: 10.1007/s00395-016-0570-5. Epub 2016 Jun 24.
890 The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR(-/-) mice.Int J Biol Sci. 2018 Jan 1;14(1):36-46. doi: 10.7150/ijbs.23082. eCollection 2018.
891 Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.Nature. 2019 May;569(7755):236-240. doi: 10.1038/s41586-019-1167-6. Epub 2019 May 1.
892 Genotype at the P554L variant of the hexose-6 phosphate dehydrogenase gene is associated with carotid intima-medial thickness.PLoS One. 2011;6(8):e23248. doi: 10.1371/journal.pone.0023248. Epub 2011 Aug 12.
893 Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.Thromb Haemost. 2017 Aug 30;117(9):1750-1760. doi: 10.1160/TH17-02-0081. Epub 2017 Jul 20.
894 The HACD4 haplotype as a risk factor for atherosclerosis in males.Gene. 2018 Jan 30;641:35-40. doi: 10.1016/j.gene.2017.10.030. Epub 2017 Oct 12.
895 Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.Circ Res. 2004 Mar 19;94(5):592-600. doi: 10.1161/01.RES.0000119169.87429.A0. Epub 2004 Jan 29.
896 Hyaluronan synthase 3 promotes plaque inflammation and atheroprogression.Matrix Biol. 2018 Mar;66:67-80. doi: 10.1016/j.matbio.2017.09.005. Epub 2017 Oct 5.
897 Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis.Oxid Med Cell Longev. 2019 Sep 2;2019:3201062. doi: 10.1155/2019/3201062. eCollection 2019.
898 Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis.Eur J Pharmacol. 2018 Feb 15;821:49-56. doi: 10.1016/j.ejphar.2017.12.050. Epub 2017 Dec 27.
899 Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.Cardiovasc Res. 2014 Jul 1;103(1):100-10. doi: 10.1093/cvr/cvu070. Epub 2014 Mar 27.
900 High-density lipoprotein-binding protein (HBP)/vigilin is expressed in human atherosclerotic lesions and colocalizes with apolipoprotein E.Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2350-8. doi: 10.1161/01.atv.17.11.2350.
901 Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.FASEB J. 2017 Nov;31(11):4971-4984. doi: 10.1096/fj.201700235R. Epub 2017 Jul 31.
902 A clinically applicable adjuvant for an atherosclerosis vaccine in mice.Eur J Immunol. 2018 Sep;48(9):1580-1587. doi: 10.1002/eji.201847584. Epub 2018 Aug 12.
903 Loss of HMBOX1 promotes LPS-induced apoptosis and inhibits LPS-induced autophagy of vascular endothelial cells in mouse.Apoptosis. 2019 Dec;24(11-12):946-957. doi: 10.1007/s10495-019-01572-6.
904 MicroRNA-99a-5p alleviates atherosclerosis via regulating Homeobox A1.Life Sci. 2019 Sep 1;232:116664. doi: 10.1016/j.lfs.2019.116664. Epub 2019 Jul 17.
905 Homeobox B9 integrates bone morphogenic protein 4 with inflammation at atheroprone sites.Cardiovasc Res. 2020 Jun 1;116(7):1300-1310. doi: 10.1093/cvr/cvz235.
906 Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1152-63. doi: 10.1161/ATVBAHA.115.306991. Epub 2016 Apr 14.
907 The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.Cardiovasc Res. 2015 Jan 1;105(1):65-74. doi: 10.1093/cvr/cvu224. Epub 2014 Oct 23.
908 Genetic variations of HSPA1A, the heat shock protein levels, and risk of atherosclerosis.Cell Stress Chaperones. 2012 Jul;17(4):507-16. doi: 10.1007/s12192-012-0328-4. Epub 2012 Feb 11.
909 Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response.Mech Ageing Dev. 2006 Jun;127(6):517-25. doi: 10.1016/j.mad.2006.01.010. Epub 2006 Mar 2.
910 B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.Circ Res. 2015 Jul 17;117(3):e28-39. doi: 10.1161/CIRCRESAHA.117.306044. Epub 2015 Jun 16.
911 Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFB to Enhance Pro-inflammatory Transcription.Front Immunol. 2019 Jun 4;10:1253. doi: 10.3389/fimmu.2019.01253. eCollection 2019.
912 Cloning and characterization of rhesus IL-18 binding protein, a natural antagonist to IL-18.Cytokine. 2010 Sep;51(3):232-9. doi: 10.1016/j.cyto.2010.05.010.
913 Is Interleukin-38 a key player cytokine in atherosclerosis immune gene therapy?.Med Hypotheses. 2019 Apr;125:139-143. doi: 10.1016/j.mehy.2019.02.048. Epub 2019 Feb 28.
914 IL-27R signaling controls myeloid cells accumulation and antigen-presentation in atherosclerosis.Sci Rep. 2017 May 23;7(1):2255. doi: 10.1038/s41598-017-01828-8.
915 IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway.Sci Rep. 2018 Nov 26;8(1):17347. doi: 10.1038/s41598-018-35485-2.
916 Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.Biomater Sci. 2019 Jan 29;7(2):657-668. doi: 10.1039/c8bm01224e.
917 The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts.BMC Med Genet. 2009 Jun 12;10:56. doi: 10.1186/1471-2350-10-56.
918 Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury.Front Cell Neurosci. 2017 Jul 19;11:201. doi: 10.3389/fncel.2017.00201. eCollection 2017.
919 Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.Circulation. 2017 Sep 19;136(12):1140-1154. doi: 10.1161/CIRCULATIONAHA.117.027844. Epub 2017 Jul 11.
920 Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and development.Atherosclerosis. 2016 Aug;251:282-290. doi: 10.1016/j.atherosclerosis.2016.07.011. Epub 2016 Jul 10.
921 Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study.Atherosclerosis. 2011 May;216(1):151-6. doi: 10.1016/j.atherosclerosis.2011.01.038. Epub 2011 Feb 2.
922 Regulation of alpha7-integrin expression in vascular smooth muscle by injury-induced atherosclerosis.Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H381-9. doi: 10.1152/ajpheart.00939.2003. Epub 2004 Feb 26.
923 The Upregulation of Integrin (D)(2) (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis.J Immunol. 2017 Jun 15;198(12):4855-4867. doi: 10.4049/jimmunol.1602175. Epub 2017 May 12.
924 Modulation of vascular endothelial cell senescence by integrin 4.J Cell Physiol. 2010 Nov;225(3):673-81. doi: 10.1002/jcp.22262.
925 Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice.Ann Biomed Eng. 2013 Apr;41(4):682-93. doi: 10.1007/s10439-012-0702-5. Epub 2012 Nov 22.
926 APOE-knockout in rabbits causes loss of cells in nucleus pulposus and enhances the levels of inflammatory catabolic cytokines damaging the intervertebral disc matrix.PLoS One. 2019 Nov 21;14(11):e0225527. doi: 10.1371/journal.pone.0225527. eCollection 2019.
927 The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis.Eur Heart J. 2019 Aug 1;40(29):2398-2408. doi: 10.1093/eurheartj/ehz303.
928 KALRN Rare and Common Variants and Susceptibility to Ischemic Stroke in Chinese Han Population.Neuromolecular Med. 2015 Sep;17(3):241-50. doi: 10.1007/s12017-015-8352-z. Epub 2015 Apr 28.
929 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol. 2002 Apr;282(4):G586-97.
930 Kcne2 deletion promotes atherosclerosis and diet-dependent sudden death.J Mol Cell Cardiol. 2015 Oct;87:148-51. doi: 10.1016/j.yjmcc.2015.08.013. Epub 2015 Aug 22.
931 Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress.Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1420-5. doi: 10.1073/pnas.0237367100. Epub 2003 Jan 13.
932 7-Ketocholesterol induces the reduction of KCNMB1 in atherosclerotic blood vessels.Biochem Biophys Res Commun. 2015 Feb 13;457(3):324-7. doi: 10.1016/j.bbrc.2014.12.109. Epub 2015 Jan 7.
933 Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study.Am J Epidemiol. 2013 Sep 1;178(5):780-90. doi: 10.1093/aje/kwt028. Epub 2013 Jul 2.
934 A Novel Y-Specific Long Non-Coding RNA Associated with Cellular Lipid Accumulation in HepG2 cells and Atherosclerosis-related Genes.Sci Rep. 2017 Dec 1;7(1):16710. doi: 10.1038/s41598-017-17165-9.
935 Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.PLoS One. 2014 May 30;9(5):e98289. doi: 10.1371/journal.pone.0098289. eCollection 2014.
936 Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke.Atherosclerosis. 2011 Jan;214(1):101-6. doi: 10.1016/j.atherosclerosis.2010.10.010. Epub 2010 Oct 16.
937 Kruppel-like factor 15 is critical for vascular inflammation.J Clin Invest. 2013 Oct;123(10):4232-41. doi: 10.1172/JCI68552. Epub 2013 Sep 3.
938 mircroRNA-152 prevents the malignant progression of atherosclerosis via down-regulation of KLF5.Biomed Pharmacother. 2019 Jan;109:2409-2414. doi: 10.1016/j.biopha.2018.08.014. Epub 2018 Nov 30.
939 Alternation of histone and DNA methylation in human atherosclerotic carotid plaques.Thromb Haemost. 2015 Aug;114(2):390-402. doi: 10.1160/TH14-10-0852. Epub 2015 May 21.
940 Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.PLoS Genet. 2014 Feb 27;10(2):e1004201. doi: 10.1371/journal.pgen.1004201. eCollection 2014 Feb.
941 MicroRNA-24 inhibits the proliferation and migration of endothelial cells in patients with atherosclerosis by targeting importin-3 and regulating inflammatory responses.Exp Ther Med. 2018 Jan;15(1):338-344. doi: 10.3892/etm.2017.5355. Epub 2017 Oct 23.
942 KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.Int J Mol Sci. 2019 Oct 5;20(19):4930. doi: 10.3390/ijms20194930.
943 The in vitro effect of oxidized LDL and PHA on proliferation and gene expression of regulatory T cells in patients with atherosclerosis.Iran J Allergy Asthma Immunol. 2012 Sep;11(3):217-23.
944 Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism.Circulation. 2018 Oct 30;138(18):2007-2020. doi: 10.1161/CIRCULATIONAHA.117.031589.
945 Premature senescence in cells from patients with autosomal recessive hypercholesterolemia (ARH): evidence for a role for ARH in mitosis.Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2270-7. doi: 10.1161/ATVBAHA.111.232223. Epub 2011 Jul 21.
946 Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.PLoS One. 2017 Apr 4;12(4):e0174717. doi: 10.1371/journal.pone.0174717. eCollection 2017.
947 Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.Lipids Health Dis. 2012 Nov 26;11:163. doi: 10.1186/1476-511X-11-163.
948 Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.Nat Genet. 2017 Jul;49(7):1113-1119. doi: 10.1038/ng.3874. Epub 2017 May 22.
949 MicroRNA 28-5p regulates ATP-binding cassette transporter A1 via inhibiting extracellular signal-regulated kinase 2.Mol Med Rep. 2016 Jan;13(1):433-40. doi: 10.3892/mmr.2015.4563. Epub 2015 Nov 12.
950 LncRNA-RP11-714G18.1 suppresses vascular cell migration via directly targeting LRP2BP.Immunol Cell Biol. 2018 Feb;96(2):175-189. doi: 10.1111/imcb.1028. Epub 2017 Dec 7.
951 Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients.J Hum Hypertens. 2018 Sep;32(8-9):564-571. doi: 10.1038/s41371-018-0077-7. Epub 2018 Jun 5.
952 Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.J Am Coll Cardiol. 2017 Mar 7;69(9):1129-1142. doi: 10.1016/j.jacc.2016.11.081.
953 Transcription Factor MafB Suppresses Type I Interferon Production by CD14(+) Monocytes in Patients With Chronic Hepatitis C.Front Microbiol. 2019 Aug 7;10:1814. doi: 10.3389/fmicb.2019.01814. eCollection 2019.
954 MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.JCI Insight. 2019 Apr 4;4(7):e125570. doi: 10.1172/jci.insight.125570. eCollection 2019 Apr 4.
955 miR-133b Downregulation Reduces Vulnerable Plaque Formation in Mice with AS through Inhibiting Macrophage Immune Responses.Mol Ther Nucleic Acids. 2019 Jun 7;16:745-757. doi: 10.1016/j.omtn.2019.04.024. Epub 2019 May 2.
956 Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.JAMA. 2007 Apr 11;297(14):1551-61. doi: 10.1001/jama.297.14.1551.
957 MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis-Brief Report.Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1645-1651. doi: 10.1161/ATVBAHA.119.312478. Epub 2019 Jun 6.
958 A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.Eur J Hum Genet. 2016 Jan;24(1):86-91. doi: 10.1038/ejhg.2015.70. Epub 2015 Apr 22.
959 Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1470-1481. doi: 10.1161/ATVBAHA.117.309672. Epub 2017 Jun 22.
960 Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.Immunopharmacol Immunotoxicol. 2019 Jun;41(3):446-454. doi: 10.1080/08923973.2019.1616753. Epub 2019 May 24.
961 MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.Sci Rep. 2015 Jul 17;5:12276. doi: 10.1038/srep12276.
962 Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.Clin Ther. 2019 Jan;41(1):41-48. doi: 10.1016/j.clinthera.2018.11.016. Epub 2018 Dec 24.
963 Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis.Diabetes Res Clin Pract. 2019 Apr;150:57-63. doi: 10.1016/j.diabres.2019.02.026. Epub 2019 Feb 27.
964 Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.World J Gastroenterol. 2017 Feb 21;23(7):1241-1249. doi: 10.3748/wjg.v23.i7.1241.
965 A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis.Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):736-742. doi: 10.26355/eurrev_201802_14304.
966 Chronic hypertension increases aortic endothelial hydraulic conductivity by upregulating endothelial aquaporin-1 expression.Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H1063-H1073. doi: 10.1152/ajpheart.00651.2016. Epub 2017 Jul 21.
967 Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway.J Med Food. 2018 Feb;21(2):146-153. doi: 10.1089/jmf.2017.4052. Epub 2017 Oct 16.
968 Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation.Cell Rep. 2015 Oct 6;13(1):132-144. doi: 10.1016/j.celrep.2015.08.068. Epub 2015 Sep 24.
969 Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.Clin Neurol Neurosurg. 2018 May;168:163-166. doi: 10.1016/j.clineuro.2018.01.034. Epub 2018 Feb 2.
970 Suppression of proatherogenic leukocyte interactions by MCS-18--Impact on advanced atherosclerosis in ApoE-deficient mice.Atherosclerosis. 2016 Feb;245:101-10. doi: 10.1016/j.atherosclerosis.2015.12.001. Epub 2015 Dec 15.
971 Exogenous hydrogen sulfide protects human umbilical vein endothelial cells against high glucoseinduced injury by inhibiting the necroptosis pathway.Int J Mol Med. 2018 Mar;41(3):1477-1486. doi: 10.3892/ijmm.2017.3330. Epub 2017 Dec 19.
972 Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney.J Am Soc Nephrol. 2019 Aug;30(8):1471-1480. doi: 10.1681/ASN.2019020183. Epub 2019 Jul 5.
973 MRTF-A regulates proliferation and survival properties of pro-atherogenic macrophages.J Mol Cell Cardiol. 2019 Aug;133:26-35. doi: 10.1016/j.yjmcc.2019.05.015. Epub 2019 May 22.
974 Identification of a new locus and validation of previously reported loci showing differential methylation associated with smoking. The REGICOR study.Epigenetics. 2015;10(12):1156-65. doi: 10.1080/15592294.2015.1115175.
975 Atherosclerosis-associated differentially methylated regions can reflect the disease phenotype and are often at enhancers.Atherosclerosis. 2019 Jan;280:183-191. doi: 10.1016/j.atherosclerosis.2018.11.031. Epub 2018 Nov 27.
976 Five common gene variants identify elevated genetic risk for coronary heart disease.Genet Med. 2007 Oct;9(10):682-9. doi: 10.1097/gim.0b013e318156fb62.
977 The MYH9/APOL1 region and chronic kidney disease in European-Americans.Hum Mol Genet. 2011 Jun 15;20(12):2450-6. doi: 10.1093/hmg/ddr118. Epub 2011 Mar 23.
978 PACAP deficiency aggravates atherosclerosis in ApoE deficient mice.Immunobiology. 2019 Jan;224(1):124-132. doi: 10.1016/j.imbio.2018.09.008. Epub 2018 Oct 26.
979 Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques.Cardiovasc Res. 1999 Aug 15;43(3):744-54. doi: 10.1016/s0008-6363(99)00148-0.
980 Disinhibition of SOD-2 expression to compensate for a genetically determined NO deficit in endothelial cells--brief report.Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1890-3. doi: 10.1161/ATVBAHA.109.190678. Epub 2009 Aug 20.
981 A SAS macro for the joint modeling of longitudinal outcomes and multiple competing risk dropouts.Comput Methods Programs Biomed. 2017 Jan;138:23-30. doi: 10.1016/j.cmpb.2016.10.003. Epub 2016 Oct 18.
982 Integrated assessment of exposure to PM(2.5) in South India and its relation with cardiovascular risk: Design of the CHAI observational cohort study.Int J Hyg Environ Health. 2017 Aug;220(6):1081-1088. doi: 10.1016/j.ijheh.2017.05.005. Epub 2017 Jun 3.
983 Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.PLoS One. 2018 Mar 29;13(3):e0195015. doi: 10.1371/journal.pone.0195015. eCollection 2018.
984 Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.J Atheroscler Thromb. 2019 Mar 1;26(3):246-259. doi: 10.5551/jat.44040. Epub 2018 Oct 4.
985 Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries.Circulation. 2010 Feb 2;121(4):549-59. doi: 10.1161/CIRCULATIONAHA.109.908319. Epub 2010 Jan 18.
986 Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPAR signature.Eur Heart J. 2020 Mar 1;41(9):995-1005. doi: 10.1093/eurheartj/ehz667.
987 CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis.J Hypertens. 2004 Aug;22(8):1523-8. doi: 10.1097/01.hjh.0000133724.16947.a3.
988 Proteomic analysis of rat aorta during atherosclerosis induced by high cholesterol diet and injection of vitamin D3.Clin Exp Pharmacol Physiol. 2006 Apr;33(4):305-9. doi: 10.1111/j.1440-1681.2006.04366.x.
989 Poliovirus Receptor-Related 2: A Cholesterol-Responsive Gene Affecting Atherosclerosis Development by Modulating Leukocyte Migration.Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):534-542. doi: 10.1161/ATVBAHA.116.308715. Epub 2017 Jan 5.
990 A positive feedback loop between IL-1, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages.Vascul Pharmacol. 2018 Apr;103-105:16-28. doi: 10.1016/j.vph.2018.01.005. Epub 2018 Jan 31.
991 Atorvastatin inhibits pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human vascular endothelial cells.Atherosclerosis. 2020 Jan;293:26-34. doi: 10.1016/j.atherosclerosis.2019.11.033. Epub 2019 Dec 3.
992 NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium.Cell Commun Signal. 2019 Aug 20;17(1):102. doi: 10.1186/s12964-019-0406-7.
993 Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.J Intern Med. 2008 Dec;264(6):563-70. doi: 10.1111/j.1365-2796.2008.01995.x. Epub 2008 Sep 6.
994 Dihydrocapsaicin suppresses proinflammatory cytokines expression by enhancing nuclear factor IA in a NF-B-dependent manner.Arch Biochem Biophys. 2016 Aug 15;604:27-35. doi: 10.1016/j.abb.2016.06.002. Epub 2016 Jun 3.
995 Cytoprotective effects of transgenic neuroglobin overexpression in an acute and chronic mouse model of ischemic heart disease.Heart Vessels. 2018 Jan;33(1):80-88. doi: 10.1007/s00380-017-1065-5. Epub 2017 Nov 2.
996 Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.Circulation. 2011 Oct 25;124(17):1860-70. doi: 10.1161/CIRCULATIONAHA.111.029272. Epub 2011 Oct 3.
997 NINJ2- A novel regulator of endothelial inflammation and activation.Cell Signal. 2017 Jul;35:231-241. doi: 10.1016/j.cellsig.2017.04.011. Epub 2017 Apr 18.
998 Nkx2-5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E-Deficient Mice.J Am Heart Assoc. 2016 Dec 19;5(12):e004440. doi: 10.1161/JAHA.116.004440.
999 NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis.Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R743-50. doi: 10.1152/ajpregu.00373.2006. Epub 2006 Aug 3.
1000 Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):295-307. doi: 10.1161/ATVBAHA.115.307012. Epub 2015 Dec 29.
1001 NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis.Redox Biol. 2019 Feb;21:101063. doi: 10.1016/j.redox.2018.11.021. Epub 2018 Nov 29.
1002 Fluorescence in situ hybridization for the diagnosis of NPHP1 deletion-related nephronophthisis on renal biopsy.Hum Pathol. 2018 Nov;81:71-77. doi: 10.1016/j.humpath.2018.06.021. Epub 2018 Jun 24.
1003 Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.Circulation. 2002 Mar 26;105(12):1440-5. doi: 10.1161/01.cir.0000012145.80593.25.
1004 NR6A1 couples with cAMP response element binding protein and regulates vascular smooth muscle cell migration.Int J Biochem Cell Biol. 2015 Dec;69:225-32. doi: 10.1016/j.biocel.2015.10.026. Epub 2015 Nov 4.
1005 Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.Circ Res. 2015 Jul 17;117(3):266-78. doi: 10.1161/CIRCRESAHA.117.305624. Epub 2015 May 22.
1006 Transcriptional co-regulator RIP140: An important mediator of the inflammatory response and its associated diseases (Review).Mol Med Rep. 2017 Aug;16(2):994-1000. doi: 10.3892/mmr.2017.6683. Epub 2017 Jun 2.
1007 Elevated N-acetyl--d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.J Diabetes Complications. 2018 Aug;32(8):777-783. doi: 10.1016/j.jdiacomp.2018.05.019. Epub 2018 Jun 1.
1008 ORMDL3 and its implication in inflammatory disorders.Int J Rheum Dis. 2018 Jun;21(6):1154-1162. doi: 10.1111/1756-185X.13324.
1009 Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice.Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1618-24. doi: 10.1161/ATVBAHA.107.144121. Epub 2007 May 3.
1010 A single nucleotide polymorphism located in microRNA-499a causes loss of function resulting in increased expression of osbpl1a and reduced serum HDL level.Oncol Rep. 2017 Dec;38(6):3515-3521. doi: 10.3892/or.2017.6016. Epub 2017 Oct 9.
1011 Fatty acid epoxyisoprostane E2 stimulates an oxidative stress response in endothelial cells.Biochem Biophys Res Commun. 2014 Jan 31;444(1):69-74. doi: 10.1016/j.bbrc.2014.01.016. Epub 2014 Jan 14.
1012 PACS2 is required for ox-LDL-induced endothelial cell apoptosis by regulating mitochondria-associated ER membrane formation and mitochondrial Ca(2+) elevation.Exp Cell Res. 2019 Jun 15;379(2):191-202. doi: 10.1016/j.yexcr.2019.04.002. Epub 2019 Apr 7.
1013 Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis.Eur J Clin Invest. 2011 Apr;41(4):365-71. doi: 10.1111/j.1365-2362.2010.02416.x. Epub 2010 Nov 4.
1014 Pannexin1 links lymphatic function to lipid metabolism and atherosclerosis.Sci Rep. 2017 Oct 20;7(1):13706. doi: 10.1038/s41598-017-14130-4.
1015 Pregnancy-associated plasma protein-a is associated with subclinical atherosclerosis in men with HIV infection.J Investig Med. 2019 Jun;67(5):821-825. doi: 10.1136/jim-2018-000859. Epub 2018 Nov 28.
1016 Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.Atherosclerosis. 1999 Jun;144(2):315-21. doi: 10.1016/s0021-9150(98)00332-3.
1017 Computational identification of potential transcriptional regulators of TGF-1 in human atherosclerotic arteries.Genomics. 2014 May-Jun;103(5-6):357-70. doi: 10.1016/j.ygeno.2014.05.001. Epub 2014 May 10.
1018 Dioxin-like PCB 126 Increases Systemic Inflammation and Accelerates Atherosclerosis in Lean LDL Receptor-Deficient Mice.Toxicol Sci. 2018 Apr 1;162(2):548-558. doi: 10.1093/toxsci/kfx275.
1019 Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo.J Biol Chem. 2007 Oct 26;282(43):31460-8. doi: 10.1074/jbc.M704267200. Epub 2007 Aug 28.
1020 Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs.Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2041-6. doi: 10.1161/ATVBAHA.109.196592. Epub 2009 Oct 1.
1021 Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.J Biol Chem. 2015 Jun 19;290(25):15496-15511. doi: 10.1074/jbc.M115.646240. Epub 2015 May 6.
1022 Peptide 19 of Porphyromonas gingivalis Heat Shock Protein Is a Potent Inducer of Low-Density Lipoprotein Oxidation.J Periodontol. 2017 Feb;88(2):e58-e64. doi: 10.1902/jop.2016.160402. Epub 2016 Oct 7.
1023 Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):806-12. doi: 10.1161/01.ATV.0000258867.79411.96. Epub 2007 Jan 25.
1024 Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation.Sci Rep. 2015 Nov 12;5:16577. doi: 10.1038/srep16577.
1025 SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).Circ Cardiovasc Genet. 2016 Oct;9(5):408-418. doi: 10.1161/CIRCGENETICS.116.001402. Epub 2016 Sep 20.
1026 Piezo Ion Channels in Cardiovascular Mechanobiology.Trends Pharmacol Sci. 2019 Dec;40(12):956-970. doi: 10.1016/j.tips.2019.10.002. Epub 2019 Nov 5.
1027 Impaired mitochondrial respiration in human carotid plaque atherosclerosis: A potential role for Pink1 in vascular smooth muscle cell energetics.Atherosclerosis. 2018 Jan;268:1-11. doi: 10.1016/j.atherosclerosis.2017.11.009. Epub 2017 Nov 13.
1028 Quantitative trait locus mapping in mice identifies phospholipase Pla2g12a as novel atherosclerosis modifier.Atherosclerosis. 2017 Oct;265:197-206. doi: 10.1016/j.atherosclerosis.2017.08.030. Epub 2017 Sep 4.
1029 Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice.Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):466-73. doi: 10.1161/ATVBAHA.112.300309. Epub 2013 Jan 24.
1030 Proteolysis of apolipoprotein A-I by secretory phospholipase A? a new link between inflammation and atherosclerosis.J Biol Chem. 2014 Apr 4;289(14):10011-23. doi: 10.1074/jbc.M113.525717. Epub 2014 Feb 12.
1031 Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins.Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):197-205. doi: 10.1161/ATVBAHA.114.304342. Epub 2014 Nov 13.
1032 CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REG.Nat Commun. 2019 Jan 25;10(1):425. doi: 10.1038/s41467-018-07895-3.
1033 Perilipin 5 deficiency promotes atherosclerosis progression through accelerating inflammation, apoptosis, and oxidative stress.J Cell Biochem. 2019 Nov;120(11):19107-19123. doi: 10.1002/jcb.29238. Epub 2019 Jul 11.
1034 Coronary Artery Disease Risk-Associated Plpp3 Gene and Its Product Lipid Phosphate Phosphatase 3 Regulate Experimental Atherosclerosis.Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2261-2272. doi: 10.1161/ATVBAHA.119.313056. Epub 2019 Sep 19.
1035 Acquired Coronary Fenestration.J Invasive Cardiol. 2019 Dec;31(12):E396.
1036 Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.J Biomol Screen. 2007 Mar;12(2):211-9. doi: 10.1177/1087057106297568. Epub 2007 Jan 26.
1037 Silencing MR-1 attenuates atherosclerosis in ApoE(-/-) mice induced by angiotensin II through FAK-Akt-mTOR-NF-kappaB signaling pathway.Korean J Physiol Pharmacol. 2018 Mar;22(2):127-134. doi: 10.4196/kjpp.2018.22.2.127. Epub 2018 Feb 23.
1038 LncRNA SRA deregulation contributes to the development of atherosclerosis by causing dysfunction of endothelial cells through repressing the expression of adipose triglyceride lipase.Mol Med Rep. 2018 Dec;18(6):5207-5214. doi: 10.3892/mmr.2018.9497. Epub 2018 Sep 20.
1039 Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.Circulation. 2013 Nov 26;128(22):2351-63. doi: 10.1161/CIRCULATIONAHA.113.004634. Epub 2013 Sep 16.
1040 Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis.Sci Rep. 2018 Jan 10;8(1):245. doi: 10.1038/s41598-017-18647-6.
1041 Regulation of Telomere Length and Atherosclerosis by Protection of Telomeres 1 Protein.J Nanosci Nanotechnol. 2019 Dec 1;19(12):7953-7959. doi: 10.1166/jnn.2019.16938.
1042 No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction.Blood Coagul Fibrinolysis. 2003 Dec;14(8):749-53. doi: 10.1097/00001721-200312000-00010.
1043 CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women.Menopause. 2008 Nov-Dec;15(6):1163-8. doi: 10.1097/gme.0b013e31817727c3.
1044 MicroRNA-136 Promotes Vascular Muscle Cell Proliferation Through the ERK1/2 Pathway by Targeting PPP2R2A in Atherosclerosis.Curr Vasc Pharmacol. 2015;13(3):405-12. doi: 10.2174/1570161112666141118094612.
1045 Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.J Biol Chem. 2011 Jun 24;286(25):22665-77. doi: 10.1074/jbc.M110.202135. Epub 2011 May 2.
1046 Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.Arterioscler Thromb Vasc Biol. 2018 May;38(5):e71-e84. doi: 10.1161/ATVBAHA.117.310678. Epub 2018 Mar 29.
1047 Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux.Autophagy. 2018;14(1):120-133. doi: 10.1080/15548627.2017.1327942. Epub 2017 Nov 25.
1048 AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz020. doi: 10.1210/clinem/dgz020.
1049 Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury.J Muscle Res Cell Motil. 2009;30(1-2):41-55. doi: 10.1007/s10974-009-9173-1. Epub 2009 Feb 10.
1050 Expression of REG in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis.Cell Cycle. 2019 Sep;18(17):2083-2098. doi: 10.1080/15384101.2019.1639304. Epub 2019 Jul 7.
1051 The impact of PSRC1 overexpression on gene and transcript expression profiling in the livers of ApoE(-/-) mice fed a high-fat diet.Mol Cell Biochem. 2020 Feb;465(1-2):125-139. doi: 10.1007/s11010-019-03673-x. Epub 2019 Dec 14.
1052 PTOV1: a novel testosterone-induced atherogenic gene in human aorta.J Pathol. 2006 Aug;209(4):522-31. doi: 10.1002/path.1993.
1053 PTPN22 Gene Polymorphisms Are Associated with Susceptibility to Large Artery Atherosclerotic Stroke and Microembolic Signals.Dis Markers. 2019 May 5;2019:2193835. doi: 10.1155/2019/2193835. eCollection 2019.
1054 Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.J Biol Chem. 2007 Jul 6;282(27):19808-19. doi: 10.1074/jbc.M610452200. Epub 2007 May 11.
1055 Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.J Atheroscler Thromb. 2019 Aug 1;26(8):738-745. doi: 10.5551/jat.47167. Epub 2019 Jan 23.
1056 Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1 Production.Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):328-340. doi: 10.1161/ATVBAHA.116.308507. Epub 2016 Nov 10.
1057 Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.Scand J Immunol. 2018 May;87(5):e12661. doi: 10.1111/sji.12661.
1058 Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1283-1296. doi: 10.1161/ATVBAHA.117.309940. Epub 2018 Mar 29.
1059 Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification.Medicine (Baltimore). 2019 Jul;98(27):e16333. doi: 10.1097/MD.0000000000016333.
1060 Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.Clin Sci (Lond). 2019 Aug 20;133(16):1779-1796. doi: 10.1042/CS20190336. Print 2019 Aug 30.
1061 Cloning, genomic organization, and tissue-specific expression of the RASL11B gene.Biochim Biophys Acta. 2007 Jul-Aug;1769(7-8):514-24. doi: 10.1016/j.bbaexp.2007.05.005. Epub 2007 Jun 6.
1062 A major role for RCAN1 in atherosclerosis progression.EMBO Mol Med. 2013 Dec;5(12):1901-17. doi: 10.1002/emmm.201302842. Epub 2013 Oct 15.
1063 Loss of reticulocalbin 2 lowers blood pressure and restrains ANG II-induced hypertension in vivo.Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1141-F1150. doi: 10.1152/ajprenal.00567.2018. Epub 2019 Apr 3.
1064 Adipose-Derived Stem Cell Transplantation Inhibits Vascular Inflammatory Responses and Endothelial Dysfunction in Rats with Atherosclerosis.Yonsei Med J. 2019 Nov;60(11):1036-1044. doi: 10.3349/ymj.2019.60.11.1036.
1065 Resistin-like molecule is abundantly expressed in foam cells and is involved in atherosclerosis development.Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1986-93. doi: 10.1161/ATVBAHA.113.301546. Epub 2013 May 23.
1066 Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease.Front Genet. 2019 Nov 1;10:1098. doi: 10.3389/fgene.2019.01098. eCollection 2019.
1067 Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.Circ Res. 2006 Mar 3;98(4):472-9. doi: 10.1161/01.RES.0000204725.46332.97. Epub 2006 Jan 26.
1068 RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):e36-e47. doi: 10.1161/ATVBAHA.117.310656. Epub 2018 Feb 15.
1069 RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.Nat Commun. 2015 Mar 18;6:6614. doi: 10.1038/ncomms7614.
1070 RGS3 inhibits TGF-1/Smad signalling in adventitial fibroblasts.Cell Biochem Funct. 2017 Aug;35(6):334-338. doi: 10.1002/cbf.3280.
1071 Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.Cardiovasc Res. 2021 Jan 1;117(1):240-255. doi: 10.1093/cvr/cvz268.
1072 Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis.Acta Pharmacol Sin. 2018 Jul;39(7):1243-1248. doi: 10.1038/aps.2018.8. Epub 2018 Mar 22.
1073 Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages.Atherosclerosis. 2019 Feb;281:128-136. doi: 10.1016/j.atherosclerosis.2018.12.009. Epub 2018 Dec 19.
1074 Active principle of kimchi, 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid, retards fatty streak formation at aortic sinus of apolipoprotein E knockout mice.J Med Food. 2009 Dec;12(6):1206-12. doi: 10.1089/jmf.2009.0034.
1075 The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents.Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):e113-6. doi: 10.1161/01.ATV.0000170130.85334.38. Epub 2005 May 12.
1076 Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer.J Proteomics. 2017 Feb 5;153:21-29. doi: 10.1016/j.jprot.2016.11.006. Epub 2016 Nov 11.
1077 Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis.Clin Exp Dermatol. 2018 Apr;43(3):262-267. doi: 10.1111/ced.13370. Epub 2018 Jan 14.
1078 Editorial: dose-dependent ZnO particle-induced acute phase response in humans warrants re-evaluation of occupational exposure limits for metal oxides.Part Fibre Toxicol. 2018 Feb 12;15(1):7. doi: 10.1186/s12989-018-0247-3.
1079 Atherin: a newly identified, lesion-specific, LDL-binding protein in human atherosclerosis.Atherosclerosis. 2005 Oct;182(2):219-30. doi: 10.1016/j.atherosclerosis.2005.01.041.
1080 A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic.PLoS One. 2017 Mar 29;12(3):e0173880. doi: 10.1371/journal.pone.0173880. eCollection 2017.
1081 SASH1, a new potential link between smoking and atherosclerosis.Atherosclerosis. 2015 Oct;242(2):571-9. doi: 10.1016/j.atherosclerosis.2015.08.013. Epub 2015 Aug 14.
1082 Knockdown of SCARA5 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppression of the PDGF signaling pathway.Mol Med Rep. 2016 May;13(5):4455-60. doi: 10.3892/mmr.2016.5074. Epub 2016 Mar 30.
1083 Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E??mice without influencing systemic atherosclerosis.Cardiovasc Res. 2015 Jan 1;105(1):96-106. doi: 10.1093/cvr/cvu237. Epub 2014 Nov 5.
1084 Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.J Biol Chem. 2018 Jun 15;293(24):9223-9231. doi: 10.1074/jbc.RA118.002290. Epub 2018 Apr 26.
1085 miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress.Biomed Res Int. 2015;2015:497280. doi: 10.1155/2015/497280. Epub 2015 Jun 28.
1086 A trimetallic CuAuPd nanowire as a multifunctional nanocomposites applied to ultrasensitive electrochemical detection of Sema3E.Biosens Bioelectron. 2019 Dec 1;145:111677. doi: 10.1016/j.bios.2019.111677. Epub 2019 Sep 6.
1087 miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1.Cell Cycle. 2019 Mar-Apr;18(6-7):682-695. doi: 10.1080/15384101.2019.1580493. Epub 2019 Mar 20.
1088 Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke.J Cell Mol Med. 2019 Apr;23(4):2901-2906. doi: 10.1111/jcmm.14186. Epub 2019 Feb 7.
1089 SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.FASEB J. 2019 Jan;33(1):163-174. doi: 10.1096/fj.201800353R. Epub 2018 Jul 3.
1090 Visceral adipose tissue-derived serine protease inhibitor accelerates cholesterol efflux by up-regulating ABCA1 expression via the NF-B/miR-33a pathway in THP-1 macropahge-derived foam cells.Biochem Biophys Res Commun. 2018 Jun 2;500(2):318-324. doi: 10.1016/j.bbrc.2018.04.066. Epub 2018 Apr 17.
1091 Tet3 enhances IL-6 expression through up-regulation of 5-hmC in IL-6 promoter in chronic hypoxia induced atherosclerosis in offspring rats.Life Sci. 2019 Sep 1;232:116601. doi: 10.1016/j.lfs.2019.116601. Epub 2019 Jun 25.
1092 Effect of SFRP5 (Secreted Frizzled-Related Protein 5) on the WNT5A (Wingless-Type Family Member 5A)-Induced Endothelial Dysfunction and Its Relevance With Arterial Stiffness in Human Subjects.Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1358-1367. doi: 10.1161/ATVBAHA.117.310649. Epub 2018 Apr 19.
1093 Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.Thorax. 2017 May;72(5):472-474. doi: 10.1136/thoraxjnl-2016-209568. Epub 2017 Jan 27.
1094 Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response.EBioMedicine. 2019 Jul;45:578-587. doi: 10.1016/j.ebiom.2019.06.038. Epub 2019 Jun 28.
1095 Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.Eur J Med Chem. 2019 Feb 1;163:864-882. doi: 10.1016/j.ejmech.2018.12.028. Epub 2018 Dec 13.
1096 Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.Thromb Haemost. 2018 Nov;118(11):1940-1950. doi: 10.1055/s-0038-1673613. Epub 2018 Oct 8.
1097 IL-37 inhibits the maturation of dendritic cells through the IL-1R8-TLR4-NF-B pathway.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1338-1349. doi: 10.1016/j.bbalip.2019.05.009. Epub 2019 May 21.
1098 Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose.Life Sci. 2019 Jan 1;216:189-199. doi: 10.1016/j.lfs.2018.11.049. Epub 2018 Nov 22.
1099 SIRT7 Regulates the Vascular Smooth Muscle Cells Proliferation and Migration via Wnt/-Catenin Signaling Pathway.Biomed Res Int. 2018 Dec 4;2018:4769596. doi: 10.1155/2018/4769596. eCollection 2018.
1100 Intima-Media Thickness in the Carotid and Femoral Arteries for Detection of Arteriosclerosis in Human Immunodeficiency Virus-Positive Individuals.Arq Bras Cardiol. 2017 Jan;108(1):3-11. doi: 10.5935/abc.20160197.
1101 Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.Nucleus. 2016 Nov;7(6):560-571. doi: 10.1080/19491034.2016.1255835.
1102 Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.Lipids Health Dis. 2011 Jan 17;10:7. doi: 10.1186/1476-511X-10-7.
1103 Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects.Int J Cardiovasc Imaging. 2019 May;35(5):947-954. doi: 10.1007/s10554-019-01527-7. Epub 2019 Feb 2.
1104 Identification of CAD candidate genes in GWAS loci and their expression in vascular cells.J Lipid Res. 2013 Jul;54(7):1894-905. doi: 10.1194/jlr.M037085. Epub 2013 May 10.
1105 SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.Biochem Biophys Res Commun. 2018 Jun 22;501(2):343-350. doi: 10.1016/j.bbrc.2018.03.137. Epub 2018 May 11.
1106 Polymorphic variants of extracellular superoxide dismutase gene in a Romanian population with atheroma.Biochem Genet. 2008 Oct;46(9-10):634-43. doi: 10.1007/s10528-008-9177-3. Epub 2008 Aug 26.
1107 MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma.Oncol Rep. 2016 Nov;36(5):2884-2892. doi: 10.3892/or.2016.5102. Epub 2016 Sep 19.
1108 Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis.J Cell Mol Med. 2005 Jan-Mar;9(1):153-9. doi: 10.1111/j.1582-4934.2005.tb00345.x.
1109 'Blow my mind(in)' - mindin neutralization for the prevention of atherosclerosis?.Clin Sci (Lond). 2018 Jul 23;132(14):1509-1512. doi: 10.1042/CS20180358. Print 2018 Jul 31.
1110 Spexin Levels Are Associated with Metabolic Syndrome Components.Dis Markers. 2018 Sep 4;2018:1679690. doi: 10.1155/2018/1679690. eCollection 2018.
1111 Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase.Free Radic Res. 2015 Jun;49(6):743-9. doi: 10.3109/10715762.2015.1019347. Epub 2015 Mar 27.
1112 Down-regulation of single-stranded DNA-binding protein 1 expression induced by HCMV infection promotes lipid accumulation in cells.Braz J Med Biol Res. 2017 Sep 12;50(11):e6389. doi: 10.1590/1414-431X20176389.
1113 Low-dose phloretin alleviates diabetic atherosclerosis through endothelial KLF2 restoration.Biosci Biotechnol Biochem. 2020 Apr;84(4):815-823. doi: 10.1080/09168451.2019.1699396. Epub 2019 Dec 3.
1114 ST6GAL1 negatively regulates monocyte transendothelial migration and atherosclerosis development.Biochem Biophys Res Commun. 2018 Jun 2;500(2):249-255. doi: 10.1016/j.bbrc.2018.04.053. Epub 2018 Apr 16.
1115 Novel Computational Approaches to Developing Potential STAT4 Silencing siRNAs for Immunomodulation of Atherosclerosis.Curr Comput Aided Drug Des. 2020;16(5):599-604. doi: 10.2174/1573409915666191018125653.
1116 Stamp2 controls macrophage inflammation through nicotinamide adenine dinucleotide phosphate homeostasis and protects against atherosclerosis.Cell Metab. 2012 Jul 3;16(1):81-9. doi: 10.1016/j.cmet.2012.05.009. Epub 2012 Jun 14.
1117 STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1723-1737. doi: 10.1161/ATVBAHA.118.311241.
1118 STRIP2 silencing inhibits vascular smooth muscle cell proliferation and migration via P38-AKT-MMP-2 signaling pathway.J Cell Physiol. 2019 Dec;234(12):22463-22476. doi: 10.1002/jcp.28810. Epub 2019 May 15.
1119 Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.JAMA Cardiol. 2019 Jan 1;4(1):25-33. doi: 10.1001/jamacardio.2018.3965.
1120 European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction.Arterioscler Thromb Vasc Biol. 1995 Jan;15(1):96-104. doi: 10.1161/01.atv.15.1.96.
1121 Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation.J Mol Cell Cardiol. 2019 Mar;128:62-76. doi: 10.1016/j.yjmcc.2019.01.004. Epub 2019 Jan 11.
1122 Silencing of CD40 invivo reduces progression of experimental atherogenesis through an NF-B/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.Atherosclerosis. 2016 Dec;255:80-89. doi: 10.1016/j.atherosclerosis.2016.11.002. Epub 2016 Nov 2.
1123 Thioredoxin and related molecules--from biology to health and disease.Antioxid Redox Signal. 2007 Jan;9(1):25-47. doi: 10.1089/ars.2007.9.25.
1124 T-box20 suppresses oxidized low-density lipoprotein-induced human vascular endothelial cell injury by upregulation of PPAR-.Cell Physiol Biochem. 2013;32(5):1137-50. doi: 10.1159/000354514. Epub 2013 Nov 11.
1125 Cardiac Endothelial Cell Transcriptome.Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):566-574. doi: 10.1161/ATVBAHA.117.310549. Epub 2018 Jan 4.
1126 TFEB drives PGC-1 expression in adipocytes to protect against diet-induced metabolic dysfunction.Sci Signal. 2019 Nov 5;12(606):eaau2281. doi: 10.1126/scisignal.aau2281.
1127 Tissue Factor Pathway Inhibitor-2 Gene Polymorphisms Associate With Coronary Atherosclerosis in Chinese Population.Medicine (Baltimore). 2015 Oct;94(42):e1675. doi: 10.1097/MD.0000000000001675.
1128 Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.Cardiovasc Res. 2015 Mar 1;105(3):361-71. doi: 10.1093/cvr/cvv003. Epub 2015 Jan 12.
1129 Sequence variation in TMEM18 in association with body mass index: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.Circ Cardiovasc Genet. 2014 Jun;7(3):344-9. doi: 10.1161/CIRCGENETICS.13.000067.
1130 Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis.FASEB J. 2001 Feb;15(2):458-66. doi: 10.1096/fj.00-0051com.
1131 Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis.Int J Mol Sci. 2018 Feb 5;19(2):465. doi: 10.3390/ijms19020465.
1132 TIPE1 accelerates atherogenesis by inducing endothelial dysfunction in response to oxidative stress.Biochim Biophys Acta Mol Basis Dis. 2020 Jan 1;1866(1):165578. doi: 10.1016/j.bbadis.2019.165578. Epub 2019 Oct 28.
1133 TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway.Exp Ther Med. 2019 Apr;17(4):2937-2944. doi: 10.3892/etm.2019.7316. Epub 2019 Feb 26.
1134 Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.J Am Heart Assoc. 2017 Apr 10;6(4):e004078. doi: 10.1161/JAHA.116.004078.
1135 Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.Circulation. 2010 May 11;121(18):2033-44. doi: 10.1161/CIRCULATIONAHA.109.895037. Epub 2010 Apr 26.
1136 The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.J Clin Invest. 2008 Sep;118(9):3025-37. doi: 10.1172/JCI30836.
1137 Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.Biochimie. 2016 May;124:34-52. doi: 10.1016/j.biochi.2016.02.005. Epub 2016 Feb 6.
1138 TRIM14 promotes endothelial activation via activating NF-B signaling pathway.J Mol Cell Biol. 2020 Apr 24;12(3):176-189. doi: 10.1093/jmcb/mjz040.
1139 Metabolic profiling of intra- and extracranial carotid artery atherosclerosis.Atherosclerosis. 2018 May;272:60-65. doi: 10.1016/j.atherosclerosis.2018.03.015. Epub 2018 Mar 8.
1140 Adiponectin Regulation and Function.Compr Physiol. 2018 Jun 18;8(3):1031-1063. doi: 10.1002/cphy.c170046.
1141 Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart: IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS.J Biol Chem. 2016 Sep 9;291(37):19413-24. doi: 10.1074/jbc.M116.741454. Epub 2016 Jul 19.
1142 Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.Nat Genet. 2005 Apr;37(4):365-72. doi: 10.1038/ng1524. Epub 2005 Mar 6.
1143 CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.Atherosclerosis. 2018 Nov;278:197-209. doi: 10.1016/j.atherosclerosis.2018.09.037. Epub 2018 Sep 28.
1144 Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice.Mol Cell Biochem. 2019 May;455(1-2):99-108. doi: 10.1007/s11010-018-3473-y. Epub 2018 Nov 13.
1145 Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program.Am Heart J. 2019 Jul;213:47-56. doi: 10.1016/j.ahj.2019.04.004. Epub 2019 Apr 15.
1146 Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. EARS Group.J Lipid Res. 1999 Feb;40(2):287-94.
1147 HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.Matrix Biol. 2017 Nov;63:69-90. doi: 10.1016/j.matbio.2017.01.003. Epub 2017 Jan 23.
1148 Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.J Lipid Res. 2002 Jun;43(6):872-7.
1149 A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis.J Intern Med. 2019 Jan;285(1):118-123. doi: 10.1111/joim.12819. Epub 2018 Aug 28.
1150 Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.Nat Commun. 2018 Jun 12;9(1):2292. doi: 10.1038/s41467-018-04602-0.
1151 Unaltered mRNA expression of calcitonin-like receptor and receptor activity modifying proteins in human arteries in stroke and myocardial infarction.Ideggyogy Sz. 2007 Nov 30;60(11-12):459-66.
1152 Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events Among African Americans in 2 Large Cohort Studies.Circ Cardiovasc Genet. 2017 Apr;10(2):e001569. doi: 10.1161/CIRCGENETICS.116.001569.
1153 Vinexin Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor B Inflammatory Axis.J Am Heart Assoc. 2017 Feb 16;6(2):e004585. doi: 10.1161/JAHA.116.004585.
1154 Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis.Singapore Med J. 2019 Apr;60(4):210-215. doi: 10.11622/smedj.2018123. Epub 2018 Oct 10.